1. ABERKANE, A., ESSAHIB, W., SPITS, C., DE PAEPE, C., SERMON, K., ADRIAENSSENS, T., MACKENS, S., TOURNAYE, H., BROSENS, J. J. & VAN DE VELDE, H. 2018. Expression of adhesion and extracellular matrix genes in human blastocysts upon attachment in a 2D co-culture system. Molecular Human Reproduction, 24, 375-387. (IF 3.449)
2. BELVA, F., BONDUELLE, M., PROVYN, S., PAINTER, R. C., TOURNAYE, H., ROELANTS, M. & DE SCHEPPER, J. 2018. Metabolic Syndrome and Its Components in Young Adults Conceived by ICSI. Int J Endocrinol, 2018, 8170518. (IF 2.340)
3. BELVA, F., DE SCHEPPER, J., ROELANTS, M., TOURNAYE, H., BONDUELLE, M. & PROVYN, S. 2018. Body fat content, fat distribution and adipocytokine production and their correlation with fertility markers in young adult men and women conceived by intracytoplasmic sperm injection (ICSI). Clin Endocrinol (Oxf), 88, 985-992. (IF 3.077)
4. DE VOS, A., SANTOS-RIBEIRO, S., VAN LANDUYT, L., VAN DE VELDE, H., TOURNAYE, H. & VERHEYEN, G. 2018. Birthweight of singletons born after cleavage-stage or blastocyst transfer in fresh and warming cycles. Hum Reprod, 33, 196-201. (IF 4.990)
5. DE VOS, M., PAREYN, S., DRAKOPOULOS, P., RAIMUNDO, J. M., ANCKAERT, E., SANTOS-RIBEIRO, S., POLYZOS, N. P., TOURNAYE, H. & BLOCKEEL, C. 2018. Cumulative live birth rates after IVF in patients with polycystic ovaries: phenotype matters. Reprod Biomed Online, 37, 163-171. (IF 2.967)
6. DONFACK, N. J., ALVES, K. A., ALVES, B. G., ROCHA, R. M. P., BRUNO, J. B., BERTOLINI, M., DOS SANTOS, R. R., DOMINGUES, S. F. S., DE FIGUEIREDO, J. R., SMITZ, J. & RODRIGUES, A. P. R. 2018. Stroma cell-derived factor 1 and connexins (37 and 43) are preserved after vitrification and in vitro culture of goat ovarian cortex. Theriogenology, 116, 83-88. (IF 2.136)
7. DONFACK, N. J., ALVES, K. A., ALVES, B. G., ROCHA, R. M. P., BRUNO, J. B., LIMA, L. F., LOBO, C. H., SANTOS, R. R., DOMINGUES, S. F. S., BERTOLINI, M., SMITZ, J. & RODRIGUES, A. P. R. 2018. In vivo and in vitro strategies to support caprine preantral follicle development after ovarian tissue vitrification. Reprod Fertil Dev, 30, 8, 1055-1065. (IF 2.105)
8. DRAKOPOULOS, P., ROSETTI, J., PLUCHINO, N., BLOCKEEL, C., SANTOS-RIBEIRO, S., DE BRUCKER, M., DRAKAKIS, P., CAMUS, M., TOURNAYE, H. & POLYZOS, N. P. 2018. Does the type of GnRH analogue used, affect live birth rates in women with endometriosis undergoing IVF/ICSI treatment, according to the rAFS stage? Gynecol Endocrinol, 1-6. (IF 1.453)
9. DRAKOPOULOS, P., SANTOS-RIBEIRO, S., BOSCH, E., GARCIA-VELASCO, J., BLOCKEEL, C., ROMITO, A., TOURNAYE, H. & POLYZOS, N. P. 2018. The Effect of Dose Adjustments in a Subsequent Cycle of Women With Suboptimal Response Following Conventional Ovarian Stimulation. Front Endocrinol (Lausanne), 9, 361. (IF 3.519)
10. ERRÁZURIZ, J., RACCA, A., SCHUTYSER, V., FREDERIX, B. & BLOCKEEL, C. 2018. Cornual twin pregnancy in reproductive medicine. Ultrasound Obstet Gynecol, 52: 287–288. (IF 5.654)
11. GRIESINGER, G., BLOCKEEL, C. & TOURNAYE, H. 2018. Oral dydrogesterone for luteal phase support in fresh in vitro fertilization cycles: a new standard? Fertil Steril, 109, 756-762. (IF 4.803)
12. GUERREIRO, D. D., DE LIMA, L. F., MBEMYA, G. T., MASIDE, C. M., MIRANDA, A. M., TAVARES, K. C. S., ALVES, B. G., FAUSTINO, L. R., SMITZ, J., DE FIGUEIREDO, J. R. & RODRIGUES, A. P. R. 2018. ATP-binding cassette (ABC) transporters in caprine preantral follicles: gene and protein expression. Cell Tissue Res, 372, 611-620. (IF 3.043)
13. HARPER, J. C., AITTOMÄKI, K., BORRY, P., CORNEL, M. C., DE WERT, G., DONDORP, W., GERAEDTS, J., GIANAROLI, L., KETTERSON, K., LIEBAERS, I., LUNDIN, K., MERTES, H., MORRIS, M., PENNINGS, G., SERMON, K., SPITS, C., SOINI, S., VAN MONTFOORT, A. P. A., VEIGA, A., VERMEESCH, J. R., VIVILLE, S., MACEK, M., on behalf of the ESHRE and ESHG, 2018. Recent developments in genetics and medically assisted reproduction: from research to clinical applications. Eur J Hum Genet., 1:12-33 (IF 3.636) 
14. HERTA, A. C., LOLICATO, F. & SMITZ, J. E. J. 2018. follicle culture in the context of IVF. Reproduction, 156, F59-F73. (IF 3.086)
15. JANS, V., DONDORP, W., GOOSSENS, E., MERTES, H., PENNINGS, G. & DE WERT, G. 2018. Balancing animal welfare and assisted reproduction: ethics of preclinical animal research for testing new reproductive technologies. Med Health Care Philos. (IF 1.407) (open access)
16. KELLER, A., DZIEDZICKA, D., ZAMBELLI, F., MARKOULI, C., SERMON, K., SPITS, C. & GEENS, M. 2018. Genetic and epigenetic factors which modulate differentiation propensity in human pluripotent stem cells. Hum Reprod Update, 24, 162-175. (IF 11.852)
17. LA MARCA, A., BLOCKEEL, C., BOSCH, E., FANCHIN, R., FATEMI, H. M., FAUSER, B. C., GARCÍA-VELASCO, J. A., HUMAIDAN, P., TARLATZIS, B. C. & NELSON, S. M. 2018. Corrigendum: Letter to the Editor: Individualized FSH dosing improves safety and reduces iatrogenic poor response while maintaining live-birth rates. Hum Reprod, 33, 982-983. (IF 4.9990)
18. LEAL, É., VIEIRA, L. A., SÁ, N. A. R., SILVA, G. M., LUNARDI, F. O., FERREIRA, A.C. A., CAMPELLO, C. C., ALVES, B. G., CIBIN, F. W. S., SMITZ, J.,FIGUEIREDO, J. R. & RODRIGUES, A. P. R. 2018. In vitro growth and development of isolated secondary follicles from vitrified caprine ovariancortex. Reprod Fertil Dev. 30, 359-370 (IF 2.105)
19. MATEIZEL, I., VERHEYEN, G., VAN DE VELDE, H., TOURNAYE, H. & BELVA, F. 2018. Obstetric and neonatal outcome following ICSI with assisted oocyte activation by calcium ionophore treatment. J Assist Reprod Genet, 35, 1005-1010. (IF 2.788)
20. MEDRANO, J., ANDRES, M., GARCIA, S., HERRAIZ, S., VILANOVA-PEREZ, T., GOOSSENS, E. & PELLICER, A. 2018. Basic and Clinical Approaches for Fertility Preservation and Restoration in Cancer Patients. Trends in Biotechnology, 36, 199-215. (IF 13.578)
21. MISHRA, S., KACIN, E., STAMATIADIS, P., FRANCK, S., VAN DER JEUGHT, M., MERTES, H., PENNINGS, G., DE SUTTER, P., SERMON, K., HEINDRYCKX, B. & GEENS, M. 2018. The role of the reprogramming method and pluripotency state in gamete differentiation from patient-specific human pluripotent stem cells. Mol Hum Reprod, 24, 173-184. (IF 3.449)
22. ONOFRE, J., FAES, K., KADAM, P., VICINI, E., VAN PELT, A. M. M. & GOOSSENS, E. 2018. What is the best protocol to cryopreserve immature mouse testicular cell suspensions? Reprod Biomed Online, 37, 6-17. (IF 2.967)
23. PAPANIKOLAOU, E., YARALI, H., TIMOTHEOU, E., GRYNBERG, M., ZAFEIRATIS, O., TOURNAYE, H. & NAJDECKI, R. 2018. A Proof-of-Concept Clinical Trial of A Single Luteal Use of Long-Acting Gonadotropin-Releasing Hormone Antagonist Degarelix in Controlled Ovarian Stimulation for In Vitro Fertilization: Long Antagonist Protocol. Frontiers in Endocrinology, 9, 1-7. (IF 3.519) (open access)
24. PENNINGS, G., SEGERS, S., DEBROCK, S., HEINDRYCKX, B., KONTOZOVA-DEUTSCH, V., PUNJABI, U., VAN DE VELDE, H., VAN STEIRTEGHEM, A. & MERTES, H. 2018. Onderzoek op menselijke embryo's in België: een overzicht. Tijdschrift voor Geneeskunde, 74, 5, 316-323
25. POLYZOS, N. P., DAVIS, S. R., DRAKOPOULOS, P., HUMAIDAN, P., DE GEYTER, C., VEGA, A. G., MARTINEZ, F., EVANGELOU, E., VAN DE VIJVER, A., SMITZ, J., TOURNAYE, H., BARRI, P. & GROUP, T. T. I. 2018. Testosterone for Poor Ovarian Responders: Lessons From Ovarian Physiology. Reproductive Sciences, 25, 980-982. (IF 2.548)
26. POPOVIC-TODOROVIC, B., RACCA, A. & BLOCKEEL, C. 2018. Added value today of hormonal measurements in ovarian stimulation in gonadotropin-releasing hormone antagonist treatment cycle. Curr Opin Obstet Gynecol, 30, 145-150. (IF 2.821)
27. RACCA, A., SANTOS-RIBEIRO, S., DE MUNCK, N., MACKENS, S., DRAKOPOULOS, P., CAMUS, M., VERHEYEN, G., TOURNAYE, H. & BLOCKEEL, C. 2018. Impact of late-follicular phase elevated serum progesterone on cumulative live birth rates: is there a deleterious effect on embryo quality? Hum Reprod, 33, 860-868. (IF 4.990)
28. RIBEIRO, V., SANTOS-RIBEIRO, S., DE MUNCK, N., DRAKOPOULOS, P., POLYZOS, N., SCHUTYSER, V., VERHEYEN, G., TOURNAYE, H. & BLOCKEEL, C. 2018. Should we continue to measure endometrial thickness in modern-day medicine? The effect on live birth rates and birth weight. Reprod Biomed Online, 36, 416-426. (IF 2.967)
29. ROMBAUT, C., MERTES, H., HEINDRYCKX, B. & GOOSSENS, E. 2018. HUMAN IN-VITRO SPERMATOGENESIS FROM PLURIPOTENT STEM CELLS: IN NEED OF A STEPWISE DIFFERENTIATION PROTOCOL? Mol Hum Reprod., 24, 47-54 (IF 3.449)
30. SLOPIEN, R., PLUCHINO, N., WARENIK-SZYMANKIEWICZ, A., SAJDAK, S., LUISI, M., DRAKOPOULOS, P. & GENAZZANI, A. 2018. Correlation between allopregnanolone levels and depressive symptoms during late menopausal transition and early postmenopause. Gynecological Endocrinology, 34, 144-147. (IF 1.453)
31. STOUFFS, K., STERGACHIS, A. B., VANDERHASSELT, T., DICA, A., JANSSENS, S., VANDERVORE, L., GHELDOF, A., BODAMER, O., KEYMOLEN, K., SENECA, S., LIEBAERS, I., JAYARAMAN, D., HILL, H. E., PARTLOW, J. N., WALSH, C. A. & JANSEN, A. C. 2018. Expanding the clinical spectrum of biallelic ZNF335 variants. Clinical Genetics, 94, 246-251. (IF 3.512)
32. UVIN, V., DE BRUCKER, S., DE BRUCKER, M., VLOEBERGHS, V., DRAKOPOULOS, P., SANTOS-RIBEIRO, S. & TOURNAYE, H. 2018. Pregnancy after vasectomy: surgical reversal or assisted reproduction? Hum Reprod, 33, 1218-1227. (IF 4.990)
33. VAN MALDEREN, S., DANEELS, D., KERKHOVE, D., PEETERS, U., THEUNS, D., DROOGMANS, S., VAN CAMP, G., WEYTJENS, C., BIERVLIET, M., BONDUELLE, M., VAN DOOREN, S. & BRUGADA, P. 2018. Prolonged Right Ventricular Ejection Delay in Brugada Syndrome Depends on the Type of SCN5A Variant - Electromechanical Coupling Through Tissue Velocity Imaging as a Bridge Between Genotyping and Phenotyping. Circulation Journal, 82, 53-61. (IF 2.895)
34. VAN SAEN, D., VLOEBERGHS, V., GIES, I., MATEIZEL, I., SERMON, K., DE SCHEPPER, J., TOURNAYE, H. & GOOSSENS, E. 2018. When does germ cell loss and fibrosis occur in patients with Klinefelter syndrome? Hum Reprod, 33, 1009-1022. (IF 4.990)
35. VLOEBERGHS, V., VERHEYEN, G., SANTOS-RIBEIRO, S., STAESSEN, C., VERPOEST, W., GIES, I. & TOURNAYE, H. 2018. Is genetic fatherhood within reach for all azoospermic Klinefelter men? PLoS One, 13, e0200300. (IF 2.766)
36. ZAMBELLI, F., MERTENS, J., DZIEDZICKA, D., STERCKX, J., MARKOULI, C., KELLER, A., TROPEL, P., JUNG, L., VIVILLE, S., VAN DE VELDE, H., GEENS, M., SENECA, S., SERMON, K. & SPITS, C. 2018. Random Mutagenesis, Clonal Events, and Embryonic or Somatic Origin Determine the mtDNA Variant Type and Load in Human Pluripotent Stem Cells. Stem Cell Reports, 11, 102-114. (IF 6.537)
37.            

Internationale-, nationale tijdschriften

Impact factor 2017

1. ANDERSEN A.N., NELSON, S. M., FAUSER, B. C. J. M., GARCIA-VELASCO, J. A., KLEIN,B. M., ARCE, J.-C. & ESTHER-1 STUDY, G. 2017. Individualized versusconventional ovarian stimulation for in vitro fertilization: a multicenter,randomized, controlled, assessor-blinded, phase 3 noninferiority trial. Fertil Steril, 107(2), 387-396. (IF 4.803)
2. APTER, S., BALABAN, B., CAMPBELL, A., CATT, J., COTICCHIO, G., DE LOS SANTOS, M., DEBROCK, S., EBNER, T., HARBOTTLE, S., HUGHES, C., JANSSENS, R., LE CTEF, N., LUNDIN, K., MAGLI, C., MORTIMER, D., MORTIMER, S., NAGY, Z., SMITZ, J., SUNDE, A., VERMEULEN, N. & EMBRYOL, E. S. I. G. 2017. The Vienna consensus: report of an expert meeting on the development of ART laboratory performance indicators. Reproductive Biomed Online, 35, 494-510. (IF 3.249)
3. BAERT, Y. & GOOSSENS, E. 2017. Preparation of Scaffolds from DecellularizedTesticular Matrix. Methods Mol Biol, book series. Humana Press, pp 1-7.
4. BAERT, Y., ROMBAUT, C. & GOOSSENS, E. 2017b. Scaffold-Based and Scaffold-FreeTesticular Organoids from Primary Human Testicular Cells. Methods Mol Biol, book series. Humana Press, pp 1-8.
5. BAERT, Y., DE KOCK, J., ALVES-LOPES, J. P., SÖDER, O., STUKENBORG, J. B. & GOOSSENS, E. 2017. Primary Human Testicular Cells Self-Organize into Organoids with Testicular Properties. Stem Cell Reports, 8, 30-38. (IF 7.338)
6. BARBERINO, R. S., MENEZES, V. G., RIBEIRO, A. E. A. S., PALHETA, R. C., JIANG, X., SMITZ,J. E. J. & MATOS, M. H. T. 2017. Melatonin protects againstcisplatin-induced ovarian damage in mice via the MT1 receptor andantioxidant activity. Biol Reprod, 96, 1244-1255. (IF 3.184)
7. BARBÉ, L., LANNI, S., LÓPEZ-CASTEL, A., FRANCK, S., SPITS, C., KEYMOLEN, K.,SENECA, S., TOMÉ, S., MIRON, I., LETOURNEAU, J., LIANG, M., CHOUFANI, S.,WEKSBERG, R., WILSON, M. D., SEDLACEK, Z., GAGNON, C., MUSOVA, Z.,CHITAYAT, D., SHANNON, P., MATHIEU, J., SERMON, K. & PEARSON, C. E.2017. CpG Methylation, a Parent-of-Origin Effect for Maternal-BiasedTransmission of Congenital Myotonic Dystrophy. Am J Hum Genet, 100, 488-505. (IF 8.855)
8. BARRATT, C. L. R., BJÖRNDAHL, L., DE JONGE, C. J., LAMB, D. J., OSORIO MARTINI, F.,MCLACHLAN, R., OATES, R. D., VAN DER POEL, S., ST JOHN, B., SIGMAN, M.,SOKOL, R. & TOURNAYE, H. 2017. The diagnosis of male infertility: ananalysis of the evidence to support the development of global WHOguidance-challenges and future research opportunities. Hum Reprod Update, 23(6): 660-680. (IF 11.852)
9. BELVA, F., ROELANTS, M., VLOEBERGHS, V., SCHIETTECATTE, J., EVENEPOEL, J.,BONDUELLE, M. & DE VOS, M. 2017. Serum reproductive hormone levels andultrasound findings in female offspring after intracytoplasmic sperminjection: first results. Fertil Steril, 107(4): 934-939. (IF 4.803)
10. BELVA, F., ROELANTS, M., DE SCHEPPER, J., VAN STEIRTEGHEM, A., TOURNAYE, H. & BONDUELLE, M. 2017. Reproductive hormones of ICSI-conceived young adult men: the first results. Hum Reprod, 32, 439-446. (IF 5.020)
11. BLOCKEEL, C., DRAKOPOULOS, P., POLYZOS, N. P., TOURNAYE, H. & GARCÍA-VELASCO, J.A. 2017. Review the 'peer review'. Reprod Biomed Online, 35(6):747-749. (IF: 2.967)
12. CADENAS, J., LEIVA-REVILLA, J., VIEIRA, L. A., APOLLONI, L. B., AGUIAR, F. L., ALVES,B. G., LOBO, C. H., RODRIGUES, A. P., APGAR, G. A., SMITZ, J., FIGUEIREDO,J. R. & MASIDE, C. 2017. Caprine ovarian follicle requirements differbetween preantral and early antral stages after IVC in medium supplementedwith GH and VEGF alone or in combination. Theriogenology, 87, 321-332. (IF 2.136)
13. CANOSA, S., ADRIAENSSENS, T., COUCKE, W., DALMASSO, P., REVELLI, A., BENEDETTO, C.& SMITZ, J. 2017. Zona pellucida gene mRNA expression in human oocytesis related to oocyte maturity, zona inner layer retardance andfertilization competence. Mol Hum Reprod, 23,292-303. (IF 3.449)
14. DAHHAN, T., BALKENENDE, E. M. E., BEERENDONK, C. C. M., FLEISCHER, K., STOOP, D.,BOS, A. M. E., LAMBALK, C. B., SCHATS, R., VAN GOLDE, R. J. T., SCHIPPER,I., LOUWE, L. A., CANTINEAU, A. E. P., SMEENK, J. M. J., DE BRUIN, J. P.,REDDY, N., KOPEIKA, Y., VAN DER VEEN, F., VAN WELY, M., LINN, S. C. &GODDIJN, M. 2017. Stimulation of the ovaries in women with breast cancerundergoing fertility preservation: Alternative versus standard stimulationprotocols; the study protocol of the STIM-trial. Contemporary Clinical Trials, 61, 96-100. (IF 2.658)
15. DE MUNCK, N. & VAJTA, G. 2017. Safety and efficiency of oocyte vitrification. Cryobiology, 78, 119-127. (IF: 2.050)
16. DERKS-SMEETS, I. A. P., VAN TILBORG, T. C., VAN MONTFOORT, A., SMITS, L., TORRANCE, H. L.,MEIJER-HOOGEVEEN, M., BROEKMANS, F., DREESEN, J. C. F. M., PAULUSSEN, A. D.C., TJAN-HEIJNEN, V. C. G., HOMMINGA, I., VAN DEN BERG, M. M. J., AUSEMS,M. G. E. M., DE RYCKE, M., DE DIE-SMULDERS, C. E. M., VERPOEST, W. &VAN GOLDE, R. 2017. BRCA1 mutation carriers have a lower number of matureoocytes after ovarian stimulation for IVF/PGD. J Assist Reprod Genet. Open access. 34 (11):1475-1482. (IF 2.788)
17. DE RYCKE, M., GOOSSENS, V., KOKKALI, G., MEIJER-HOOGEVEEN, M., COONEN, E. &MOUTOU, C. 2017. ESHRE PGD Consortiumdata collection XIV-XV: cycles fromJanuary 2011 to December 2012 with pregnancy follow-up to October 2013. Hum Reprod, 32, 1974-1994. (IF 4.990)
18. DE WACHTER, E., THOMAS, M., WANYAMA, S. S., SENECA, S. & MALFROOT, A. 2017. What can the CF registry tell us about rare CFTR-mutations? A Belgian study. Orphanet Journal of Rare Diseases, 12:142. (IF 5.680) (open access)
19. DONFACK, N. J., ALVES, K. A., ARAÚJO, V. R., CORDOVA, A., FIGUEIREDO, J. R., SMITZ, J.& RODRIGUES, A. P. R. 2017. Expectations and limitations of ovariantissue transplantation. Zygote, 25, 391-403. (IF 1.114)
20. DONKER, R. B., VLOEBERGHS, V., GROEN, H., TOURNAYE, H., VAN RAVENSWAAIJ-ARTS, C. M. A.& LAND, J. A. 2017. Chromosomal abnormalities in 1663 infertile menwith azoospermia: the clinical consequences. Hum Reprod, 32, 2574-2580. (IF 4.990)
21. DRAKOPOULOS, P., MAT, C., POLYZOS, N. P., SANTOS-RIBEIRO, S., VAN DE VIJVER, A., VANLANDUYT, L., TOURNAYE, H. & BLOCKEEL, C. 2017. The impact of elevatedprogesterone at the initiation of an artificially prepared frozen embryotransfer cycle: a case series. Curr Pharm Biotechnol , 18, 619-621. (IF 1.819)
22. DRAKOPOULOS, P., VAN DE VIJVER, A., SCHUTYSER, V., MILATOVIC, S., ANCKAERT, E.,SCHIETTECATTE, J., BLOCKEEL, C., CAMUS, M., TOURNAYE, H. & POLYZOS, N.P. 2017. The effect of serum vitamin D levels on ovarian reserve markers: aprospective cross-sectional study. Hum Reprod, 32 , 208-214. (IF 4.990)
23. DRAKOPOULOS, P., LA MARCA, A. & POLYZOS, N. P. 2017. Vitamin D and ovarian reserve: making clinical decisions. Hum Reprod, 32, 1138-1139. (IF 5.020)
24. DRAKOPOULOS, P., VUONG, T. N. L., HO, N. A. V., VAIARELLI, A., HO, M. T., BLOCKEEL, C.,CAMUS, M., LAM, A. T., VAN DE VIJVER, A., HUMAIDAN, P., TOURNAYE, H. &POLYZOS, N. P. 2017. Corifollitropin alfa followed by highly purified HMGversus recombinant FSH in young poor ovarian responders: a multicentrerandomized controlled clinical trial. Hum Reprod, 32: 2225-2233. (IF 4.990)
25. DURAIRAJ, R. R.P., ABERKANE, A., POLANSKI, L., MARUYAMA, Y., BAUMGARTEN, M., LUCAS, E. S., QUENBY, S., CHAN, J. K., RAINE-FENNING, N., BROSENS, J. J., VAN DE VELDE, H. & LEE, Y. H. 2017. Deregulation of the endometrial stromal cell secretome precedes embryo implantation failure. Mol Hum Reprod, 23, 478-487. CORRIGENDUM DURAIRAJ, R. R. P. et al. (vol 23, pg 481, 2017). Mol Hum Reprod, 23, 582-582. (IF 3.449)
26. FAES, K. & GOOSSENS, E. 2017. Short-term storage of human testicular tissue:effect of storage temperature and tissue size. Reprod Biomed Online, 35, 180-188. (IF 2.967)
27. FAES, K., LAHOUTTE, T., HOORENS, A., TOURNAYE, H. & GOOSSENS, E. 2017. In search of an improved injection technique for the clinical application of spermatogonial stem cell transplantation. Reprod Biomed Online, 34, 291-297. (IF 2.967)
28. FERRARETTI, A. P., DEVROEY, P., MAGLI, M. C. & GIANAROLI, L. 2017. No need for luteal phase support in IVF cycles after mild stimulation: proof-of-concept study. Reprod Biomed Online, 34, 162-165. (IF 2.967)
29. GAZZO, A., RAIMONDI, D., DANEELS, D., MOREAU, Y., SMITS, G., VAN DOOREN, S. & LENAERTS, T. 2017. Understanding mutational effects in digenic diseases. Nucleic Acids Research, 45:15. (IF 11.561)
30. GEENS, M. & CHUVA DE SOUSA LOPES, S. M. 2017. X chromosome inactivation inhuman pluripotent stem cells as a model for human development: back to the drawing board? Hum Reprod Update, 23: 520-532.(IF 11.852)
31. JACOBS, K., VAN DE VELDE, H., DE PAEPE, C., SERMON, K. & SPITS, C. 2017. Mitoticspindle disruption in human preimplantation embryos activates the spindleassembly checkpoint but not apoptosis until Day 5 of development. Mol Hum Reprod, 23, 321-329. (IF 3.449)
32. KADAM, P., VAN SAEN, D. & GOOSSENS, E. 2017. Can mesenchymal stem cells improvespermatogonial stem cell transplantation efficiency? Andrology, 5 , 2-9. (IF 2.734)
33. LUNARDI, F. O., DE AGUIAR, F. L. N., APOLLONI, L. B., DUARTE, A. B. G., DE SÁ, N. A. R.,LEAL, É., SALES, A. D., LOBO, C. H., CAMPELLO, C. C., SMITZ, J., APGAR, G.A., DE FIGUEIREDO, J. R. & RODRIGUES, A. P. R. 2017. Sheep IsolatedSecondary Follicles Are Able to Produce Metaphase II Oocytes AfterVitrification and Long-Term In Vitro Growth. Biopreserv Biobank,15, 321-331. (IF 1.827)
34. MACKENS, S., SANTOS-RIBEIRO, S., VAN DE VIJVER, A., RACCA, A., VAN LANDUYT, L.,TOURNAYE, H. & BLOCKEEL, C. 2017. Frozen embryo transfer: a review onthe optimal endometrial preparation and timing. Hum Reprod, 32, 2234-2242. (IF 4.990)
35. MAZZILLI, R., CIMADOMO, D., VAIARELLI, A., CAPALBO, A., DOVERE, L., ALVIGGI, E., DUSI,L., FORESTA, C., LOMBARDO, F., LENZI, A., TOURNAYE, H., ALVIGGI, C.,RIENZI, L. & UBALDI, F. M. 2017. Effect of the male factor on theclinical outcome of intracytoplasmic sperm injection combined withpreimplantation aneuploidy testing: observational longitudinal cohort studyof 1,219 consecutive cycles. Fertil Steril. 108(6):961-972. (IF 4.803)
36. OKUTMAN, O., MULLER, J., SKORY, V., GARNIER, J. M., GAUCHEROT, A., BAERT, Y., LAMOUR, V., SERDAROGULLARI, M., GULTOMRUK, M., RÖPKE, A., KLIESCH, S., HERBEPIN, V., AKNIN, I., BENKHALIFA, M., TELETIN, M., BAKIRCIOGLU, E., GOOSSENS, E., CHARLET-BERGUERAND, N., BAHCECI, M., TÜTTELMANN, F. & VIVILLE, S. 2017. A no-stop mutation in MAGEB4 is a possible cause of rare X-linked azoospermia and oligozoospermia in a consanguineous Turkish family. J Assist Reprod Genet, 34, 683-694. (IF 2.163)
37. PENNINGS, G., SEGERS, S., DEBROCK, S., HEINDRYCKX, B., KONTOZOVA-DEUTSCH, V., PUNJABI, U., VANDE VELDE, H., VAN STEIRTEGHEM, A. & MERTES, H. 2017. Human embryo research in Belgium: an overview. Fertil Steril, 108(1), 96-107. (IF 4.803)
38. PEREZ-CALVO, A ., MARTINEZ, F., BLOCKEEL, C., CLUA, E., RODRIGUEZ, I., BARRI, P. N. & COROLEU, B. 2017. Importance of a 5-versus 7-day pill-free interval in a GnRH antagonist protocol using corifollitropin alfa: a prospective cohort study in oocyte donors. Reprod Biomed Online, 35 , 425-431. (IF 2.967)
39. ROCHA, R. M. P ., LIMA, L. F., BRITO, I. R., SILVA, G. M., CORREIA, H. H. V., DE SA, N. A., FERREIRA, A. C. A., SALES, A. D., LOBO, C. H., CAMPELLO, C. C., SMITZ, J., WHEELER, M. B. & FIGUEIREDO, J. R. 2017. Anti-Mullerian hormone reduces growth rate without altering follicular survival in isolated caprine preantral follicles cultured in vitro. Reproduction Fertility and Development, 29, 1144-1154. (IF 2.105)
40. SANCHEZ, F., LOLICATO, F., ROMERO, S., DE VOS, M., VAN RANST, H., VERHEYEN, G.,ANCKAERT, E. & SMITZ, J. E. J. 2017. An improved IVM method forcumulus-oocyte complexes from small follicles in polycystic ovary syndromepatients enhances oocyte competence and embryo yield. Hum Reprod,32, 2056-2068. (IF 4.990)
41. SERMON, K. . Novel technologies emerging for preimplantation genetic diagnosis andpreimplantation genetic testing for aneuploidy. Expert Rev Mol Diagn, 17, 71-82. (IF 3.326)
42. SERMON, K. D., SPITS, C., MERTZANIDOU, A., VERMEESCH, J. R. & FIORENTINO, F. 2017.Detecting mosaicism in trophectoderm biopsies. Hum Reprod, 32 , 712-713. (IF 4.990)
43. STEVENS, T., TEN BOSCH, J. V. D. W., DE RADEMAEKER, M., VAN DEN BOGAERT, A. & VAN DEN AKKER, M. 2017. Risk of malignancy in 22q11.2 deletion syndrome. Clinical Case Reports, 5, 486-490. (open access)
44. STOUFFS, K., VLOEBERGHS, V., GHELDOF, A., TOURNAYE, H. & SENECA, S. 2017. AreAZFb deletions always incompatible with sperm production? Andrology, 5, 691-694. (IF 2.734)
45. SUKHIKH, G. T ., BARANOV, I. I., MELNICHENKO, G. A., BASHMAKOVA, N. V., BLOCKEEL, C., GRIESINGER, G., LOMAKINA, A. A. & PEXMAN-FIETH, C. 2017. Lotus I: A Phase III randomized controlled trial of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization, with focus on the Russian subpopulation; Lotus I: Randomizirovannoe III fazy kontroliruemoe issledovanie sravneniya peroral'noi formy didrogesterona i vaginal'noi formy mikronizirovan-nogo progesterona dlya podderzhki lyuteinovoi fazy v tsiklakh ekstrakorporal'nogo oplodotvoreniya, fokus na subanaliz rossiiskoi populyatsii. Akusherstvo i ginekologiya, 75-95. (IF 0.733)
46. SUNKARA, S. K., LAMARCA, A., POLYZOS, N. P., SEED, P. T. & KHALAF, Y. 2017. Reply: Rapid changes in practice make analysis of historical databases irrelevant for contemporary counselling. Hum Reprod, 32, 964-965. (IF 4.990)
47. TOURNAYE, H., SUKHIKH, G. T., KAHLER, E. & GRIESINGER, G. 2017. A Phase IIIrandomized controlled trial comparing the efficacy, safety and tolerabilityof oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Hum Reprod, 32, 1019-1027. (IF 4.990)
48. TOURNAYE, H., KRAUSZ, C. & OATES, R. D. 2017. Novel concepts in the aetiology of male reproductive impairment. Lancet Diabetes Endo, 5 , 544-553. (IF 19.313)
49. TOURNAYE, H., KRAUSZ, C. & OATES, R. D. 2017. Concepts in diagnosis and therapy for male reproductive impairment. Lancet Diabetes Endo, 5 , 554-564. (IF 19.313)
50. UNUANE, D., VELKENIERS, B., BRAVENBOER, B., DRAKOPOULOS, P., TOURNAYE, H., PARRA, J.& DE BRUCKER, M. 2017. Impact of thyroid autoimmunity in euthyroidwomen on live birth rate after IUI. Hum Reprod, 32 , 915-922. (IF 4.990)
51. VANDECASTEELE, S. J., SENECA, S., SMET, J., REYNDERS, M., DE CEULAER, J., VANLANDER, A. V. & VAN COSTER, R. 2017. Tigecycline-induced inhibition of mitochondrial DNA translation may cause lethal mitochondrial dysfunction in humans. Clin Microbiol Infect, 24(4): 431.e1-431.e.3. (IF 5.394)
52. VANDERVORE, L., STOUFFS, K., TANYALCIN, I., VANDERHASSELT, T., ROELENS, F., HOLDER-ESPINASSE, M., JORGENSEN, A., PEPIN, M. G., PETIT, F., VAN KIEN, P. K., BAHI-BUISSON, N., LISSENS, W., GHELDOF, A., BYERS, P. H. & JANSEN, A. C. 2017. Bi-allelic variants in COL3A1 encoding the ligand to GPR56 are associated with cobblestone-like cortical malformation, white matter changes and cerebellar cysts. Journal of Medical Genetics, 54, 432-440. (IF 5.751)
53. VAN DE VIJVER, A., DRAKOPOULOS, P., POLYZOS, N. P., VAN LANDUYT, L., MACKENS, S.,SANTOS-RIBEIRO, S., VLOEBERGHS, V., TOURNAYE, H. & BLOCKEEL, C. 2017.Vitrified-warmed blastocyst transfer on the 5th or 7th day of progesteronesupplementation in an artificial cycle: a randomised controlled trial. Gynecol Endocrinol, 33: 783-786. (IF 1.453)
54. VAN STEIRTEGHEM, A. 2017. ICSI, 25 jaar na de eerste geboorte. Nederlands Tijdschrift voor Obstetrie & Gynaecologie (NTOG), 130: 43-45.
55. VANTROYS, E., LARSON, A., FRIEDERICH, M., KNIGHT, K., SWANSON, M. A., POWELL, C. A., SMET, J., VERGULT, S., DE PAEPE, B., SENECA, S., ROEYERS, H., MENTEN, B., MINCZUK, M., VANLANDER, A., VAN HOVE, J. & VAN COSTER, R. 2017. New insights into the phenotype of FARS2 deficiency. Molecular Genetics and Metabolism, 122, 172-181. (IF 3.774)
56. VERHEYEN, G., POPOVIC-TODOROVIC, B. & TOURNAYE, H. 2017. Processing and selection of surgically-retrieved sperm for ICSI: a review. Basic Clin Androl, 27, 6, 1-10. (open access)
57. VERLOES, A., SPITS, C., VERCAMMEN, M., GEENS, M., LEMAOULT, J., SERMON, K., COUCKE,W. & VAN DE VELDE, H. 2017. The role of methylation, DNA polymorphismsand microRNAs on HLA-G expression in human embryonic stem cells. Stem Cell Res, 19, 118-127. (IF 1.829)
58. VERPOEST, W., DE VOS, A., DE RYCKE, M., PARIKH, S., STAESSEN, C., TOURNAYE, H., DEVOS, M., VLOEBERGHS, V. & BLOCKEEL, C. 2017. Gonadotropin releasinghormone agonists or antagonists for preimplantation genetic diagnosis(PGD)? A prospective randomised trial. Curr Pharm Biotechno. 8, 622-627. (IF 1.819)
59. VEYS, K. R., D'HAUWERS, K. W., VAN DONGEN, A. J., JANSSEN, M. C., BESOUW, M. T.,GOOSSENS, E., VAN DEN HEUVEL, L. P., WETZELS, A. A. & LEVTCHENKO, E. N.2017. First Successful Conception Induced by a Male Cystinosis Patient. JIMD Reports, Springer, Berlin, Heidelberg, pp1-6. (IF 4.092)
60. ZAMBELLI, F., VANCAMPENHOUT, K., DANEELS, D., BROWN, D., MERTENS, J., VAN DOOREN, S.,CALJON, B., GIANAROLI, L., SERMON, K., VOET, T., SENECA, S. & SPITS, C.2017. Accurate and comprehensive analysis of single nucleotide variants andlarge deletions of the human mitochondrial genome in DNA and single cells. Eur J Hum Genet, 25, 1229-1236. (IF 3.636)

Internationale-, nationale tijdschriften

Impact factor 2016

1. ABOULGHAR, M., ALBERTINI, D., ALLEN, J., BHATTACHARYA, S., TERRALIS, J., EVERS, J.,GERAEDTS, J., GLASIER, A., HUNT, K., HUSSEIN, J., LA VECCHIA, C., LUY, W.,MICHAUD, P., NEGRI, E., PETERS, S., SETHI, D., BAIRD, D., CROSIGNANI, P.,DEVROEY, P., DIEDRICH, K., FARQUHARSON, R., FRASER, L., GIANAROLI, L.,LUNDIN, K., SUNDE, A., TAPANAINEN, J., TARLATZIS, B., VAN STEIRTEGHEM, A.,VEIGA, A., VOLPE, A. & GRP, E. C. W. 2016. The influence of socialfactors on gender(aEuro) health. Hum Reprod, 31,1631-1637. (IF 5.020)
2. ALVIGGI, C., ANDERSEN, C. Y., BUEHLER, K., CONFORTI, A., DE PLACIDO, G., ESTEVES,S. C., FISCHER, R., GALLIANO, D., POLYZOS, N. P., SUNKARA, S. K., UBALDI,F. M., HUMAIDAN, P. & NUMBER), P. G. P.-O. S. E. I. O. 2016. A new moredetailed stratification of low responders to ovarian stimulation: from apoor ovarian response to a low prognosis concept. Fertil Steril,105, 1452-3. (IF 4.373)
3. ATAMAN, L. M., RODRIGUES, J. K., MARINHO, R. M., CAETANO, J. P., CHEHIN, M. B.,ALVES DA MOTTA, E. L., SERAFINI, P., SUZUKI, N., FURUI, T., TAKAE, S.,SUGISHITA, Y., MORISHIGE, K. I., ALMEIDA-SANTOS, T., MELO, C., BUZAGLO, K.,IRWIN, K., WALLACE, W. H., ANDERSON, R. A., MITCHELL, R. T., TELFER, E. E.,ADIGA, S. K., ANAZODO, A., STERN, C., SULLIVAN, E., JAYASINGHE, Y., ORME,L., COHN, R., MCLACHLAN, R., DEANS, R., AGRESTA, F., GERSTL, B., LEDGER, W.L., ROBKER, R. L., DE MENESES E SILVA, J. M., SILVA, L. H., LUNARDI, F. O.,LEE, J. R., SUH, C. S., DE VOS, M., VAN MOER, E., STOOP, D., VLOEBERGHS,V., SMITZ, J., TOURNAYE, H., WILDT, L., WINKLER-CREPAZ, K., ANDERSEN, C.Y., SMITH, B. M., SMITH, K. & WOODRUFF, T. K. 2016. Creating a GlobalCommunity of Practice for Oncofertility. J Glob Oncol, 2 , 83-96.
4. BELVA, F.,BONDUELLE, M., ROELANTS, M., MICHIELSEN, D., VAN STEIRTEGHEM, A., VERHEYEN,G. & TOURNAYE, H. 2016. Semen quality of young adult ICSI offspring:the first results. Hum Reprod, 31, 2811-2820. (IF 5.020)
5. BELVA, F., BONDUELLE, M., ROELANTS, M., VERHEYEN, G. & VAN LANDUYT, L. 2016.Neonatal health including congenital malformation risk of 1072 childrenborn after vitrified embryo transfer. Hum Reprod, 31 , 1610-20. (IF 5.020)
6. BELVA, F.,ROELANTS, M., DE SCHEPPER, J., VAN STEIRTEGHEM, A., TOURNAYE, H. &BONDUELLE, M. 2016. Reproductive hormones of ICSI-conceived young adultmen: the first results. Hum Reprod, 32, 439-446. (IF 5.020)
7. BLOCKEEL, C., DRAKOPOULOS, P., SANTOS-RIBEIRO, S., POLYZOS, N. P. & TOURNAYE,H. 2016. A fresh look at the freeze-all protocol: a SWOT analysis. Hum Reprod, 31, 491-7. (IF 5.020)
8. COSYNS, S., DE SUTTER, P., TOURNAYE, H. & POLYZOS, N. P. 2016. Necessity ofappendectomy for mucinous borderline ovarian tumors. Systematic review. Arch Gynecol Obstet, 294, 1283-1289. (IF 2.090)
9. COSYNS, S., DONY, N. & POLYZOS, N. P. 2016. Can ulipristal acetate be atreatment option for patients with menorrhagia and a history of ischemiccerebrovascular accident? J Obstet Gynaecol, 36,859-860. (IF 0.629)
10. COSYNS, S., POLYZOS, N. P., CARPRIEAUX, M., TOURNAYE, H. & DE SUTTER, P.2016. The role of appendectomy as part of the treatment of a mucinousborderline ovarian tumor. Eur J Gynaecol Oncol, 37 , 167-70. (IF 0.692)
11. DE GROOT, M., DANCET, E., REPPING, S., GODDIJN, M., STOOP, D., VAN DER VEEN, F.& GERRITS, T. 2016. Perceptions of oocyte banking from women intendingto circumvent age-related fertility decline.Acta Obstetricia Et Gynecologica Scandinavica, 95 , 1396-1401. (IF 2.480)
12. DE LOS SANTOS,M., APTER, S., COTICCHIO, G., DEBROCK, S., LUNDIN, K., PLANCHA, C., PRADOS,F., RIENZI, L., VERHEYEN, G., WOODWARD, B. & VERMEULEN, N. 2016.Revised guidelines for good practice in IVF laboratories (2015). Hum Reprod, 31, 685-686. (IF 5.020)
13. DE MUNCK, N., SANTOS-RIBEIRO, S., STOOP, D., VAN DE VELDE, H. & VERHEYEN, G. 2016.Open versus closed oocyte vitrification in an oocyte donation programme: aprospective randomized sibling oocyte study. Hum Reprod, 31 , 377-84. (IF 5.020)
14. DE MUNCK, N., BELVA, F., VAN DE VELDE, H., VERHEYEN, G. & STOOP, D. 2016. Closedoocyte vitrification and storage in an oocyte donation programme: obstetricand neonatal outcome. Hum Reprod, 31, 1024-33. (IF 5.020)
15. DE NEUBOURG, D., BOGAERTS, K., BLOCKEEL, C., COETSIER, T., DELVIGNE, A., DEVREKER, F.,DUBOIS, M., GILLAIN, N., GORDTS, S. & WYNS, C. 2016. How do cumulativelive birth rates and cumulative multiple live birth rates over completecourses of assisted reproductive technology treatment per woman compareamong registries? Hum Reprod, 31, 93-9. (IF 5.020)
16. DE VOS, A., VAN LANDUYT, L., SANTOS-RIBEIRO, S., CAMUS, M., VAN DE VELDE, H.,TOURNAYE, H. & VERHEYEN, G. 2016. Cumulative live birth rates afterfresh and vitrified cleavage-stage versus blastocyst-stage embryo transferin the first treatment cycle. Hum Reprod, 31,2442-2449. (IF 5.020)
17. DE VOS, M., SMITZ, J., THOMPSON, J. G. & GILCHRIST, R. B. 2016. The definitionof IVM is clear-variations need defining. Hum Reprod, 31 , 2411-2415. (IF 5.020)
18. DECLEER, W., OSMANAGAOGLU, K., VERSCHUEREN, K., COMHAIRE, F. & DEVROEY, P. 2016.RCT to evaluate the influence of adjuvant medical treatment of peritonealendometriosis on the outcome of IVF. Hum Reprod, 31 , 2017-23. (IF 5.020)
19. DRAKOPOULOS, P., BLOCKEEL, C., STOOP, D., CAMUS, M., DE VOS, M., TOURNAYE, H. &POLYZOS, N. P. 2016. Conventional ovarian stimulation and single embryotransfer for IVF/ICSI. How many oocytes do we need to maximize cumulativelive birth rates after utilization of all fresh and frozen embryos? Hum Reprod, 31, 370-6. (IF 5.020)
20. FAES, K., LAHOUTTE, T., HOORENS, A., TOURNAYE, H. & GOOSSENS, E. 2016. Insearch of an improved injection technique for the clinical application ofspermatogonial stem cell transplantation. Reprod Biomed Online,34(3): 291-297. (IF 3.249)
21. FAES, K . & GOOSSENS, E. 2016. Short-term hypothermic preservation of human testicular tissue: the effect of storage medium and storage period. Fertil Steril, 105, 1162-1169. (IF 4.373)
22. FERRARETTI, A. P., DEVROEY, P., MAGLI, M. C. & GIANAROLI, L. 2016. No need for lutealphase support in IVF cycles after mild stimulation: proof-of-concept study. Reprod Biomed Online. (IF 3.249)
23. GIES, I.,TOURNAYE, H. & DE SCHEPPER, J. 2016. Attitudes of parents ofKlinefelter boys and pediatricians towards neonatal screening and fertilitypreservation techniques in Klinefelter syndrome. Eur J Pediatr,175, 399-404. (IF 1.921)
24. GIES, I.,OATES, R., DE SCHEPPER, J. & TOURNAYE, H. 2016. Testicular biopsy andcryopreservation for fertility preservation of prepubertal boys withKlinefelter syndrome: a pro/con debate. Fertil Steril, 105 , 249-55. (IF 4.373)
25. GILCHRIST, R., LUCIANO, A., RICHANI, D., ZENG, H., WANG, X., DE VOS, M., SUGIMURA, S.,SMITZ, J., RICHARD, F. & THOMPSON, J. 2016. Oocyte maturation andquality: role of cyclic nucleotides. Reproduction, 152 , R143-R157. (I: 3.100)
26. GIRARDET, A ., VIART, V., PLAZA, S., DAINA, G., DE RYCKE, M., DES GEORGES, M., FIORENTINO, F., HARTON, G., ISHMUKHAMETOVA, A., NAVARRO, J., RAYNAL, C., RENWICK, P., SAGUET, F., SCHWARZ, M., SENGUPTA, S., TZETIS, M., ROUX, A. F. & CLAUSTRES, M. 2016. The improvement of the best practice guidelines for preimplantation genetic diagnosis of cystic fibrosis: toward an international consensus. Eur J Hum Genet, 24, 469-78. (IF 4.287)
27. GRIESINGER, G., VERWEIJ, P. J., GATES, D., DEVROEY, P., GORDON, K., STEGMANN, B. J.& TARLATZIS, B. C. 2016. Prediction of Ovarian HyperstimulationSyndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRHAntagonist Protocol. PloS One, e0149615. (IF 2.806)
28. HUMAIDAN, P., NELSON, S. M., DEVROEY, P., CODDINGTON, C. C., SCHWARTZ, L. B., GORDON,K., FRATTARELLI, J. L., TARLATZIS, B. C., FATEMI, H. M., LUTJEN, P. &STEGMANN, B. J. 2016. Ovarian hyperstimulation syndrome: review and newclassification criteria for reporting in clinical trials. Hum Reprod, 31, 1997-2004. (IF 5.020)
29. MATEIZEL, I., SANTOS-RIBEIRO, S., DONE, E., VAN LANDUYT, L., VAN DE VELDE, H.,TOURNAYE, H. & VERHEYEN, G. 2016. Do ARTs affect the incidence ofmonozygotic twinning? Hum Reprod, 31, 2435-2441. (IF 5.020)
30. MEDRANO, J. V., ROMBAUT, C., SIMON, C., PELLICER, A. & GOOSSENS, E. 2016. Human spermatogonial stem cells display limited proliferation in vitro under mouse spermatogonial stem cell culture conditi
31. MONTAGUT, M., SANTOS-RIBEIRO, S., DE VOS, M., POLYZOS, N. P., DRAKOPOULOS, P.,MACKENS, S., VAN DE VIJVER, A., VAN LANDUYT, L., VERHEYEN, G., TOURNAYE, H.& BLOCKEEL, C. 2016. Frozen-thawed embryo transfers in natural cycleswith spontaneous or induced ovulation: the search for the best protocolcontinues. Hum Reprod, 31, 2803-2810. (IF 5.020)
32. ONOFRE, J ., BAERT, Y., FAES, K. & GOOSSENS, E. 2016. Cryopreservation of testicular tissue or testicular cell suspensions: a pivotal step in fertility preservation. Hum Reprod Update, 22 , 744-761. (IF 11.748)
33. PETRUSSA, L., VAN DE VELDE, H. & DE RYCKE, M. 2016. Similar kinetics for5-methylcytosine and 5-hydroxymethylcytosine during human preimplantationdevelopment in vitro. Mol Reprod Dev, 83,594-605. (IF 2.316)
34. POLYZOS, N. P., DAVIS, S. R., DRAKOPOULOS, P., HUMAIDAN, P., DE GEYTER, C., VEGA, A.G., MARTINEZ, F., EVANGELOU, E., VAN DE VIJVER, A., SMITZ, J., TOURNAYE,H., BARRI, P. & GROUP, T.-T. I. 2016. Testosterone for Poor OvarianResponders: Lessons From Ovarian Physiology. Reprod Sci. (IF 2.443)
35. POLYZOS, N.P., DRAKOPOULOS, P. & TOURNAYE, H. 2016. Modified natural cycle IVF forpoor ovarian responders: rethink before concluding. Hum Reprod, 31 , 221-2. (IF 5.020)
36. PUNJABI, U., WYNS, C., MAHMOUD, A., VERNELEN, K., CHINA, B. & VERHEYEN, G. 2016.Fifteen years of Belgian experience with external quality assessment ofsemen analysis. Andrology, 4, 1084-1093. (IF 2.427)
37. ROMBAUT, C ., FAES, K. & GOOSSENS, E. 2016. The Effect of a Unilateral Orchiectomy before Gonadotoxic Treatment on the Contralateral Testis in Adult and Prepubertal Rats. PLoS One, 11. (IF 2.806)
38. SAENZ-DE-JUANO, M. D ., BILLOOYE, K., SMITZ, J. & ANCKAERT, E. 2016. The loss of imprinted DNA methylation in mouse blastocysts is inflicted to a similar extent by in vitro follicle culture and ovulation induction. Mol Hum Reprod, 22 , 427-41. (IF 3.585)
39. SANTOS-RIBEIRO, S., POLYZOS, N. P., LAN, V. T., SIFFAIN, J., MACKENS, S., VAN LANDUYT, L.,TOURNAYE, H. & BLOCKEEL, C. 2016. The effect of an immediate frozenembryo transfer following a freeze-all protocol: a retrospective analysisfrom two centres. Hum Reprod, 31, 2541-2548. (IF 5.020)
40. SANTOS-RIBEIRO, S., SIFFAIN, J., POLYZOS, N. P., VAN DE VIJVER, A., VAN LANDUYT, L., STOOP,D., TOURNAYE, H. & BLOCKEEL, C. 2016. To delay or not to delay a frozenembryo transfer after a failed fresh embryo transfer attempt? Fertil Steril, 105, 1202-1207. (IF 4.373)
41. SANTOS-RIBEIRO, S., TOURNAYE, H. & POLYZOS, N. P. 2016. Trends in ectopic pregnancyrates following assisted reproductive technologies in the UK: a 12-yearnationwide analysis including 160 000 pregnancies. Hum Reprod, 31 , 393-402. (IF 5.020)
42. SCHIEWE,MC., VERHEYEN,G., TOURNAYE,H., PLETINCX,I., SIMS,CA., ROTHMANN,C. 2016.Development and validation of CryoCocoonsTM for the safe, aseptic storageof sperm cryovials. Journal of reproductive biotechnology & fertility, 5, 1-6.
43. SERMIJN, E ., DELESIE, L., DESCHEPPER, E., PAUWELS, I., BONDUELLE, M., TEUGELS, E. & DE GRÈVE, J. 2016. The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation: efficacy and safety. Fam Cancer, 15, 155-62. (IF 1.660)
44. SERMON, K., CAPALBO, A., COHEN, J., COONEN, E., DE RYCKE, M., DE VOS, A.,DELHANTY, J., FIORENTINO, F., GLEICHER, N., GRIESINGER, G., GRIFO, J.,HANDYSIDE, A., HARPER, J., KOKKALI, G., MASTENBROEK, S., MELDRUM, D.,MESEGUER, M., MONTAG, M., MUNNÉ, S., RIENZI, L., RUBIO, C., SCOTT, K.,SCOTT, R., SIMON, C., SWAIN, J., TREFF, N., UBALDI, F., VASSENA, R.,VERMEESCH, J. R., VERPOEST, W., WELLS, D. & GERAEDTS, J. 2016. The why,the how and the when of PGS 2.0: current practices and expert opinions offertility specialists, molecular biologists, and embryologists. Mol Hum Reprod, 22, 845-57. (IF 3.585)
45. STOOP, D. 2016. Oocyte vitrification for elective fertility preservation:lessons for patient counseling. Fertil Steril, 105 , 603-604. (IF 4.373)
46. STOUFFS, K., GHELDOF, A., TOURNAYE, H., VANDERMAELEN, D., BONDUELLE, M., LISSENS,W. & SENECA, S. 2016. Sertoli Cell-Only Syndrome: Behind the GeneticScenes. Biomed Res Int, 2016, 6191307. (IF 2.476)
47. SUNKARA, S. K., LAMARCA, A., POLYZOS, N. P., SEED, P. T. & KHALAF, Y. 2016.Live birth and perinatal outcomes following stimulated and unstimulatedIVF: analysis of over two decades of a nationwide data. Hum Reprod, 31, 2261-7. (IF 5.020)
48. Tournaye, H., Krausz, C., Oates, RD. 2016. Novel concepts in the aetiology of malereproductive impairment. Lancet Diabetes Endocrinol, Jul 6. pii:S2213-8587(16). (IF 19.742)
49. Tournaye,H., Krausz, C., Oates, RD. 2016. Concepts in diagnosis and therapy for malereproductive impairment. Lancet Diabetes Endocrinol, Jul 6. pii:S2213-8587(16). (IF 19.742)
50. UNUANE, D., VELKENIERS, B., DERIDDER, S., BRAVENBOER, B., TOURNAYE, H. & DEBRUCKER, M. 2016. Impact of thyroid autoimmunity on cumulative deliveryrates in in vitro fertilization/intracytoplasmic sperm injection patients. Fertil Steril, 106, 144-50. (IF 4.373)
51. VAIARELLI, A., DRAKOPOULOS, P., BLOCKEEL, C., DE VOS, M., VAN DE VIJVER, A., CAMUS,M., COSYNS, S., TOURNAYE, H. & POLYZOS, N. P. 2016. Limited ability ofcirculating anti-Müllerian hormone to predict dominant follicularrecruitment in PCOS women treated with clomiphene citrate: a comparison oftwo different assays. Gynecol Endocrinol, 32, 227-30. (IF 1.585)
52. VAN DE VIJVER, A., POLYZOS, N. P., VAN LANDUYT, L., MACKENS, S., STOOP, D., CAMUS, M.,DE VOS, M., TOURNAYE, H. & BLOCKEEL, C. 2016. What is the optimalduration of progesterone administration before transferring avitrified-warmed cleavage stage embryo? A randomized controlled trial. Hum Reprod, 31, 1097-104 (IF 5.020).
53. VAN DE VIJVER, A., DRAKOPOULOS, P., VAN LANDUYT, L., VAIARELLI, A., BLOCKEEL, C.,SANTOS-RIBEIRO, S., TOURNAYE, H. & POLYZOS, N. P. 2016. Vitamin Ddeficiency and pregnancy rates following frozen-thawed embryo transfer: aprospective cohort study. Hum Reprod, 31, 1749-54. (IF 5.020)
54.  WINTER, C.,VAN ACKER, F., BONDUELLE, M., VAN BERKEL, K., BELVA, F., LIEBAERS, I.,NEKKEBROECK, J. 2016.Depression, pregnancy-related anxiety and parental-antenatal attachmentin couples using preimplantation genetic diagnosis.Hum Reprod. 31, 1288-99. (IF 5.020)

Internationale en nationale tijdschriften en boeken

Impact factor 2015

1. BairdDT, Barri PN,Bhattacharya S,Devroey P, Evers JL,Gianaroli L,Somigliana E,Tapanainen JS,van Wely M,Crosignani PG,Diedrich K, Fraser L,Geraedts JP,Lundin K, Sunde A,Tarlatzis B,Van Steirteghem A, Veiga A,Bhattacharya S,Crosignani PG, Evers JL,Somigliana E. ESHRE Capri workshop Group. Economic aspects of infertility care: achallenge for researchers and clinicians. Human Reproduction,Oct;30(10):2243-8, 2015. (IF 4.621)

2. BEVILACQUA,A., CARLOMAGNO, G., GERLI, S., OLIVA, M., DEVROEY, P., LANZONE, A.,SOULANGE, C., FACCHINETTI, F., DI RENZO, G., BIZZARRI, M., HOD, M.,CAVALLI, P., D'ANNA, R., BENVENGA, S., CHIU, T. & KAMENOV, Z. 2015.Results from the International Consensus Conference on myo-inositol andD-chiro-inositol in Obstetrics and Gynecology - assisted reproductiontechnology. Gynecological Endocrinology, 31,441-446. (IF 1.413)

3. DE MUNCK, N., PETRUSSA, L., VERHEYEN, G., STAESSEN, C., VANDESKELDE, Y., STERCKX, J.,BOCKEN, G., JACOBS, K., STOOP, D., DE RYCKE, M. & VAN DE VELDE, H.2015. Chromosomal meiotic segregation, embryonic developmental kinetics andDNA (hydroxy)methylation analysis consolidate the safety of human oocytevitrification. Molecular Human Reproduction, 21,535-544.
(IF 3.943)

4. DE MUNCK, N.,SANTOS-RIBEIRO, S., MATEIZEL, I. & VERHEYEN, G. 2015. Reducedblastocyst formation in reduced culture volume.Journal of Assisted Reproduction and Genetics, 32 , 1365-1370. (IF 1.858)

5. DE SCHEPPER, J. & TOURNAYE, H. 2015. Het syndroom van Klinefelter: Het vergetensyndroom. Tijdschrift voor Geneeskunde, 71, 5:306-307.

6. DE VOS, A., ABRAHAM, M., FRANCEUS, N., HAENTJENS, P., TOURNAYE, H., VERHEYEN, G.& VAN DE VELDE, H. 2015. Deposition of the spermatozoon in the humanoocyte at ICSI: impact on oocyte survival, fertilization and blastocystformation. Journal of Assisted Reproduction and Genetics, 32 , 865-871. (IF 1.858)

7. DE VOS, A.,JANSSENS, R., VAN DE VELDE, H., HAENTJENS, P., BONDUELLE, M., TOURNAYE, H.& VERHEYEN, G. 2015. The type of culture medium and the duration of invitro culture do not influence birthweight of ART singletons. Human Reproduction, 30, 20-27.
(IF 4.621)

8. DEN HOND, E.,TOURNAYE, H., DE SUTTER, P., OMBELET, W., BAEYENS, W., COVACI, A., COX, B.,NAWROT, T., VAN LAREBEKE, N. & D'HOOGHE, T. 2015. Human exposure toendocrine, disrupting chemicals and fertility: A case-control study in malesubfertility patients. Environment International, 84 , 154-160. (IF 5.929)

9. DRAKOPOULOS, P., CASAROSA, E., BUCCI, F., PICCININO, M., WENGER, J., NAPPI, R., POLYZOS,N., GENAZZANI, A. & PLUCHINO, N. 2015. Diurnal Variation of PlasmaBrain-Derived Neurotrophic Factor Levels in Women with FunctionalHypothalamic Amenorrhea. Neuroendocrinology, 101,256-262. (IF 2.583)

10. FACCHINETTI, F., BIZZARRI, M., BENVENGA, S., D'ANNA, R., LANZONE, A., SOULAGE, C., DIRENZO, G., HOD, M., CAVALLI, P., CHIU, T., KAMENOV, Z., BEVILACQUA, A.,CARLOMAGNO, G., GERLI, S., OLIVA, M. & DEVROEY, P. 2015. Results fromthe International Consensus Conference on Myo-inositol and D-chiro-inositolin Obstetrics and Gynecology: the link between metabolic syndrome and PCOS.European Journal of Obstetrics & Gynecology and ReproductiveBiology,195, 72-76. (IF 1.662)

11. FERRARETTI, A., GIANAROLI, L., MAGLI, M. & DEVROEY, P. 2015. Mild ovarianstimulation with clomiphene citrate launch is a realistic option for invitro fertilization. Fertility and Sterility, 104 , 333-338. (IF 4.426)

12. GIBREEL, A., EL-ADAWI, N., ELGINDY, E., AL-INANY, H., ALLAKANY, N. & TOURNAYE, H.2015. Endometrial scratching for women with previous IVF failure undergoingIVF treatment. Gynecological Endocrinology, 31,313-316. (IF 1.413)

13. GIES, I., DE SCHEPPER, J. & TOURNAYE, H. 2015. Progress and prospects forfertility preservation in prepubertal boys with cancer.Current Opinion in Endocrinology Diabetes and Obesity, 22 , 203-208. (IF 3.119)

14. KOSMAS, I., KITSOU, C., LAZAROS, L., MARKOULA, S., PESCHOS, D., MYNBAEV, O.,TOURNAYE, H., PRAPAS, N., PRAPAS, I., ZIKOPOULOS, A., GALANI, V. &GEORGIOU, I. 2015. Everolimus, an mTOR pathway inhibitor, is highlysuccessful on ovarian hyperstimulation syndrome by reducing ovarian weightand progesterone levels: a preclinical experimental randomized controlledstudy. Gynecological Endocrinology, 31, 702-707. (IF 1.413)

15. KOVACIC, B., PLAS, C., WOODWARD, B., VERHEYEN, G., PRADOS, F., HREINSSON, J., SANTOS,M., MAGLI, M., LUNDIN, K. & PLANCHA, C. 2015. The educational andprofessional status of clinical embryology and clinical embryologists inEurope. Human Reproduction, 30, 1755-1762. (IF 4.621)

16. KRIVEGA, M., ESSAHIB, W. & VAN DE VELDE, H. 2015. WNT3 and membrane-associatedbeta-catenin regulate trophectoderm lineage differentiation in humanblastocysts. Molecular Human Reproduction, 21,711-722. (IF 3.943)

17. KRIVEGA, M., GEENS, M., HEINDRYCKX, B., SANTOS-RIBEIRO, S., TOURNAYE, how doH. &VAN DE VELDE, H. 2015. Cyclin E1 plays a key role in balancing betweentotipotency and differentiation in human embryonic cells. Molecular Human Reproduction, 21, 942-956. (IF 3.943)

18. PICTON, H.,WYNS, C., ANDERSON, R., GOOSSENS, E., JAHNUKAINEN, K., KLIESCH, S.,MITCHELL, R., PENNINGS, G., RIVES, N., TOURNAYE, H., VAN PELT, A.,EICHENLAUB-RITTER, U., SCHLATT, S. & PRESERV, E. T. F. F. 2015. AEuropean perspective on testicular tissue cryopreservation for fertilitypreservation in prepubertal and adolescent boys. Human Reproduction, 30, 2463-2475. (IF 4.621)

19. POLYZOS, N., CORONA, R., VAN DE VIJVER, A., BLOCKEEL, C., DRAKOPOULOS, P.,VLOEBERGHS, V., DE VOS, M., CAMUS, M., HUMAIDAN, P. & TOURNAYE, H.2015. Corifollitropin alfa followed by hpHMG in GnRH agonist protocols. Twoprospective feasibility studies in poor ovarian responders. Gynecological Endocrinology, 31, 885-890. (IF 1.413)

20. POLYZOS, N., SAKKAS, E., VAIARELLI, A., POPPE, K., CAMUS, M. & TOURNAYE, H. 2015.Thyroid autoimmunity, hypothyroidism and ovarian reserve: a cross-sectionalstudy of 5000 women based on age-specific AMH values. Human Reproduction, 30, 1690-1696.
(IF 4.621)

21. POLYZOS, N.& SUNKARA, S. 2015. Reply: Is it necessary to recognize the sub-optimalresponder. Human Reproduction, 30, 2959-2959. (IF 4.621)

22. POLYZOS, N. & SUNKARA, S. 2015b. Sub-optimal responders following controlledovarian stimulation: an overlooked group? Human Reproduction, 30 , 2005-2008. (IF 4.621)

23. SANCHEZ, F., ROMERO, S., DE VOS, M., VERHEYEN, G. & SMITZ, J. 2015. Humancumulus-enclosed germinal vesicle oocytes fromearly antral follicles revealheterogeneous cellular and molecular features associated with in vitromaturation capacity. Human Reproduction, 30,1396-1409. (IF 4.621)

24. SANTOS-RIBEIRO, S., POLYZOS, N., STOUFFS, K., DE VOS, M., SENECA, S., TOURNAYE, H. &BLOCKEEL, C. 2015. Ovarian hyperstimulation syndrome aftergonadotropin-releasing hormone agonist triggering and "freeze-all":in-depth analysis of genetic predisposition.Journal of Assisted Reproduction and Genetics, 32 , 1063-1068. (IF 1.858)

25. SEGERS, I.,MATEIZEL, I., VAN MOER, E., SMITZ, J., TOURNAYE, H., VERHEYEN, G. & DEVOS, M. 2015. In vitro maturation (IVM) of oocytes recovered fromovariectomy specimens in the laboratory: a promising "ex vivo" method ofoocyte cryopreservation resulting in the first report of an ongoingpregnancy in Europe.Journal of Assisted Reproduction and Genetics, 32 , 1221-1231. (IF 1.858)

26. STOOP, D., MAES, E., POLYZOS, N., VERHEYEN, G., TOURNAYE, H. & NEKKEBROECK, J.2015. Does oocyte banking for anticipated gamete exhaustion influencefuture relational and reproductive choices? A follow-up of bankers andnon-bankers. Human Reproduction, 30, 338-344. (IF 4.621)

27. STOOP, D.,SILBER, S. & COBO, A. 2015. Fertility preservation for age-relatedfertility decline reply. Lancet, 385, 507-508. (IF 44.002)

28. TOURNAYE, H. 2015. Het syndroom van Klinefelter: Welke oplossingen bestaan er bij eenkinderwens? Tijdschrift voor Geneeskunde, 71, 5:308-310.

29. VAN LANDUYT, L., POLYZOS, N., DE MUNCK, N., BLOCKEEL, C., VAN DE VELDE, H. &VERHEYEN, G. 2015. A prospective randomized controlled trial investigatingthe effect of artificial shrinkage (collapse) on the implantation potentialof vitrified blastocysts. Human Reproduction, 30,2509-2518. (IF 4.621)

30. VAN SAEN, D., SANCHEZ, J., FERSTER, A., TEN BOSCH, J., TOURNAYE, H. & GOOSSENS, E.2015. Is the protein expression window during testicular developmentaffected in patients at risk for stem cell loss? Human Reproduction, 30, 2859-2870. (IF 4.621)

31. VERDYCK, P., BERCKMOES, V., DE VOS, A., VERPOEST, W., LIEBAERS, I., BONDUELLE, M.& DE RYCKE, M. 2015. Chromosome fragility at FRAXA in human cleavagestage embryos at risk for fragile X syndrome. American Journal of Medical Genetics Part a, 167,2306-2313. (IF 2.082)

32. VISSENBERG, R., VAN DIJK, M., FLIERS, E., VAN DER POST, J., VAN WELY, M., BLOEMENKAMP,K., HOEK, A., KUCHENBECKER, W., VERHOEVE, H., SCHEEPERS, H., ROMBOUT-DEWEERD, S., KOKS, C., ZWART, J., BROEKMANS, F., VERPOEST, W., CHRISTIANSEN,O., POST, M., PAPATSONIS, D., VERBERG, M., SIKKEMA, J., MOL, B., BISSCHOP,P. & GODDIJN, M. 2015. Effect of levothyroxine on live birth rate ineuthyroid women with recurrent miscarriage and TPO antibodies (T4-LIFEstudy). Contemporary Clinical Trials, 44,134-138. (IF 2.052)

33. VLOEBERGHS, V.,VERHEYEN, G., HAENTJENS, P., GOOSSENS, A., POLYZOS, N. & TOURNAYE, H.2015. How successful is TESE-ICSI in couples with non-obstructiveazoospermia? Human Reproduction, 30, 1790-1796. (IF 4.621)

34. Welling, M, Chen, HH, Muñoz, J, Musheev, MU, Kester, L, Junker, JP, Mischerikow, N,Arbab, M, Kuijk, EW, Silberstein, L, Kharchenko, PV, Geens, M, Niehrs, C,Van de Velde, H, van Oudenaarden, A, Heck, AJR & Geijsen, N. 2015.'DAZL regulates Tet1 translation in murine embryonic stem cells' EMBO Reports, vol 16, no. 7, pp. 791-802. (IF 7.739)

35. WINTER, C, VAN ACKER, F, BONDUELLE, M, DESMYTTERE, S, NEKKEBROECK, J. 2015.Psychosocial development of full term singletons, born afterpreimplantation genetic diagnosis (PGD) at preschool age and familyfunctioning: a prospective case-controlled study and multi-informantapproach. Human Reproduction, 30, 1122-36. (IF 4.621)

1. Albertini D JARG
   Albertini, D., Evers, J., Geraedts, J., Gianaroli, L., Sharpe, R., Sinclair, K., Sunde, A., Van Steirteghem, A., Baird, D., Crosignani, P., Devroey, P., Diedrich, K., Fauser, B., Fraser, L., Tapanainen, J., Tarlatzis, B., Veiga, A. & Grp, E. C. W. 2014. Birth defects and congenital health risks in children conceived through assisted reproduction technology (ART): a meeting report. Journal of Assisted Reproduction and Genetics, 31, 947-958. (IF 1.718)
2. Blockeel Ch HR LH rise
   Blockeel, C., Knez, J., Polyzos, N., De Vos, M., Camus, M. & Tournaye, H. 2014a. Should an intrauterine insemination with donor semen be performed 1 or 2 days after the spontaneous LH rise? A prospective RCT. Human Reproduction, 29, 697-703. (IF 4.569) 
3. Blockeel Ch HR Corifollitropin
   Blockeel, C., Polyzos, N., Derksen, L., De Brucker, M., Vloeberghs, V., van de Vijver, A., De Vos, M. & Tournaye, H. 2014b. Administration of corifollitropin alfa on Day 2 versus Day 4 of the cycle in a GnRH antagonist protocol: A randomized controlled pilot study. Human Reproduction, 29, 1500-1507. (IF 4.569)
4. Bodri D RBMO
   Bodri, D., Kawachiya, S., De Brucker, M., Tournaye, H., Kondo, M., Kato, R. & Matsumoto, T. 2014. Cumulative success rates following mild IVF in unselected infertile patients: a 3-year, single-centre cohort study. Reproductive Biomedicine Online, 28, 572-581. (IF 3.015)
5. Cauffman G JARG
   Cauffman, G., Verheyen, G., Tournaye, H. & Van de Velde, H. 2014. Developmental capacity and pregnancy rate of tetrahedral- versus non-tetrahedral-shaped 4-cell stage human embryos. Journal of Assisted Reproduction and Genetics, 31, 427-434.
   (IF 1.718)
   
6. De Brucker, M., Camus, M., Haentjens, P., Francotte, J., Verheyen, G. & Tournaye, H. 2014a. Cumulative delivery rates after ICSI with donor spermatozoa in different age groups. Reproductive Biomedicine Online, 28, 599-605. (IF 3.015) De Brucker M RBMO
7. De Brucker M Europ J Ob&Gyn & Reprod Biol Letter
   De Brucker, M., Tournaye, H., Crener, K., Francotte, J. & Camus, M. 2014b. Unique coral-like image on hysteroscopy. European Journal of Obstetrics & Gynecology and Reproductive Biology, 177, 153-153. (IF 1.695)
8. De Paepe, C., Krivega, M., Cauffman, G., Geens, M. & Van de Velde, H. 2014. Totipotency and lineage segregation in the human embryo. Molecular Human Reproduction, 20, 599-618. (IF 3.747) De Paepe C Mol Hum Reprod 
9. De Vos M The Lancet
   De Vos, M., Smitz, J. & Woodruff, T. 2014. Fertility preservation in women with cancer. Lancet, 384, 1302-1310. (IF 45.217) 
10. De Wert HumReprod PGD
    De Wert, G., Dondorp, W., Shenfield, F., Barri, P., Devroey, P., Diedrich, K., Tarlatzis, B., Provoost, V. & Pennings, G. 2014a. ESHRE Task Force on Ethics and Law 23: medically assisted reproduction in singles, lesbian and gay couples, and transsexual people. Human Reproduction, 29, 1859-1865. (IF 4.569)
11. De Wert G HR
    De Wert, G., Dondorp, W., Shenfield, F., Devroey, P., Tarlatzis, B., Barri, P., Diedrich, K., Provoost, V. & Pennings, G. 2014b. ESHRE Task Force on Ethics and Law22: Preimplantation Genetic Diagnosis. Human Reproduction, 29, 1610-1617. (IF 4.569)
12. Decleer W Fertil Steril
    Decleer, W., Osmanagaoglu, K., Meganck, G. & Devroey, P. 2014. Slightly lower incidence of ectopic pregnancies in frozen embryo transfer cycles versus fresh in vitro fertilization-embryo transfer cycles: a retrospective cohort study. Fertility and Sterility, 101, 162-165. (IF 4.590)
13. Derksen L RBMO
    Derksen, L., Tournaye, H., Stoop, D., Van Vaerenbergh, I., Bourgain, C., Polyzos, N., Haentjens, P. & Blockeel, C. 2014. Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger. Reproductive Biomedicine Online, 28, 359-368. (IF 3.015)
14. Derks-Smeets I Breast cancer Research&Treatment
    Derks-Smeets, I., de Die-Smulders, C., Mackens, S., van Golde, R., Paulussen, A., Dreesen, J., Tournaye, H., Verdyck, P., Tjan-Heijnen, V., Meijer-Hoogeveen, M., De Greve, J., Geraedts, J., De Rycke, M., Bonduelle, M. & Verpoest, W. 2014. Hereditary breast and ovarian cancer and reproduction: an observational study on the suitability of preimplantation genetic diagnosis for both asymptomatic carriers and breast cancer survivors. Breast Cancer Research and Treatment, 145, 673-681. (IF 5.490)
15. Devroey P HR; Devroey P HR suppl_table2; Devroey P HR suppl_table3
    Devroey, P., Boostanfar, R., Koper, N., Mannaerts, B., Verweij, P., Stegmann, B., Ijzerman-Boon, P., Fauser, B. & Investigators, E. 2014. A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol (vol 24, pg 3063, 2009). Human Reproduction, 29, 1116-1120. (IF 4.569)
    
16. Dondorp W HR
    Dondorp, W., De Wert, G., Pennings, G., Shenfield, F., Devroey, P., Tarlatzis, B., Barri, P., Diedrich, K., Eichenlaub-Ritter, U., Tuttelmann, F. & Provoost, V. 2014. ESHRE Task Force on Ethics and Law 21: genetic screening of gamete donors: ethical issues(aEuro). Human Reproduction, 29, 1353-1359. (IF 4.569)
17. Fatemi H Fertil Steril
    Fatemi, H., Popovic-Todorovic, B., Humaidan, P., Kol, S., Banker, M., Devroey, P. & Garcia-Velasco, J. 2014. Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and "freeze-all'' approach in GnRH antagonist protocol. Fertility and Sterility, 101, 1008-1011. (IF 4.590)
18. Fauser B RBMO
    Fauser, B., Devroey, P., Diedrich, K., Balaban, B., Bonduelle, M., Delemarre-van de Waal, H., Estella, C., Ezcurra, D., Geraedts, J., Howles, C., Lerner-Geva, L., Serna, J., Wells, D. & Workshop, E. A. R. E. 2014. Health outcomes of children born after IVF/ICSI: a review of current expert opinion and literature. Reproductive Biomedicine Online, 28, 162-182. (IF 3.015)
    
19. Gerris J HR
    Gerris, J., Delvigne, A., Dhont, N., Vandekerckhove, F., Madoc, B., Buyle, M., Neyskens, J., Deschepper, E., De Bacquer, D., Pil, L., Annemans, L., Verpoest, W. & De Sutter, P. 2014. Self-operated endovaginal telemonitoring versus traditional monitoring of ovarian stimulation in assisted reproduction: an RCT. Human Reproduction, 29, 1941-1948. (IF 4.569) 
20. Goossens E Annales d'Endocrinologie
    Goossens, E. & Tournaye, H. 2014. Male fertility preservation, where are we in 2014? Annales D Endocrinologie, 75, 115-117.
    (IF 0.871)
21. Humaidan P Fertil Steril
    Humaidan, P. & Polyzos, N. 2014. Human chorionic gonadotropin vs. gonadotropin-releasing hormone agonist trigger in assisted reproductive technology-"The king is dead, long live the king!'' Fertility and Sterility, 102, 339-341. (IF 4.590)
22. Kitsou C Gynecol Endocrinol
    Kitsou, C., Kosmas, I., Lazaros, L., Hatzi, E., Euaggelou, A., Mynbaev, O., Tournaye, H., Prapas, N., Prapas, I., Zikopoulos, K., Galani, V. & Georgiou, I. 2014. Ovarian hyperstimulation syndrome inhibition by targeting VEGF, COX-2 and Calcium pathways: a preclinical randomized study. Gynecological Endocrinology, 30, 587-592. (IF 1.333) 
23. Krivega Reproduction 2014
    Krivega, M., Geens, M. & Van de Velde, H. 2014. CAR expression in human embryos and hESC illustrates its role in pluripotency and tight junctions. Reproduction, 148, 531-544. (IF 3.174)
24. Kyrou D Europ J Ob& Gyn & Reprod Biol Letter
    Kyrou, D., Kosmas, I., Popovic-Todorovic, B., Donoso, P., Devroey, P. & Fatemi, H. 2014. Ejaculatory sperm production in non-obstructive azoospermic patients with a history of negative testicular biopsy after the administration of an aromatase inhibitor: report of two cases. European Journal of Obstetrics & Gynecology and Reproductive Biology, 173, 120-121. (IF 1.695) 
25. Ortega-Hrepich Reprod Biol Endocrin
    Ortega-Hrepich, C., Polyzos, N., Anckaert, E., Guzman, L., Tournaye, H., Smitz, J. & De Vos, M. 2014. The effect of ovarian puncture on the endocrine profile of PCOS patients who undergo IVM. Reproductive Biology and Endocrinology, 12:18. (IF 2.226)
26. Ory S Fertil Steril
    Ory, S., Devroey, P., Banker, M., Brinsden, P., Buster, J., Fiadjoe, M., Horton, M., Nygren, K., Pai, H., Le Roux, P. & Sullivan, E. 2014. International Federation of Fertility Societies Surveillance 2013: preface and conclusions. Fertility and Sterility, 101, 1582-1583. (IF 4.590)
27. Petrussa L Mol Hum Reprod
    Petrussa, L., Van de Velde, H. & De Rycke, M. 2014. Dynamic regulation of DNA methyltransferases in human oocytes and preimplantation embryos after assisted reproductive technologies. Molecular Human Reproduction, 20, 861-874. (IF 3.747) 
28. Polyzos N HR Letter
    Polyzos, N. & Tournaye, H. 2014. Poor ovarian responders: to meta-analyse or not, that is the question. Human Reproduction, 29, 634-635. (IF 4.569)
29. Polyzos N HR
    Polyzos, N., Anckaert, E., Guzman, L., Schiettecatte, J., Van Landuyt, L., Camus, M., Smitz, J. & Tournaye, H. 2014a. Vitamin D deficiency and pregnancy rates in women undergoing single embryo, blastocyst stage, transfer (SET) for IVF/ICSI. Human Reproduction, 29, 2032-2040. (IF 4.569)
30. Polyzos N RBMO
    Polyzos, N., Nwoye, M., Corona, R., Blockeel, C., Stoop, D., Haentjens, P., Camus, M. & Tournaye, H. 2014b. Live birth rates in Bologna poor responders treated with ovarian stimulation for IVF/ICSI. Reproductive Biomedicine Online, 28, 469-474. (IF 3.015) 
31. Santos Ribeiro HR, Santos Ribeiro HR 2014 supp_table1; Santos Ribeiro HR 2014 supp_table2
    Santos-Ribeiro, S., Polyzos, N., Haentjens, P., Smitz, J., Camus, M., Tournaye, H. & Blockeel, C. 2014. Live birth rates after IVF are reduced by both low and high progesterone levels on the day of human chorionic gonadotrophin administration. Human Reproduction, 29, 1698-1705. (IF 4.569) 
32. Stoop D The Lancet; Stoop D The Lancet Editorial; Stoop D The lancet Comment by Li
    Stoop, D., Cobo, A. & Silber, S. 2014b. Fertility preservation for age-related fertility decline (vol 384, pg 1311, 2014). Lancet, 384, 2110-2110. (IF 45.217)
33. Stoop D RBMO
    Stoop, D., van der Veen, F., Deneyer, M., Nekkebroeck, J. & Tournaye, H. 2014. Oocyte banking for anticipated gamete exhaustion (AGE) is a preventive intervention, neither social nor nonmedical. Reproductive Biomedicine Online, 28, 548-551. (IF 3.015) 
34. Tournaye H The Lancet
    Tournaye, H., Dohle, G. & Barratt, C. 2014. Fertility preservation in men with cancer. Lancet, 384, 1295-1301. (IF 45.217) 
35. van de Vijver A RBMO
    van de Vijver, A., Polyzos, N., Van Landuyt, L., De Vos, M., Camus, M., Stoop, D., Tournaye, H. & Blockeel, C. 2014. Cryopreserved embryo transfer in an artificial cycle: is GnRH agonist down-regulation necessary? Reproductive Biomedicine Online, 29, 588-594. (IF 3.015) 
36. Winter HR
    Winter, C., Van Acker, F., Bonduelle, M., Desmyttere, S., De Schrijver, F., Nekkebroeck, J. 2014. Cognitive and psychomotor development of 5- to 6-year-old singletons born after PGD: a prospective case-controlled matched study. Human Reproduction, 29, 1968-1977. (IF 4.569)

1. Abu Hashim H, Al-Inany H, De Vos M, Tournaye H. Three decades after Gjonnaess's laparoscopic ovarian drilling for treatment of PCOS; what do we know? An evidence-based approach. Archives of Gynecology and Obstetrics 2013;288: 409-422. (IF 1.330) Abu Hashim Arch Gynecol Obstet
2. Alsbjerg B, Polyzos NP, Elbaek HO, Povlsen BB, Andersen CY, Humaidan P. Increasing vaginal progesterone gel supplementation after frozen-thawed embryo transfer significantly increases the delivery rate. Reproductive Biomedicine Online 2013;26: 133-137. (IF 2.675) Alsbjerg RBMO
3. Anifandis G, Dafopoulos K, Messini CI, Polyzos N, Messinis IE. The BMI of men and not sperm parameters impact on embryo quality and the IVF outcome. Andrology 2013;1: 85-89. Anifandis Andrology
4. Baert Y, Van Saen D, Haentjens P, In't Veld P, Tournaye H, Goossens E. What is the best cryopreservation protocol for human testicular tissue banking? Human Reproduction 2013;28: 1816-1826. (IF 4.670) Baert HR
5. Baird DT, Bhattacharya S, Devroey P, Diedrich K, Evers JLH, Fauser BCJM, Jouannet P, Pellicer A, Walters E, Crosignani PG, Fraser L, Geraedts JPM, Gianaroli L, Glasier A, Liebaers I, Sunde A, Tapanainen JS, Tarlatzis B, Van Steirteghem A, Veiga A. ESHRE Capri Workshop Group. Failures (with some successes) of assisted reproduction and gamete donation programs. Human Reproduction Update 2013;19(4):354-365. (IF 8.847) Baird HRU
6. Belva F, Painter RC, Schiettecatte J, Bonduelle M, Roelants M, Roseboom TJ, Tournaye H, De Schepper J. Gender-Specific Alterations in Salivary Cortisol Levels in Pubertal Intracytoplasmic Sperm Injection Offspring. Hormone Research in Paediatrics 2013;80: 350-355. (IF 1.553) Belva Hormone Res Pediatrics
7. De Brucker M, Camus M, Haentjens P, Verheyen G, Collins J, Tournaye H. Assisted reproduction using donor spermatozoa in women aged 40 and above: the high road or the low road? Reproductive Biomedicine Online 2013;26: 577-585. (IF 2.675) De Brucker RBMO
8. De Brucker M, Tournaye H, Haentjens P, Verheyen G, Collins J, Camus M. Assisted reproduction counseling in women aged 40 and above: a cohort study. Journal of Assisted Reproduction and Genetics 2013;30: 1431-1438. (IF 1.823) De Brucker JARG
9. De Munck N, Verheyen G, Van Landuyt L, Stoop D, Van de Velde H. Survival and post-warming in vitro competence of human oocytes after high security closed system vitrification. Journal of Assisted Reproduction and Genetics 2013;30: 361-369. (IF 1.823) De Munck N JARG
10. De Neubourg D, Bogaerts K, Wyns C, Albert A, Camus M, Candeur M, Degueldre M, Delbaere A, Delvigne A, De Sutter P, Dhont M, Dubois M, Englert Y, Gillain N, Gordts S, Hautecoeur W, Lesaffre E, Lejeune B, Leroy F, Ombelet W, Perrier D'Hauterive S, Vandekerckhove F, Van der Elst J, D'Hooghe T. The history of Belgian assisted reproduction technology cycle registration and control: a case study in reducing the incidence of multiple pregnancy. Human Reproduction 2013;28: 2709-2719. (IF 4.670) De Neubourg HR
11. De Paepe C, Cauffman G, Verloes A, Sterckx J, Devroey P, Tournaye H, Liebaers I, Van de Velde H. Human trophectoderm cells are not yet committed. Human Reproduction 2013;28: 740-749. (IF 4.670) De Paepe HR
12. De Vos A, Polyzos N, Verheyen G, Tournaye H. Intracytoplasmic morphologically selected sperm injection (IMSI): A critical and evidence-based review. Basic and Clinical Andrology. 2013;23:10. De Vos A Basic & Clin Andro
13. De Vos A, Van de Velde H, Bocken G, Eylenbosch G, Franceus N, Meersdom G, Tistaert S, Vankelecom A, Tournaye H, Verheyen G. Does intracytoplasmic morphologically selected sperm injection improve embryo development? A randomized sibling-oocyte study. Human Reproduction 2013;28: 617-626. (IF 4.670) De Vos A HR
14. Dondorp W, De Wert G, Pennings G, Shenfield F, Devroey P, Tarlatzis B, Barri P, Diedrich K. ESHRE Task Force on ethics and Law 20: sex selection for non-medical reasons. Human Reproduction 2013;28: 1448-1454. (IF 4.670) Dondorp HR
15. Donoso P, Devroey P. Low tolerance for complications. Fertility and Sterility 2013;100: 299-301. (IF 4.174) Donoso FS
16. Faes K, Tournaye H, Goethals L, Lahoutte T, Hoorens A, Goossens E. Testicular cell transplantation into the human testes. Fertility and Sterility 2013;100: 981-988. (IF 4.174) Faes FS
17. Fatemi HM, Doody K, Griesinger G, Witjes H, Mannaerts B. High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates and in a GnRH-antagonist protocol. Human Reproduction 2013;28: 442-452. (IF 4.670) Fatemi HR
18. Fatemi HM, Polyzos NP, van Vaerenbergh I, Bourgain C, Blockeel C, Alsbjerg B, Papanikolaou EG, Humaidan P. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertility and Sterility 2013;100: 742-747. (IF 4.174) Fatemi FS
19. Fatemi HM, Popovic-Todorovic B. Implantation in assisted reproduction: a look at endometrial receptivity. Reproductive Biomedicine Online 2013;27: 530-538. (IF 2.675) Fatemi RBMO
20. Fleming R, Broekmans F, Calhaz-Jorge C, Dracea L, Alexander H, Andersen AN, Blockeel C, Jenkins J, Lunenfeld B, Platteau P, Smitz J, de Ziegler D. Can anti-Mullerian hormone concentrations be used to determine gonadotrophin dose and treatment protocol for ovarian stimulation? Reproductive Biomedicine Online 2013;26: 431-439. (IF 2.675) Fleming RBMO
21. Goossens E, Tournaye H. Adult Stem Cells in the Human Testis. Seminars in Reproductive Medicine 2013;31: 39-48. (IF 3.211) Goossens E Seminars in reprod med
22. Goossens E, Tournaye H. Fertility preservation in boys: Spermatogonial stem cell transplantation and testicular grafting. Gynécologie Obstétrique & Fertilité 2013;41: 529-531. (IF 0.553) Goossens E Gynecol Obstet Fertil
23. Goossens E, Tournaye H. Functional sperm produced after spermatogonial stem cell transplantation into rhesus. Asian Journal of Andrology 2013;15: 216-217. (IF 2.140) Goossens E Asian J Androl
24. Goossens E, Van Saen D, Tournaye H. Spermatogonial stem cell preservation and transplantation: from research to clinic. Human Reproduction 2013;28: 897-907. (IF 4.670) Goosssens E HR
25. Guzman L, Adriaenssens T, Ortega-Hrepich C, Albuz FK, Mateizel I, Devroey P, De Vos M, Smitz J. Human antral follicles 6 mm: a comparison between in vivo maturation and in vitro maturation in non-hCG primed cycles using cumulus cell gene expression. Molecular Human Reproduction 2013;19: 7-16. (IF 4.542) Guzman MHR
26. Guzman L, Ortega-Hrepich C, Polyzos NP, Anckaert E, Verheyen G, Coucke W, Devroey P, Tournaye H, Smitz J, De Vos M. A prediction model to select PCOS patients suitable for IVM treatment based on anti-Mullerian hormone and antral follicle count. Human Reproduction 2013;28: 1261-1266. (IF 4.670) Guzman HR
27. Humaidan P, Polyzos NP, Alsbjerg B, Erb K, Mikkelsen AL, Elbaek HO, Papanikolaou EG, Andersen CY. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients. Human Reproduction 2013;28: 2511-2521. (IF 4.670) Humaidan HR
28. Iliodromit S, Blockeel C, Tremellen KP, Fleming R, Tournaye H, Humaidan P, Nelson SM. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study. Human Reproduction 2013;Sep;28(9): 2529-36. (IF 4.670) Iliodromit HR
29. Kasius JC, Eijkemans RJ, Mol BW, Fauser BC, Fatemi HM, Broekmans FJ. Cost-effectiveness of hysteroscopy screening for infertile women. Reproductive Biomedicine online 2013;26: 619-626. (IF 2.675)
30. Leader A, Devroey P, Witjes H, Gordon K. Corifollitropin alfa or rFSH treatment flexibility options for controlled ovarian stimulation: a post hoc analysis of the Engage trial. Reproductive Biology and Endocrinology 2013;11:52. (IF 2.144) Leader Reprod Biol & Endocrinol
31. Mateizel I, Van Landuyt L, Tournaye H, Verheyen G. Deliveries of normal healthy babies from embryos originating from oocytes showing the presence of smooth endoplasmic reticulum aggregates. Human Reproduction 2013;28: 2111-2117. (IF 4.670) Mateizel HR
32. Mertzanidou A, Spits C, Nguyen HT, Van de Velde H, Sermon K. Evolution of aneuploidy up to Day 4 of human preimplantation development. Human Reproduction 2013;28: 1716-1724. (IF 4.670) Mertzanidou HR
33. Ortega-Hrepich C, Stoop D, Guzman L, Van Landuyt L, Tournaye H, Smitz J, De Vos M. A ‘freeze-all’ embryo strategy after in vitro maturation: a novel approach in women with polycystic ovary syndrome? Fertility and Sterility 2013;100:1002. (IF 4.174) Ortega FS
34. Polyzos NP, Camus M, Llacer J, Pantos K, Tournaye H. Corifollitropin alfa followed by menotropin for poor ovarian responders’ trial (COMPORT): a protocol of a multicentre randomised trial. British Medical Journal Open. 2013;Jun 20;3(6). (IF 17.215) Polyzos BMJ
35. Polyzos NP, De Vos M, Corona R, Vloeberghs V, Ortega-Hrepich C, Stoop D, Tournaye H. Addition of highly purified HMG after Corifollitropin alfa in antagonist treated poor ovarian responders: a pilot study. Human Reproduction 2013;May; 28(5):1254-1260. (IF 4.670) Polyzos HR
36. Polyzos NP, Nelson SM, Stoop D, Nwoye M, Humaidan P, Anckaert E, Devroey P, Tournaye H. Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective singlecenter study. Fertility and Sterility 2013;Aug; 100(2):438-444. (IF 4.174) Polyzos FS
37. Polyzos NP, DeVos M, Humaidan P, Stoop D, Ortega-Hrepich C, Devroey P, Tournaye H. Corifollitropin alfa followed by rFSH in a GnRH antagonist protocol for poor ovarian responder patients: an observational pilot study. Fertility and Sterility 2013;99: 422-426. (IF 4.174) Polyzos N FS
38. Polyzos NP, Tournaye H, Guzman L, Camus M, Nelson SM. Predictors of ovarian response in women treated with Corifollitropin alfa for in vitro fertilization/intracytoplasmic sperm injection. Fertility and Sterility 2013;100: 430-437. (IF 4.174) Polyzos NP FS
39. Smit JG, Kasius JC, Eijkemans MJ, Veersema S, Fatemi HM, Santbrink van EJ, Campo R, Broekmans FJ. The international agreement study on the diagnosis of the septate uterus at office hysteroscopy in infertile patients. Fertility and Sterility 2013;99: 2108-2113. (IF 4.174) Smit FS
40. Stoop D, Ermini B, Polyzos NP, Haentjens P, De Vos M, Verheyen G, Devroey P. Reproductive potential of a metaphase II oocyte retrieved after ovarian stimulation: an analysis of 23 354 ICSI cycles (vol 27, pg 2030, 2012). Erratum in: Human Reproduction 2013;28: 286-286. (IF 4.670) Stoop HR
41. Unuane D, Velkeniers B, Anckaert E, Schiettecatte J, Tournaye H, Haentjens P, Poppe K. Thyroglobulin autoantibodies: is there any added value in the detection of thyroid autoimmunity in women consulting for fertility treatment? Thyroid. 2013;Aug;23(8):1022-8. (IF 3.544) Unuane Thyroid
42. Valachis A, Polyzos NP, Coleman RE, Gnant M, Eidtmann H, Brufsky AM, Aft R, Tevaarwerk AJ, Swenson K, Lind P, Mauri D. Adjuvant Therapy With Zoledronic Acid in Patients With Breast Cancer: A Systematic Review and Meta-Analysis. Oncologist 2013;18: 353-361. (IF 4.095) Valachis Oncologist
43. Valachis A, Polyzos NP. Role of Zoledronate in Aromatase Activity Should Be Considered in Future Studies. In Reply. Oncologist 2013;18: E26-E27. (IF 4.095)
44. Van Landuyt l, Van de Velde H, De Vos A, Haentjens P, Blockeel C, Tournaye H and Verheyen G. Influence of cell loss after vitrification or slow-freezing on further in vitro development and implantation of human day 3 embryos. Human Reproduction 2013; 28: 2943-9. (IF 4.670) Van Landuyt HR
45. Van Saen D, Goossens E, Aerts JL, Haentjens P, Tournaye H. Does early cell death cause germ cell loss after intratesticular tissue grafting? Fertility and Sterility. 2013;Apr;99(5):1264-. (IF 4.174) Van Saen FS
46. Van Saen D, Goossens E, Haentjens P, Baert Y, Tournaye H. Exogenous administration of recombinant human FSH does not improve germ cell survival in human prepubertal xenografts. Reproductive Biomedicine Online 2013;26: 286-298. (IF 2.675) Van Saen RBMO
47. Velkeniers B, Van Meerhaeghe A, Poppe K, Unuane D, Tournaye H, Haentjens P. Levothyroxine treatment and pregnancy outcome in women with subclinical hypothyroidism undergoing assisted reproduction technologies: systematic review and meta-analysis of RCTs. Human Reproduction Update 2013;19: 251-258. (IF 8.847) Velkeniers HRU
48. Vloeberghs V, Verheyen G, Tournaye H. Intracytoplasmic spermatid injection and in vitro maturation: fact or fiction? Review Clinics, 2013;68(S1), 151-156. Vloeberghs Review Clinics
49. Wathlet S, Adriaenssens T, Segers I, Verheyen G, Van Landuyt L, Coucke W, Devroey P, Smitz J. Pregnancy Prediction in Single Embryo Transfer Cycles after ICSI Using QPCR: Validation in Oocytes from the Same Cohort. Plos One 2013;8,4:1-10. (IF 3.730) Wathlet PLOS ONE
50. Zavos A, Daponte A, Garas A, Verykouki C, Papanikolaou E, Anifandis G, Polyzos NP. Double versus single homologous intrauterine insemination for male factor infertility: a systematic review and meta-analysis. Asian Journal of Andrology 2013;15: 533-538. (IF 2.140) Zavos Asian J Andro
51. Zeng H-t, Ren Z, Guzman L, Wang X, Sutton-McDowall ML, Ritter LJ, De Vos M, Smitz J, Thompson JG, Gilchrist RB. Heparin and cAMP modulators interact during pre-in vitro maturation to affect mouse and human oocyte meiosis and developmental competence. Human Reproduction 2013;28: 1536-1545. (IF 4.670) Zeng HR

Impact factor (IF): year 2011

1. Al-Azemi M, Kyrou D, Kolibianakis EM, Humaidan P, Van Vaerenbergh I, Devroey P, Fatemi HM. Elevated progesterone during ovarian stimulation for IVF. Reprod Biomed Online. 2012 Apr;24(4):381-8. (IF 2.042) Al-Azemi RBMO
2. Alves AM, Chaves RN, Rocha RM, Lima LF, Andrade PM, Lopes CA, Souza CE, Moura AA, Campello CC, Báo SN, Smitz J, Figueiredo JR. Dynamic medium containing growth differentiation factor-9 and FSH maintains survival and promotes in vitro growth of caprine preantral follicles after long-term in vitro culture. Reprod Fertil Dev. 2012 Oct 11. (IF 2.109)
3. Anckaert E, Smitz J, Schiettecatte J, Klein BM, Arce JC. The value of anti-Mullerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments. Hum Reprod. 2012 Jun;27(6): 1829-39.
   (IF 4.475) Anckaert HR
4. Baert Y, Goossens E, van Saen D, Ning L, in't Veld P, Tournaye H. Orthotopic grafting of cryopreserved prepubertal testicular tissue: in search of a simple yet effective cryopreservation protocol. Fertil Steril. 2012 May;97(5):1152-7. (IF 3.775) Baert FS
5. Belva F, Painter R, Bonduelle M, Roelants M, Devroey P, De Schepper J. Are ICSI adolescents
   at risk for increased adiposity? Hum Reprod. 2012 Jan;27(1):257-64. (IF 4.475) Belva HR
6. Belva F, Roelants M, De Schepper J, Roseboom TJ, Bonduelle M, Devroey P, Painter RC.
   Blood pressure in ICSI-conceived adolescents. Hum Reprod. 2012 Oct;27(10):3100-8. (IF 4.475) Belva HR
7. Belva F, Roelants M, Painter R, Bonduelle M, Devroey P, De Schepper J. Pubertal development in ICSI children. Hum Reprod. 2012 Apr;27(4):1156-6. (IF 4.475) Belva HR
8. Blockeel C, Engels S, De Vos M, Haentjens P, Polyzos NP, Stoop D, Camus M, Devroey P. Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trial. Reprod Biomed Online. 2012 Mar;24(3):272-80. (IF 2.042) Blockeel RBMO
9. Blockeel C. Estradiol valerate pretreatment in GnRH-antagonist cycles. Reprod Biomed Online. 2012 Aug;25(2):223-4. (IF 2.042) Blockeel Letter RBMO
10. Bonduelle M, Mannaerts B, Leader A, Bergh C, Passier D, Devroey P. Prospective follow-up of 838 fetuses conceived after ovarian stimulation with corifollitropin alfa: comparative and overall neonatal outcome. Hum Reprod. 2012 Jul;27(7):2177-85. (IF. 4475) Bonduelle HR
11. Boostanfar R, Mannaerts B, Pang S, Fernandez-Sanchez M, Witjes H, Devroey P; Engage Investigators. A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin alfa or recombinant follicle-stimulating hormone. Fertil Steril. 2012 Jun;97(6):1351-8. (IF 3.775) Boostanfar FS
12. Desmyttere S, De Rycke M, Staessen C, Liebaers I, De Schrijver F, Verpoest W, Haentjens P, Bonduelle M. Neonatal follow-up of 995 consecutively born children after embryo biopsy for PGD. Hum Reprod. 2012 Jan;27(1):288-93. (IF 4.475) Desmyttere HR
13. Devroey P, Pellicer A, Nyboe Andersen A, Arce JC; Menopur in GnRH Antagonist Cycles with Single Embryo Transfer Trial Group. A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer. Fertil Steril. 2012 Mar;97(3):561-71. (IF 3.775) Devroey FS
14. Donnez J, Jadoul P, Pirard C, Hutchings G, Demylle D, Squifflet J, Smitz J, Dolmans MM. Live birth after transplantation of frozen-thawed ovarian tissue after bilateral oophorectomy for benign disease. Fertil Steril. 2012 Sep;98(3):720-5. (IF 3.775) Donnez FS
15. ESHRE Task Force on Ethics and Law, Dondorp W, de Wert G, Pennings G, Shenfield F, Devroey P, Tarlatzis B, Barri P, Diedrich K. Oocyte cryopreservation for age-related fertility loss. Hum Reprod. 2012 May;27(5):1231-7. (IF: 4,475) ESHRE TF Ethics HR
16. Fatemi HM, Blockeel C, Devroey P. Ovarian stimulation: today and tomorrow. Curr Pharm Biotechnol. 2012 Mar; 13(3): 392-7. Review. (IF 2.805) Fatemi CURR PHARM BIOT
17. Garcia-Velasco JA, Kupesic S, Pellicer A, Bourgain C, Simon C, Mrazek M, Devroey P, Arce JC. Follicular and endocrine profiles associated with different GnRH-antagonist regimens: a randomized controlled trial. Reprod Biomed Online. 2012 Feb;24(2):153-62. (IF 2.042) Garcia-Velasco RMBO
18. Gies I, De Schepper J, Goossens E, Van Saen D, Pennings G, Tournaye H. Spermatogonial stem cell preservation in boys with Klinefelter syndrome: to bank or not to bank, that's the question. Fertil Steril. 2012 Aug;98(2):284-9. (IF 3.775) Gies FS
19. Gies I, De Schepper J, Van Saen D, Anckaert E, Goossens E, Tournaye H. Failure of a combined clinical- and hormonal-based strategy to detect early spermatogenesis and retrieve spermatogonial stem cells in 47,XXY boys by single testicular biopsy. Hum Reprod. 2012 Apr;27(4):998-1004. (IF 4.475) Gies HR
20. Guzman L, Ortega-Hrepich C, Albuz FK, Verheyen G, Devroey P, Smitz J, De Vos M. Developmental capacity of in vitro-matured human oocytes retrieved from polycystic ovary syndrome ovaries containing no follicles larger than 6 mm. Fertil Steril. 2012 Aug; 98(2): 503-7. (IF 3.775) Guzman FS
21. Hardarson T, Van Landuyt L, Jones G. The blastocyst. Hum Reprod. 2012 Aug;27 Suppl 1:i72-91. (IF 4.475) Hardarson HR
22. Humaidan P, Papanikolaou EG, Kyrou D, Alsbjerg B, Polyzos NP, Devroey P, Fatemi HM. The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives. Reprod Biomed Online. 2012 Feb;24(2): 134-41. (IF 2.042) Humaidan RBMO
23. Humaidan P, Polyzos NP. (Meta)analyze this: Systematic reviews might lose credibility. Nat Med. 2012 Sep;18(9):1321. (IF 22.462) Humaidan NAT MED
24. Humaidan P, Van Vaerenbergh I, Bourgain C, Alsbjerg B, Blockeel C, Schuit F, Van Lommel L, Devroey P, Fatemi H. Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles. Hum Reprod. 2012 Nov;27(11):3259-72. (IF 4.475) Humaidan HR
25. Jungwirth A, Giwercman A, Tournaye H, Diemer T, Kopa Z, Dohle G, Krausz C; European Association of Urology Working Group on Male Infertility. European Association of Urology guidelines on Male Infertility: the 2012 update. Eur Urol. 2012 Aug;62(2): 324-32. (IF 8.493) Jungwirth EUR UROL
26. Kasius JC, Broekmans FJ, Sie-Go DM, Bourgain C, Eijkemans MJ, Fauser BC, Devroey P, Fatemi HM. The reliability of the histological diagnosis of endometritis in asymptomatic IVF cases: a multicenter observer study. Hum Reprod. 2012 Jan; 27(1): 153-8. (IF 4.475) Kasius HR
27. Keymolen K, Staessen C, Verpoest W, Liebaers I, Bonduelle M. Preimplantation genetic diagnosis in female and male carriers of reciprocal translocations: clinical outcome until delivery of 312 cycles. Eur J Hum Genet. 2012 Apr;20(4):376-80. (IF 4.400) Keymolen EUR J HUM GENET
28. Kuijk EW, van Tol LT, Van de Velde H, Wubbolts R, Welling M, Geijsen N, Roelen BA. The roles of FGF and MAP kinase signaling in the segregation of the epiblast and hypoblast cell lineages in bovine and human embryos. Development. 2012 Mar; 139(5): 871-82. (IF 6.596) Kuijk DEVELOPMENT
29. Kyrou D, Al-Azemi M, Papanikolaou EG, Donoso P, Tziomalos K, Devroey P, Fatemi HM. The relationship of premature progesterone rise with serum estradiol levels and number of follicles in GnRH antagonist/recombinant FSH-stimulated cycles. Eur J Obstet Gynecol Reprod Biol. 2012 Jun;162(2):165-8. (IF 1.974) Kyrou EUR J OBSTET GYNECOL REPROD BIOL
30. Kyrou D, Kolibianakis EM, Fatemi HM, Grimbizis GF, Theodoridis TD, Camus M, Tournaye H, Tarlatzis BC, Devroey P. Spontaneous triggering of ovulation versus HCG administration in patients undergoing IUI: a prospective randomized study. Reprod Biomed Online. 2012 Sep;25(3):278-83. (IF 2.042) Kyrou RBMO
31. Massart A, Lissens W, Tournaye H, Stouffs K. Genetic causes of spermatogenic failure. Asian J Androl. 2012 Jan;14(1):40-8.
    (IF 1.521) Massart ASIAN J
32. Mateizel I, Geens M, Van de Velde H, Sermon K. Establishment of hESC lines from the inner cell mass of blastocyst-stage embryos and single blastomeres of 4-cell stage embryos. Methods Mol Biol. 2012;873:81-112.
33. Nekkebroeck J, Van den Broeck W, Desmyttere S, Ponjaert-Kristoffersen I, Bonduelle M. The mental, motor, socio-emotional and language development of 2-year-old twins born after PGD/PGS and parental well-being. Hum Reprod. 2012 Jan;27(1):299-301.
    (IF 4.475) Nekkebroeck HR
34. Ning L, Meng J, Goossens E, Lahoutte T, Marichal M, Tournaye H. In search of an efficient injection technique for future clinical application of spermatogonial stem cell transplantation: infusion of contrast dyes in isolated cadaveric human testes. Fertil Steril. 2012 Dec;98(6):1443-8. (IF 3.775) Ning FS
35. Papanikolaou EG, Pados G, Grimbizis G, Bili E, Kyriazi L, Polyzos NP, Humaidan P, Tournaye H, Tarlatzis B. GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study. Hum Reprod. 2012 Jun;27(6):1822-8. (IF 4.475) Papanikolaou HR
36. Polyzos NP, Blockeel C, Verpoest W, De Vos M, Stoop D, Vloeberghs V, Camus M, Devroey P, Tournaye H. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria. Hum Reprod. 2012 Dec;27(12):3481-6. (IF 4.475) Polyzos HR
37. Polyzos NP, Devroey P. Significantly lower ectopic pregnancy rates after frozen embryo transfer: implications toward segmentation of in vitro fertilization treatment. Fertil Steril. 2012 Dec;98(6):1419-20. (IF 3.775) Polyzos FS
38. Polyzos NP, Stoop D, Blockeel C, Adriaensen P, Platteau P, Anckaert E, Smitz J, Devroey P. Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist-treated oocyte donors. Reprod Biomed Online. 2012 May;24(5):532-9.
    (IF 2.042) Polyzos RBMO
39. Polyzos NP, Tournaye H, Devroey P. AMH for predicting poor ovarian responders in GnRH antagonist cycles. Hum Reprod. 2012 Jun;27(6):1876-7; author reply 1877. (IF: 4.475) Polyzos Author reply HR
40. Polyzos NP, Tzioras S, Mauri D, Papanikolaou EG. Combined vitamin C and E supplementation for preeclampsia: no significant effect but significant heterogeneity? Hypertens Pregnancy. 2012;31(3):375-6. (IF 1.694) Polyzos HYPERTENS PREGN
41. Polyzos NP, Zavos A, Valachis A, Dragamestianos C, Blockeel C, Stoop D, Papanikolaou EG, Tournaye H, Devroey P, Messinis IE. Misoprostol prior to hysteroscopy in premenopausal and post-menopausal women. A systematic review and meta-analysis. Hum Reprod Update. 2012 Jul;18(4):393-404. (IF 9.234) Polyzos HRU
42. Sánchez F, Romero S, Albuz FK, Smitz J. In vitro follicle growth under non-attachment conditions and decreased FSH levels reduces Lhcgr expression in cumulus cells and promotes oocyte developmental competence. J Assist Reprod Genet. 2012 Feb;29(2):141-52. (IF 1.844) Sanchez JARG
43. Sánchez F, Smitz J. Molecular control of oogenesis. Biochim Biophys Acta. 2012 Dec;1822(12):1896-912. Sanchez BIOCHIM BIOPHYS ACTA
44. Segers I, Adriaenssens T, Smitz J. Expression patterns of poliovirus receptor, erythrocyte protein band 4.1-like 3, regulator of g-protein signaling 11, and oxytocin receptor in mouse ovarian cells during follicle growth and early luteinization in vitro and in vivo. Biol Reprod. 2012 Jan 16;86(1):1-11. (IF 4.009) Segers BIOL REPROD
45. Segers I, Adriaenssens T, Wathlet S, Smitz J. Gene expression differences induced by equimolar low doses of LH or hCG in combination with FSH in cultured mouse antral follicles. J Endocrinol. 2012 Nov;215(2):269-80. (IF 1.844)
46. Stoop D, Baumgarten M, Haentjens P, Polyzos NP, De Vos M, Verheyen G, Camus M, Devroey P. Obstetric outcome in donor oocyte pregnancies: a matched-pair analysis. Reprod Biol Endocrinol. 2012 Jun 6;10:42. (IF 2.045) Stoop REPROD BIOL ENDO
47. Stoop D, De Munck N, Jansen E, Platteau P, Van den Abbeel E, Verheyen G, Devroey P. Clinical validation of a closed vitrification system in an oocyte-donation programme. Reprod Biomed Online. 2012 Feb;24(2):180-5. (IF 2.042) Stoop RBMO
48. Stoop D, De Vos M, Tournaye H, Devroey P. Fertility preservation utilizing controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome. Fertil Steril. 2012 Nov;98(5):1121-2.
    (IF 3.775) Stoop FS
49. Stoop D, Ermini B, Polyzos NP, Haentjens P, De Vos M, Verheyen G, Devroey P. Reproductive potential of a metaphase II oocyte retrieved after ovarian stimulation: an analysis of 23 354 ICSI cycles. Hum Reprod. 2012 Jul;27(7):2030-5. (IF 4.475) Stoop HR
50. Stoop D, Vercammen L, Polyzos NP, De Vos M, Nekkebroeck J, Devroey P. Effect of ovarian stimulation and oocyte retrieval on reproductive outcome in oocyte donors. Fertil Steril. 2012 Jun;97(6):1328-30. (IF 3.775) Stoop FS
51. Stouffs K, Vandermaelen D, Massart A, Menten B, Vergult S, Tournaye H, Lissens W. Array comparative genomic hybridization in male infertility. Hum Reprod. 2012 Mar;27(3):921-9. (IF 4.475) Stouffs HR
52. Thuesen LL, Loft A, Egeberg AN, Smitz J, Petersen JH, Andersen AN. A randomized controlled dose-response pilot study of addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization. Hum Reprod. 2012 Oct;27(10):3074-84. (IF 4.475) Thuesen HR
53. Tournaye H. Male factor infertility and ART. Asian J Androl. 2012 Jan;14(1):103-8. (IF: 1,521) Tournaye ASIAN J ANDROL
54. Tournaye HJ, Cohlen BJ. Management of male-factor infertility. Best Pract Res Clin Obstet Gynaecol. 2012 Dec;26(6):769-75.
    (IF 1.731) Tournaye BEST PRACT
55. Valachis A, Polyzos NP, Nearchou A, Lind P, Mauri D. Financial relationships in economic analyses of targeted therapies in oncology. J Clin Oncol. 2012 Apr 20;30(12):1316-20. (IF 18.372)
56. Van Saen D, Gies I, De Schepper J, Tournaye H, Goossens E. Can pubertal boys with Klinefelter syndrome benefit from spermatogonial stem cell banking? Hum Reprod. 2012 Feb;27(2):323-30. (IF 4.475) Van Saen HR
57. Van Saen D, Tournaye H, Goossens E. Presence of spermatogonia in 47,XXY men with no spermatozoa recovered after testicular sperm extraction. Fertil Steril. 2012 Feb;97(2): 319-23.(IF 3.775) Van Saen FS
58. Van Steirteghem A. Celebrating ICSI's twentieth anniversary and the birth of more than 2.5 million children--the 'how, why, when and where'. Hum Reprod. 2012 Jan;27(1):1-2. (IF 4.475) Van Steirteghem HR
59. Van Steirteghem A. Fare well, human reproduction. Hum Reprod. 2012 Dec;27(12):3363-4. (IF: 4,475) Van Steirteghem HR
60. Van Steirteghem A. Lack of ethical approval and omission of experimental evidence. Hum Reprod. 2012 Jul;27(7):1881.
    (IF 4.475) Van Steirteghem HR
61. Wathlet S, Adriaenssens T, Segers I, Verheyen G, Janssens R, Coucke W, Devroey P, Smitz J. New candidate genes to predict pregnancy outcome in single embryo transfer cycles when using cumulus cell gene expression. Fertil Steril. 2012 Aug;98(2):432-9. (IF 3.775) Wathlet FS

1. Tournaye H: "Sperm recovery techniques: Clinical Aspects". In: Gardner Textbook of Assisted Reproductive Techniques. (Ed): Oscar Heini, Informa Healthcare, London (UK) 2012, pp. 242-257.
2. Tournaye H: "Impact of Radiotherapy and Chemotherapy on the Testis. In: Fertility Preservation. Emerging Technologies and Clinical Applications (Eds). Seli, Emre; Agarwal, Ashok, Springer Verlag 2012, pp. 261-271.
3. Tournaye H: "ART in men with 100% immotile Sperm" In: Assisted Reproduction Techniques: Challenges and Management Options (Eds). Sharif K. and Coomarasamy A. Wiley-Blackwell Publishing, Oxford, UK 2012, pp. 349-352.

1. Amps K, Andrews PW, Anyfantis G, Armstrong L, Avery S, Baharvand H, Baker J, Baker D, Munoz MB, Beil S, Benvenisty N, Ben-Yosef D, Biancotti JC, Bosman A, Brena RM, Brison D, Caisander G, Camarasa MV, Chen J, Chiao E, Choi YM, Choo AB, Collins D, Colman A, Crook JM, Daley GQ, Dalton A, De Sousa PA, Denning C, Downie J, Dvorak P, Montgomery KD, Feki A, Ford A, Fox V, Fraga AM, Frumkin T, Ge L, Gokhale PJ, Golan-Lev T, Gourabi H, Gropp M, Lu G, Hampl A, Harron K, Healy L, Herath W, Holm F, Hovatta O, Hyllner J, Inamdar MS, Irwanto AK, Ishii T, Jaconi M, Jin Y, Kimber S, Kiselev S, Knowles BB, Kopper O, Kukharenko V, Kuliev A, Lagarkova MA, Laird PW, Lako M, Laslett AL, Lavon N, Lee DR, Lee JE, Li C, Lim LS, Ludwig TE, Ma Y, Maltby E, Mateizel I, Mayshar Y, Mileikovsky M, Minger SL, Miyazaki T, Moon SY, Moore H, Mummery C, Nagy A, Nakatsuji N, Narwani K, Oh SK, Oh SK, Olson C, Otonkoski T, Pan F, Park IH, Pells S, Pera MF, Pereira LV, Qi O, Raj GS, Reubinoff B, Robins A, Robson P, Rossant J, Salekdeh GH, Schulz TC, Sermon K, Sheik Mohamed J, Shen H, Sherrer E, Sidhu K, Sivarajah S, Skottman H, Spits C, Stacey GN, Strehl R, Strelchenko N, Suemori H, Sun B, Suuronen R, Takahashi K, Tuuri T, Venu P, Verlinsky Y, Ward-van Oostwaard D, Weisenberger DJ, Wu Y, Yamanaka S, Young L, Zhou Q. International Stem Cell Initiative. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol. 2011 Nov 27;29(12):1132-44.
   (IF 23.268)
2. Arce JC, Balen A, Platteau P, Pettersson G, Andersen AN. Mid-luteal progesterone concentrations are associated with live birth rates during ovulation induction. Reprod Biomed Online. 2011 Jan 22. (IF 2.285)
3. Belva F, Bonduelle M, Schiettecatte J, Tournaye H, Painter RC, Devroey P, De Schepper J. Salivary testosterone concentrations in pubertal ICSI boys compared with spontaneously conceived boys. Hum Reprod. 2011 Feb;26(2):438-41. (IF 4.357)
4. Belva F, De Schrijver F, Tournaye H, Liebaers I, Devroey P, Haentjens P, Bonduelle M. Neonatal outcome of 724 children born after ICSI using non-ejaculated sperm. Hum Reprod. 2011 Jul;26(7):1752-8. (IF 4.357)
5. Blockeel C, Baumgarten M, De Vos M, Verheyen G, Devroey P. Administration of GnRH antagonists in case of elevated progesterone at initiation of the cycle: a prospective cohort study. Curr Pharm Biotechnol. 2011 Mar 1;12(3):423-8. (IF 3.455)
6. Blockeel C, Riva A, De Vos M, Haentjens P, Devroey P. Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm injection treatment cycle: impact on ovarian stimulation. A pilot study. Fertil Steril. 2011 Apr;95(5):1714-9. (IF 3.958)
7. Blockeel C, Sterrenburg MD, Broekmans FJ, Eijkemans MJ, Smitz J, Devroey P, Fauser BC. Follicular phase endocrine characteristics during ovarian stimulation and GnRH antagonist cotreatment for IVF: RCT comparing recFSH initiated on cycle day 2 or 5. J Clin Endocrinol Metab. 2011 Apr;96(4):1122-8. (IF 6.495)
8. Blockeel C, Van Vaerenbergh I, Fatemi HM, Van Lommel L, Devroey P, Bourgain C. Gene expression profile in the endometrium on the day of oocyte retrieval after ovarian stimulation with low-dose hCG in the follicular phase. Mol Hum Reprod. 2011 Jan;17(1):33-41. (IF 3.506)
9. Daponte A, Pournaras S, Polyzos NP, Tsezou A, Skentou H, Anastasiadou F, Lialios G, Messinis IE. Soluble FMS-like tyrosine kinase-1 (sFlt-1) and serum placental growth factor (PlGF) as biomarkers for ectopic pregnancy and missed abortion. J Clin Endocrinol Metab. 2011 Sep;96(9):E1444-51. (IF 6.495)
10. De Vos M, Ortega-Hrepich C, Albuz FK, Guzman L, Polyzos NP, Smitz J, Devroey P. Clinical outcome of non-hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome. Fertil Steril. 2011 Oct;96(4):860-4.
    (IF 3.958)
11. Devroey P, Polyzos NP, Blockeel C. An OHSS-Free Clinic by segmentation of IVF treatment. Hum Reprod. 2011 Oct;26(10):2593-7. (IF 4.357)
12. Diedrich K, Fauser BC, Devroey P; Evian Annual Reproduction (EVAR) Workshop Group 2009. Cancer and fertility: strategies to preserve fertility. Reprod Biomed Online. 2011 Mar;22(3):232-48. (IF 2.285)
13. Doody KJ, Devroey P, Leader A, Witjes H, Mannaerts BM. No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part I, corifollitropin alfa. Reprod Biomed Online. 2011 Oct;23(4):449-56. (IF 2.285)
14. ESHRE Task Force on Ethics and Law, de Wert G, Dondorp W, Pennings G, Shenfield F, Devroey P, Tarlatzis B, Barri P, Diedrich K. Intrafamilial medically assisted reproduction. Hum Reprod. 2011 Mar;26(3):504-9. (IF 4.357)
15. Evers JL, van Steirteghem A. Editorial commentary: do not put all your eggs in one basket. Hum Reprod. 2011 Jul;26(7):1729.
    (IF 4.357)
16. Fatemi HM, Kyrou D, Al-Azemi M, Stoop D, De Sutter P, Bourgain C, Devroey P. Ex-vivo oocyte retrieval for fertility preservation. Fertil Steril. 2011 Apr;95(5):1787.e15-7. (IF3.958)
17. Fauser BC, Laven JS, Tarlatzis BC, Moley KH, Critchley HO, Taylor RN, Berga SL, Mermelstein PG, Devroey P, Gianaroli L, D'Hooghe T, Vercellini P, Hummelshoj L, Rubin S, Goverde AJ, De Leo V, Petraglia F. Sex steroid hormones and reproductive disorders: impact on women's health. Reprod Sci. 2011 Aug;18(8):702-12. (IF 2.586)
18. Geens M, Goossens E, Tournaye H. Cell selection by selective matrix adhesion is not sufficiently efficient for complete malignant cell depletion from contaminated human testicular cell suspensions. Fertil Steril. 2011 Feb;95(2):787-91. (IF 3.958)
19. Geens M, Sermon KD, Van de Velde H, Tournaye H. Sertoli cell-conditioned medium induces germ cell differentiation in human embryonic stem cells. J Assist Reprod Genet. 2011 May;28(5):471-80. (IF 1.253)
20. Geens M, Tournaye H, Van de Velde H. Strategies for fertility preservation and restoration in the male. Edition F, V&V in ObGyn, 2011, vol 3, 4, 302-310.
21. Gilchrist RB, De Vos M, Smitz J, Thompson JG. IVM media are designed specifically to support immature cumulus-oocyte complexes not denuded oocytes that have failed to respond to hyperstimulation. Letter to the Editor. Fertil Steril 2011; 96 (2):e141. (IF 3.958)
22. Goossens A, De Brucker M, Cosyns S, Leunen M. Gemiste diagnose van een spontane heterotopische zwangerschap: casus en literatuuroverzicht. Gunaikeïa 2011; 16(3).
23. Goossens E, Bilgec T, Van Saen D, Tournaye H. Mouse germ cells go through typical epigenetic modifications after intratesticular tissue grafting. Hum Reprod. 2011 Dec;26(12):3388-400. (IF 4.357)
24. Henkens T, Snykers S, Vinken M, Fraczek J, Lukaszuk A, Tourwé D, Verheyen G, Van Gompel J, Vanparys P, Rogiers V, Vanhaecke T. Preservation of hepatocellular functionality in cultures of primary rat hepatocytes upon exposure to 4-Me2N-BAVAH, a hydroxamate-based HDAC-inhibitor. Toxicol In Vitro. 2011 Feb;25(1):100-9. (IF 2.546)
25. 25- Kasius JC, Broekmans FJ, Fauser BC, Devroey P, Fatemi HM. Antibiotic prophylaxis for hysteroscopy evaluation of the uterine cavity. Fertil Steril. 2011 Feb;95(2):792-4. (IF 3.958)
26. 26- Kasius JC, Broekmans FJ, Veersema S, Eijkemans MJ, van Santbrink EJ, Devroey P, Fauser BC, Fatemi HM. Observer agreement in the evaluation of the uterine cavity by hysteroscopy prior to in vitro fertilization. Hum Reprod. 2011 Apr;26(4):801-7. (IF 4.357)
27. Kasius JC, Fatemi HM, Bourgain C, Sie-Go DM, Eijkemans RJ, Fauser BC, Devroey P, Broekmans FJ. The impact of chronic endometritis on reproductive outcome. Fertil Steril. 2011 Dec;96(6):1451-6. (IF 3.958)
28. Kyrou D, Fatemi HM, Zepiridis L, Riva A, Papanikolaou EG, Tarlatzis BC, Devroey P. Does cessation of progesterone supplementation during early pregnancy in patients treated with recFSH/GnRH antagonist affect ongoing pregnancy rates? A randomized controlled trial. Hum Reprod. 2011 May;26(5):1020-4. (IF 4.357)
29. Kyrou D, Kolibianakis EM, Fatemi HM, Camus M, Tournaye H, Tarlatzis BC, Devroey P. High exposure to progesterone between the end of menstruation and the day of triggering final oocyte maturation is associated with a decreased probability of pregnancy in patients treated by in vitro fertilization and intracytoplasmic sperm injection. Fertil Steril. 2011 Oct;96(4):884-8. (IF 3.958)
30. Kyrou D, Kolibianakis EM, Fatemi HM, Tarlatzi TB, Devroey P, Tarlatzis BC. Increased live birth rates with GnRH agonist addition for luteal support in ICSI/IVF cycles: a systematic review and meta-analysis. Hum Reprod Update. 2011 Nov-Dec;17(6):734-40.
    (IF 8.755)
31. Kyrou D, Kolibianakis EM, Fatemi HM, Tarlatzis BC, Tournaye H, Devroey P. Is earlier administration of human chorionic gonadotropin (hCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone (GnRH) antagonists? A prospective randomized trial. Fertil Steril. 2011 Nov;96(5):1112-5. (IF 3.958)
32. Kyrou D, Verpoest W, Staessen C, De Vos A, Haentjens P, Liebaers I, Devroey P. No relationship between the type of pituitary suppression for IVF and chromosomal abnormality rates of blastomeres: an observational study. Fertil Steril. 2011 Feb;95(2):563-7. (IF 3.958)
33. Ledger WL, Fauser BC, Devroey P, Zandvliet AS, Mannaerts BM. Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response. Reprod Biomed Online. 2011 Aug;23(2):150-9. (IF 2.285)
34. Ortega C, Verheyen G, Raick D, Camus M, Devroey P, Tournaye H. Absolute asthenozoospermia and ICSI: what are the options? Hum Reprod Update. 2011 Sep-Oct;17(5):684-92. (IF  8.755)
35. Papanikolaou EG, Humaidan P, Polyzos N, Kalantaridou S, Kol S, Benadiva C, Tournaye H, Tarlatzis B. New algorithm for OHSS prevention. Reprod Biol Endocrinol. 2011 Nov 3;9:147. (IF  1.695)
36. Papanikolaou EG, Polyzos NP, Humaidan P, Pados G, Bosch E, Tournaye H, Tarlatzis B. Aromatase inhibitors in stimulated IVF cycles. Reprod Biol Endocrinol. 2011 Jun 21;9:85. (IF  1.695)
37. Papanikolaou EG, Verpoest W, Fatemi H, Tarlatzis B, Devroey P, Tournaye H. A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study. Fertil Steril. 2011 Mar 1;95(3):1174-7.
    (IF 3.958)
38. Polyzos NP, Devroey P. A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? Fertil Steril. 2011 Nov;96(5):1058-61. Review. (IF 3.958)
39. Polyzos NP, Fatemi HM, Zavos A, Grimbizis G, Kyrou D, Velasco JG, Devroey P, Tarlatzis B, Papanikolaou EG. Aromatase inhibitors in post-menopausal endometriosis. Reprod Biol Endocrinol. 2011 Jun 21;9:90. (IF 1.695)
40. Polyzos NP, Mauri D, Ioannidis JP. Guidelines on chemotherapy in advanced stage gynecological malignancies: an evaluation of 224 professional societies and organizations. PLoS One. 2011;6(5):e20106. (IF 4.411)
41. Polyzos NP, Valachis A, Mauri D, Ioannidis JP. Industry involvement and baseline assumptions of cost-effectiveness analyses: diagnostic accuracy of the Papanicolaou test. CMAJ. 2011 Apr 5;183(6):E337-43. (IF 9.015)
42. Polyzos NP, Valachis A, Patavoukas E, Papanikolaou EG, Messinis IE, Tarlatzis BC, Devroey P. Publication bias in reproductive medicine: from the European Society of Human Reproduction and Embryology annual meeting to publication. Hum Reprod. 2011 Jun;26(6):1371-6. (IF  4.357)
43. Poppe K, Unuane D, D'Haeseleer M, Tournaye H, Schiettecatte J, Haentjens P, Velkeniers B. Thyroid function after controlled ovarian hyperstimulation in women with and without the hyperstimulation syndrome. Fertil Steril. 2011 Jul;96(1):241-5. (IF 3.958)
44. Rizzo R, Vercammen M, van de Velde H, Horn PA, Rebmann V. The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells. Cell Mol Life Sci. 2011 Feb;68(3):341-52. (IF 7.047)
45. Sterckx S, Worthington G, Van Steirteghem A. Current controversies in prenatal diagnosis 4: does industry-sponsorship accelerate or hinder the pace of research? Prenat Diagn. 2011 Mar;31(3):244-5. (IF 2.152)
46. Stoop D, Nekkebroeck J, Devroey P. A survey on the intentions and attitudes towards oocyte cryopreservation for non-medical reasons among women of reproductive age. Hum Reprod. 2011 Mar;26(3):655-61. (IF 4.357)
47. Stoop D, Devroey P. The first DK Tank International Conference on Obstetrics, Gynecology and Fertility. Expert Rev Obstet Gynaecol 2011;6(1):17-18.
48. Stoop D, Van Landuyt L, Van den Abbeel E, Camus M, Verheyen G, Devroey P. Should a single blastocyst transfer policy be a clinical decision or should it depend on the embryological evaluation on day 3? Reprod Biol Endocrinol. 2011 May 5;9:60. (IF: 1.695)
49. Stouffs K, Lissens W, Tournaye H, Haentjens P. What about gr/gr deletions and male infertility? Systematic review and meta-analysis. Hum Reprod Update. 2011 Mar-Apr;17(2):197-209. (IF 8.755)
50. Stouffs K, Vandermaelen D, Tournaye H, Liebaers I, Lissens W. Mutation analysis of three genes in patients with maturation arrest of spermatogenesis and couples with recurrent miscarriages. Reprod Biomed Online. 2011 Jan;22(1):65-71. (IF 2.285)
51. Tournaye H. How to predict fatherhood for men with non-obstructive azoospermia opting for TESE-ICSI? Hum Reprod. 2011 Dec;26(12):3213-4. (IF 4.357)
52. Unuane D, Tournaye H, Velkeniers B, Poppe K. Endocrine disorders & female infertility. Best Pract Res Clin Endocrinol Metab. 2011 Dec;25(6):861-73. (IF 4.190)
53. Valachis A, Mauri D, Neophytou C, Polyzos NP, Tsali L, Garras A, Papanikolau EG. Translational medicine and reliability of single-nucleotide polymorphism studies: can we believe in SNP reports or not? Int J Med Sci. 2011;8(6): 492-500.
54. Valachis A, Mauri D, Polyzos NP, Chlouverakis G, Mavroudis D, Georgoulias V. Trastuzumab combined to neoadjuvant chemotherapy in patients with HER2-positive breast cancer: a systematic review and meta-analysis. Breast. 2011 Dec;20(6):485-90. (IF 2.089)
55. Van Landuyt L, Stoop D, Verheyen G, Verpoest W, Camus M, Van de Velde H, Devroey P, Van den Abbeel E. Outcome of closed blastocyst vitrification in relation to blastocyst quality: evaluation of 759 warming cycles in a single-embryo transfer policy. Hum Reprod. 2011 Mar;26(3):527-34. (IF 4.357)
56. Van Landuyt L, Verpoest W, Verheyen G, De Vos A, Van de Velde H, Liebaers I, Devroey P, Van den Abbeel E. Closed blastocyst vitrification of biopsied embryos: evaluation of 100 consecutive warming cycles. Hum Reprod. 2011 Feb;26(2):316-22. (IF 4.357)
57. Van Saen D, Goossens E, Bourgain C, Ferster A, Tournaye H. Meiotic activity in orthotopic xenografts derived from human postpubertal testicular tissue. Hum Reprod. 2011 Feb;26(2):282-93. (IF 4.357)
58. Van Steirteghem A, Williams AC. Plagiarism, retraction and the future. Hum Reprod. 2011 Aug;26(8):1940. (IF: 4.357)
59. Van Vaerenbergh I, Blockeel C, Van Lommel L, Ghislain V, In't Veld P, Schuit F, Fatemi HM, Devroey P, Bourgain C. Cyclooxygenase-2 network as predictive molecular marker for clinical pregnancy in in vitro fertilization. Fertil Steril. 2011 Jan;95(1):448-51. (IF 3.958)
60. Van Vaerenbergh I, Fatemi HM, Blockeel C, Van Lommel L, In't Veld P, Schuit F, Kolibianakis EM, Devroey P, Bourgain C. Progesterone rise on HCG day in GnRH antagonist/rFSH stimulated cycles affects endometrial gene expression. Reprod Biomed Online. 2011 Mar;22(3):263-71. (IF 2.285)
61. Van Vaerenbergh I, Fatemi HM, Bourgain C. Premature progesterone rise and gene expression. Hum Reprod. 2011 Oct;26(10):2913; author reply 2194. (IF 4.357)
62. Verloes A, Van de Velde H, LeMaoult J, Mateizel I, Cauffman G, Horn PA, Carosella ED, Devroey P, De Waele M, Rebmann V, Vercammen M. HLA-G expression in human embryonic stem cells and preimplantation embryos. J Immunol. 2011 Feb 15;186(4):2663-71. (IF 5.745)
63. Verpoest W. PGD and HLA matching: not a quick fix. Reprod Biomed Online. 2011 Sep;23(3):271-3. (IF:2.285)
64. Wathlet S, Adriaenssens T, Segers I, Verheyen G, Van de Velde H, Coucke W, Ron El R, Devroey P, Smitz J. Cumulus cell gene expression predicts better cleavage-stage embryo or blastocyst development and pregnancy for ICSI patients. Hum Reprod. 2011 May;26(5):1035-51. (IF 4.357)

1. Tournaye H. ART with 100% immotile sperm. In: Assisted Reproduction Techniques: Challenges and Management Options. Eds. Sharif K and Coomarasamy A. Wiley-Blackwell Publishing, Oxford, UK, Chapter 82, pp.349, 2011.
2. Tournaye H. Fertiliteitspreservatie op oncologische indicatie bij prepuberale jongens. In: Infertiliteit, Gynaecologie en Obstetrie. Ed. Slager E., Veenma, Rotterdam, The Netherlands, pp. 109-112, 2011.
3. Tournaye H. Assisted Reproduction: Insemination, in-vitro fertilization and intracytoplasmic sperm injection. In: Oxford Textbook on Endocrinology and Diabetes. Eds. Wass JA, Stewart PM. Oxford University Press, Oxford, UK, pp. 1440-1447, 2011.
4. Tournaye H. Impact of radiotherapy and chemotherapy on testicular function. In: Fertility Preservation: Emerging Technologies and Clinical Applications. Eds. Emre Seli and Ashok Agarwal, Humana Press, NY City, USA, Chapter 20, p.261-270, 2011.
5. Tournaye H. Diagnosis and management of male infertility. In: Infertility. Ed. Emre Seli. Wiley-Blackwell, Oxford, UK, 2011.
6. Vloeberghs V., Blockeel C., Devroey P. Chapter 15: "Agonist or antagonist for ovarian stimulation?" How to improve your ART Success Rates: An evidence based review of adjuncts to IVF. Edited by Gab Kovacs, Cambridge University Press, 80-86, 2011.

1. Devroey P, Temmerman M, Verhoeven N, Naaktgeboren N, Heip J, Amy JJ, Van Steirteghem AC (1983) Recurrence of the luteinized unruptured follicle. Br J Obstet Gynaecol 90, 381-381.

1. Adriaenssens T, Wathlet S, Segers I, Verheyen G, De Vos A, Van der Elst J, Coucke W, Devroey P, Smitz J. Cumulus cell gene expression is associated with oocyte developmental quality and influenced by patient and treatment characteristics. Hum Reprod., 25(5):1259-70, 2010. (IF 3.859)
2. Belva F, Bonduelle M, Painter RC, Schiettecatte J, Devroey P, De Schepper J. Serum inhibin B concentrations in pubertal boys conceived by ICSI: first results. Hum Reprod., 205, 2811-2814, 2010. (IF 3.859)
3. Bjorndahl L, Giwercman A, Tournaye H and Weidner W (Eds) Conventional treatment of the male in infertile couples, In: Clinical Andrology - Informa Healthcare, London (UK), 2010, pp. 49-51.
4. Bjorndahl L, Giwercman A, Tournaye H and Weidner W (Eds) IVF and ICSI for treating male infertility, In: Clinical Andrology - Informa Healthcare, London (UK), 2010, pp. 79-84.
5. Bjorndahl L, Giwercman A, Tournaye H and Weidner W (Eds) ART with surgically retrieved sperm, In: Clinical Andrology - Informa Healthcare, London (UK), 2010, pp. 116-123.
6. Bonduelle M, Oberyé J, Mannaerts B, Devroey P. Large prospective, pregnancy and infant follow-up trial assures the health of 1000 fetuses conceived after treatment with the GnRH antagonist ganirelix during controlled ovarian timulation. Hum Reprod., 25(6):1433-40, 2010. (IF 3.859)
7. De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet, 376, 911-21, 2010. (IF 30.758).
8. Donoso P, Staessen C, Collins J, Verpoest W, Fatemi HM, Papanikolaou EG, Devroey P. Prognostic factors for delivery in patients undergoing repeated preimplantation genetic aneuploidy screening. Fertil Steril., 94, 2362-4, 2010. (IF 3.970)
9. Doody K, Devroey P, Gordon K, Witjes H, Mannaerts B. LH concentrations do not correlate with pregnancy in rFSH/GnRH antagonist cycles. Reprod Biomed Online, 20, 565-7, 201. (IF 2.380)
10. ESHRE Task Force on Ethics and Law, including, Dondorp W, de Wert G, Pennings G, Shenfield F, Devroey P, Tarlatzis B, Barri P. Lifestyle-related factors and access to medically assisted reproduction. Hum Reprod., 25, 578-83, 2010. (IF 3.859)
11. ESHRE Capri Workshop Group. Europe the continent with the lowest fertility. Hum Reprod Update, 16, 590-602, 2010. (IF 7.042)
12. Fatemi HM, Kasius JC, Timmermans A, van Disseldorp J, Fauser BC, Devroey P, Broekmans FJ. Prevalence of unsuspected uterine cavity abnormalities diagnosed by office hysteroscopy prior to in vitro fertilization. Hum Reprod., 25, 1959-65, 2010. (IF 3.859)
13. Fatemi HM, Kyrou D, Bourgain C, Van den Abbeel E, Griesinger G, Devroey P. Cryopreserved-thawed human embryo transfer: spontaneous natural cycle is superior to human chorionic gonadotropin-induced natural cycle. Fertil Steril., 94, 2054-8, 2010.
    (IF 3.970)
14. Fatemi HM, Oberyé J, Popovic-Todorovic B, Witjes H, Mannaerts B, Devroey P. Corifollitropin alfa in a long GnRH agonist protocol: proof of concept trial. Fertil Steril., 94, 1922-4, 2010. (IF 3.970)
15. Goossens E, de Vos P, Tournaye H. Array comparative genomic hybridization analysis does not show genetic alterations in spermatozoa and offspring generated after spermatogonial stem cell transplantation in the mouse. Hum Reprod., 25, 1836-42, 2010. (IF 3.859)
16. In't Veld P, De Munck N, Van Belle K, Buelens N, Ling Z, Weets I, Haentjens P, Pipeleers-Marichal M, Gorus F, Pipeleers D. Beta-cell replication is increased in donor organs from young patients after prolonged life support. Diabetes, 59, 1702-1708, 2010.
    (IF 8.505)
17. Kyrou D, Fatemi HM, Popovic-Todorovic B, Van den Abbeel E, Camus M, Devroey P. Vaginal progesterone supplementation has no effect on ongoing pregnancy rate in hCG-induced natural frozen-thawed embryo transfer cycles. Eur J Obstet Gynecol, Reprod Biol., 150, 175-9, 2010. (IF 1.582)
18. Kyrou D, Fatemi HM, Tournaye H, Devroey P. Luteal phase support in normo-ovulatory women stimulated with clomiphene citrate for intrauterine insemination: need or habit? Hum Reprod., 25, 2501-6, 2010. (IF 3.859)
19. Kyrou D, Kolibianakis EM, Devroey P, Fatemi HM. Is the use of donor sperm associated with a higher incidence of preeclampsia in women who achieve pregnancy after intrauterine insemination? Fertil Steril., 93, 1124-7, 2010. (IF 3.970)
20. Kyrou D, Fatemi HM, Blockeel C, Stoop D, Albuarki H, Verheyen G, Devroey P. Transfer of cryopreserved - thawed embryos in hCG induced natural or clomiphene citrate cycles yields similar live birth rates in normo-ovulatory women. J Assist Reprod Genet., 12, 683-689, 2010. (IF 1.359)
21. Leyder M, De Vos M, Popovic-Todorovic B, Dujardin M, Devroey P, Fatemi HM. Intramyometrial ectopic pregnancy in an ICSI patient following uterine artery embolization. Reprod Biomed Online, 20, 831-5, 2010. (IF 2.380)
22. Liebaers I, Desmyttere S, Verpoest W, De Rycke M, Staessen C, Sermon K, Devroey P, Haentjens P, Bonduelle M. Report on a consecutive series of 581 children born after blastomere biopsy for preimplantation genetic diagnosis. Hum Reprod., 25, 275-82, 2010. (IF 3.859)
23. Mateizel I, Spits C, De Rycke M, Liebaers I, Sermon K Derivation, culture, and characterization of VUB hESC lines. In Vitro Cell Dev Biol Anim.; 46(3-4):300-308, 2010. (IF 971)
24. Mfopou JK, Chen B, Mateizel I, Sermon K, Bouwens L. Noggin, retinoids, and fibroblast growth factor regulate hepatic or pancreatic fate of human embryonic stem cells. Gastroenterology. 2010; 138(7):2233-45, 2245, 2010. (IF 12.899)
25. Nekkebroeck J, Barnes J, Bonduelle M, Wennerholm U-B, Ponjaert-Kristoffersen I, Loft, A and Sutcliffe A G. International comparison of parenting styles in ICSI, IVF and natural conception families: Results from a European study. European Journal of Developmental Psychology, vol. 7 issue 3, pages 329-349, 2010.
26. Ning L, Goossens E, Geens M, Van Saen D, Van Riet I, He D, Tournaye H. Mouse spermatogonial stem cells obtain morphologic and functional characteristics of hematopoietic cells in vivo. Hum Reprod., 25, 3101-9, 2010. (IF 3.859)
27. Ombelet W and Tournaye H. (Eds) Artificial insemination: an update, Universa Press Wetteren (Belgium), 2010.
28. Papanikolaou EG, Bourgain C, Fatemi H, Verpoest W, Polyzos NP, De Brabanter A, Kolibianakis E, Tarlatzis B, Devroey P, Tournaye H. Endometrial advancement after triggering with recombinant or urinary HCG: a randomized controlled pilot study. Reprod Biomed Online, 21, 50-5, 2010. (IF 2.380)
29. Papanikolaou EG, Fatemi H, Camus M, Kyrou D, Polyzos NP, Humaidan P, Tarlatzis B, Devroey P, Tournaye H. Higher birth rate after recombinant hCG triggering compared with urinary-derived hCG in single-blastocyst IVF antagonist cycles: a randomized controlled trial. Fertil Steril., 94, 2902-4, 2010. (IF 3.970)
30. Papanikolaou EG, Fatemi H, Venetis C, Donoso P, Kolibianakis E, Tournaye H, Tarlatzis B, Devroey P. Monozygotic twinning is not increased after single blastocyst transfer compared with single cleavage-stage embryo transfer. Fertil Steril., 93, 592-7, 2010.
    (IF 3.970)
31. Stoop D, De Brucker M, Haentjens P, Talebian A, de Mey J, Devroey P. Fast-release orodispersible tramadol as analgesia in hysterosalpingography with a metal cannula or a balloon catheter. Hum Reprod., 25, 1451-7, 2010. (IF 3.859)
32. Stoop D, Van Landuyt L, Paquay R, Fatemi H, Blockeel C, De Vos M, Camus M, Van den Abbeel E, Devroey P. Offering excess oocyte aspiration and vitrification to patients undergoing stimulated artificial insemination cycles can reduce the multiple pregnancy risk and accumulate oocytes for later use. Hum Reprod., 25, 1213-8, 2010. (IF 3.859)
33. Tournaye H. Update on surgical sperm recovery--the European view. Hum Fertil. (Camb), 13, 242-6., 2010.
34. Van Steirteghem A. Editor's Choice - Citation classics. Hum Reprod, 25, 1, 2010. (IF 3.859)
35. Van Steirteghem A. Editor's Choice. Singleton pregnancies' outcome were compared when oocytes and embryos were cultured in two-different commercially available sequential culture media. Hum Reprod, 25, 561, 2010. (IF 3.859)
36. Van Steirteghem A. Can an understanding of the past influence research funding of the future? Hum Reprod 25, 2155, 2010.
    (IF 3.859)
37. Van Steirteghem A. Letter of appreciation: to Bob Edwards, Founding Editor, from André Van Steirteghem, Editor-in-Chief, Human Reproduction. Hum Reprod 25, 2935-2937, 2010. (IF 3.859)
38. Van Vaerenbergh I, McIntire R, Van Lommel L, Devroey P, Giudice L, Bourgain C. Gene expression during successful implantation in a natural cycle. Fertil Steril., 93, 268.e15-8, 2010. (IF 3.970)
39. Verheyen G. Testicular tissue for ICSI. In: Clinical Andrology EAU/ESAU Course Guidelines, Bjorndahl Lars, Giwercman Aleksander, Tournaye Herman, Weidner Wolfgang (eds), London, Informa Healthcare, pp 134-148, 2010.
40. Verpoest W, Seneca S, De Rademaeker M, Sermon K, De Rycke M, De Vos M, Haentjens P, Devroey P, Liebaers I. The reproductive outcome of female patients with myotonic dystrophy type 1 (DM1) undergoing PGD is not affected by the size of the expanded CTG repeat tract. J Assist Reprod Genet., 27, 327-33, 2010. (IF 1.359)

1. Baetens P. Faire un bébé toutes seules, Alternatives Internationales, Libération, mars 2009, 42, 52-53.
2. Baetens P, Devroey P, Camus M. Motivation des femmes péri ou post-ménopausiques en vue d'une grossesse. Références en Gynécologie Obstétrique, 2009, 12, 1, 85-91.
3. Blockeel C, De Vos M, Verpoest W, Stoop D, Haentjens P, Devroey P. Can 200 IU of hCG replace recombinant FSH in the late follicular phase in a GnRH-antagonist cycle? A pilot study. Hum Reprod. 2009 Nov;24(11):2910-6.
4. Blockeel C, Mock P, Verheyen G, Bouche N, Le Goff P, Heyman Y, Wrenzycki C,Höffmann K, Niemann H, Haentjens P, de Los Santos MJ, Fernandez-Sanchez M,Velasco M, Aebischer P, Devroey P, Simón C. An in vivo culture system for humanembryos using an encapsulation technology: a pilot study. Hum Reprod. 2009 Apr;24(4):790-6.
5. Brugnon F, Ouchchane L, Verheyen G, Communal Y, Van der Elst J, Tournaye H, Janny L, Grizard G. Fluorescence microscopy and flow cytometry in measuring activated caspases in human spermatozoa. Int J Androl. 2009 Jun;32(3):265-73.
6. Cauffman G, De Rycke M, Sermon K, Liebaers I, Van de Velde H. Markers that define stemness in ESC are unable to identify the totipotent cells in human preimplantation embryos. Hum Reprod. 2009 Jan;24(1):63-70.
7. Dhont M, Devroey P, Gerris J, Jacquemyn Y, Vergote I. Handboek Gynaecologie. Uitgever Acco Leuven/Den Haag, 2009.
8. De Brucker M, Haentjens P, Evenepoel J, Devroey P, Collins J, Tournaye H. Cumulative delivery rates in different age groups after artificial insemination with donor sperm. Hum Reprod. 2009 Aug;24(8):1891-9.
9. De Rademaeker M, Verpoest W, De Rycke M, Seneca S, Sermon K, Desmyttere S, Bonduelle M, Van der Elst J, Devroey P, Liebaers I. Preimplantation genetic diagnosis for myotonic dystrophy type 1: upon request to child. Eur J Hum Genet. 2009 Nov;17(11):1403-10.
10. De Schepper J, Belva F, Schiettecatte J, Anckaert E, Tournaye H, Bonduelle M. Testicular growth and tubular function in prepubertal boys conceived byintracytoplasmic sperm injection. Horm Res. 2009;71(6):359-63.
11. De Vos A, Staessen C, De Rycke M, Verpoest W, Haentjens P, Devroey P, Liebaers , Van de Velde H. Impact of cleavage-stage embryo biopsy in view of PGD on human blastocyst implantation: a prospective cohort of single embryo transfers. Hum Reprod.2009 Dec;24(12):2988-96.
12. De Vos M, Leunen M, Fontaine C, De Sutter P. Successful primary treatment of a hydatidiform mole with methotrexate and EMA/CO. Case Report Med. 2009; 2009:454161.
13. De Vos A and Van Steirteghem A. Chapter 30: Gamete and embryo Manipulation. In "Yen and Jaffe's Reproductive Endocrinology; Physiology, Pathophysiology, and Clinical Management", 6th edition, Strauss JF and Barbieri R (eds), Elsevier Saunders, Philadelphia, USA, pp759-776, 2009.
14. De Vos A. Chapter 10: Cleavage-stage embryo biopsy. In "Preimplantation Genetic Diagnosis", 2nd edition, Harper J (ed), Cambridge University Press, Cambridge, UK, pp174-185, 2009.
15. Desmyttere S, De Schepper J, Nekkebroeck J, De Vos A, De Rycke M, Staessens C, Liebaers I, Bonduelle M. Two-year auxological and medical outcome of singletons born after embryo biopsy applied in preimplantation genetic diagnosis or preimplantation genetic screening. Hum Reprod. 2009 Feb;24(2):470-6.
16. Devroey P, Boostanfar R, Koper NP, Mannaerts BM, Ijzerman-Boon PC, Fauser BC. ENGAGE Investigators. A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol. Hum Reprod. 2009 Dec;24(12):3063-72.
17. Devroey P, Fauser BC, Diedrich K. Evian Annual Reproduction (EVAR) Workshop Group2008. Approaches to improve the diagnosis and management of infertility. Hum Reprod Update. 2009 Jul-Aug;15(4):391-408.
18. Devroey P, Aboulghar M, Garcia-Velasco J, Griesinger G, Humaidan P, Kolibianakis E, Ledger W, Tomás C, Fauser BC. Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment. Hum Reprod. 2009 Apr;24(4):764-74.
19. Doody K, Devroey P, Gordon K, Witjes H, Mannaerts B. LH concentrations do not correlate with pregnancy in rFSH/GnRH antagonist cycles. Reprod. Biomed. Online 2009Dec 21.
20. ESHRE Capri Workshop Group. Intrauterine insemination. Hum Reprod Update. 2009 May-June 15:265-77.
21. Evers JL, Van Steirteghem AC. All that glistens is not gold. Hum Reprod. 24, 2972-2973, 2009.
22. Fatemi HM, Popovic-Todorovic B, Ameryckx L, Bourgain C, Fauser B, Devroey P. In vitro fertilization pregnancy in a patient with proven chronic endometritis. Fertil Steril. 2009 Apr;91(4):1293.e9-11.
23. Fauser BC, Mannaerts BM, Devroey P, Leader A, Boime I, Baird DT. Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency. Hum Reprod Update. 2009 May-Jun;15(3):309-21.
24. Geens M, Mateizel I, Sermon K, De Rycke M, Spits C, Cauffman G, Devroey P, Tournaye H, Liebaers I, Van de Velde H. Human embryonic stem cell lines derived from single blastomeres of two 4-cell stage embryos. Hum Reprod.2009Nov;24(11):2709-17.
25. Goossens E, De Rycke M, Haentjens P, Tournaye H. DNA methylation patterns of spermatozoa and two generations of offspring obtained after murine spermatogonial stem cell transplantation. Hum Reprod. 2009 Sep;24(9):2255-63.
26. Hayward, B., De Vos, M., Talati, N., Reza Abdollahi, M., Taylor, G., Meyer, E., Williams, D., Maher, E., Setna, F., Nazir, K., Hussaini, S., Jafri, H., Rashid, Y., Sheridan, E. and Bonthron, D. (2009) Genetic and Epigenetic Analysis of Recurrent Hydatidiform Mole. Hum Mutat 30:E629-E639.
27. Keymolen K, Staessen C, Verpoest W, Michiels A, Bonduelle M, Haentjens P, Vanderelst J, Liebaers I. A proposal for reproductive counselling in carriers of Robertsonian translocations: 10 years of experience with preimplantation genetic diagnosis. Hum Reprod. 2009 Sep;24(9):2365-71.
28. Kosmas IP, Zikopoulos K, Georgiou I, Paraskevaidis E, Blockeel C, Tournaye H,Van Der Elst J, Devroey P. Low-dose HCG may improve pregnancy rates and lowerOHSS in antagonist cycles: a meta-analysis. Reprod Biomed Online.2009Nov;19(5):619-30.
29. Kyrou D, Popovic-Todorovic B, Fatemi HM, Bourgain C, Haentjens P, Van Landuyt L, Devroey P. Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH antagonist? Hum Reprod. 2009 Nov;24(11):2902-9.
30. Kyrou D, Kolibianakis EM, Venetis CA, Miliaras D, Theodoridis T, TzevelekisF, Bontis J, Tarlatzis BC. Steroid receptor expression in human endometrium during the follicular phase of stimulated cycles. Hum Reprod. 2009Nov;24(11):2931-5.
31. Kyrou D, Kolibianakis EM, Venetis CA, Papanikolaou EG, Bontis J, Tarlatzis BC. How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Fertil Steril.2009Mar;91(3):749-66.
32. Mateizel I, Spits C, Verloes A, Mertzanidou A, Liebaers I, Sermon K. Characterization of CD30 expression in human embryonic stem cell lines cultured in serum-free media and passaged mechanically. Hum Reprod. 2009Oct;24(10):2477-89.
33. Nekkebroeck, J, Barnes, J, Bonduelle, M, Wennerholm, U-B, Ponjaert-Kristoffersen, I, Loft, A and Sutcliffe, A G. International comparison of parenting styles in ICSI, IVF and natural conception families: Results from a European study. European Journal of Developmental Psychology, 2009, vol. 6 issue 3.
34. Olivennes F, Howles CM, Borini A, Germond M, Trew G, Wikland M,Zegers-Hochschild F, Saunders H, Alam V. CONSORT study group. Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study. Reprod Biomed Online. 2009 Feb;18(2):195-204.
35. Papanikolaou EG, Kolibianakis EM, Pozzobon C, Tank P, Tournaye H, Bourgain C, Van Steirteghem A, Devroey P. Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer. Fertil Steril.2009 Mar;91(3):949-52.
36. Pennings G, Autin C, Decleer W, Delbaere A, Delbeke L, Delvigne A, DeNeubourg D, Devroey P, Dhont M, D'Hooghe T, Gordts S, Lejeune B, Nijs M, Pauwels P, Perrad B, Pirard C, Vandekerckhove F. Cross-border reproductive care in Belgium. Hum Reprod. 2009 Dec;24(12):3108-18.
37. Pennings G, de Wert G, Shenfield F, Cohen J, Tarlatzis B, Devroey P. ESHRE Task Force on Ethics and Law. Providing infertility treatment in resource-poor countries. Hum Reprod. 2009 May;24(5):1008-11.
38. Stoop D, Devroey P. Arguments against preimplantation aneuploidy screening. Expert Review of Obstetrics & Gynecology. 2009, 4, 2, 115-118.
39. Stouffs K, Tournaye H, Liebaers I, Lissens W. Male infertility and the involvement of the X chromosome. Hum Reprod Update. 2009 Nov-Dec;15(6):623-37.
40. Stouffs K, Vandermaelen D, Tournaye H, Liebaers I, Van Steirteghem A, Lissens W [Genetics and male infertility]. Verh K Acad Geneeskd Belg. 2009;71(3):115-39.
41. Theodoridis TD, Zepiridis L, Zafrakas M, Grimbizis G, Tantsis A, Kyrou D, Bontis JN. Levonorgestrel-releasing intrauterine system vs. endometrial thermalablation for menorrhagia. Hormones (Athens). 2009 Jan-Mar;8(1):60-4.
42. Van de Velde H, De Rycke M, De Man C, De Hauwere K, Fiorentino F, Kahraman S, Pennings G, Verpoest W, Devroey P, Liebaers I. The experience of two European preimplantation genetic diagnosis centres on human leukocyte antigen typing. Hum Reprod. 2009 Mar;24(3):732-40.
43. Van Saen D, Goossens E, De Block G, Tournaye H. Regeneration of spermatogenesis by grafting testicular tissue or injecting testicular cells into the testes of sterile mice: a comparative study. Fertil Steril. 2009 May;91(5Suppl):2264-72.
44. Van Saen D, Goossens E, De Block G, Tournaye H. Bone marrow stem cells transplanted to the testis of sterile mice do not differentiate into spermatogonial stem cells and have no protective effect on fertility. Fertil Steril. 2009 Apr;91(4 Suppl):1549-52.
45. Van Steirteghem A. Editor's Choice. Hum Reprod, 24, 1-2, 2009.
46. Van Steirteghem A. Editor's Choice. Hum Reprod, 24, 253, 2009
47. Van Steirteghem A. Editor's Choice. Hum Reprod, 24, 495, 2009
48. Van Steirteghem A. Editor's Choice. Hum Reprod, 24, 763, 2009
49. Van Steirteghem A. Human Reproduction. Hum Reprod, 24, 1007, 2009.
50. Van Steirteghem A. Editor's choice: new debate. Hum Reprod. 24, 1531, 2009.
51. Van Steirteghem A. Worldwide, hepatitis B is the most prevalent viral liver infection and the question arises as to how best to prevent infection of the unaffected partner and the future child when ART is used. Hum Reprod. 24, 2675, 2009.
52. Van Steirteghem A. Editor's choice. Hum Reprod. 24, 2971, 2009.
53. Van Steirteghem A. Senior experts in endometriosis make a plea that all registered and completed phase II/III clinical trials on endometriosis should be published. Hum Reprod, 24, 1241, 2009.
54. Van Steirteghem A. Un quart de siècle d'assistance médicale à la procreation: realizations et defies. Editorial. Références en Gynécologie Obstétrique, 12, 9-12, 2009.
55. Van Vaerenbergh I, Van Lommel L, Ghislain V, In't Veld P, Schuit F, Fatemi HM, Devroey P, Bourgain C. In GnRH antagonist/rec-FSH stimulated cycles, advanced endometrial maturation on the day of oocyte retrieval correlates with altered gene expression. Hum Reprod. 2009 May;24(5):1085-91.
56. Verberg MF, Macklon NS, Nargund G, Frydman R, Devroey P, Broekmans FJ, Fauser BC. Mild ovarian stimulation for IVF. Hum Reprod Update. 2009Jan-Feb;15(1):13-29.
57. Vercammen M, Verloes A, Haentjens P, Van de Velde H. Can solube human leucocyte antigen-G predict successful pregnancy in assisted reproductive technology? Curr Opin Obstet Gynecol. 2009 Jun;21(3):285-90.
58. Verpoest W, Van Landuyt L, Desmyttere S, Cremers A, Devroey P, Liebaers I. The incidence of monozygotic twinning following PGD is not increased. Hum Reprod.2009 Nov;24(11):2945-50.
59. Verpoest W, Haentjens P, De Rycke M, Staessen C, Sermon K, Bonduelle M, Devroey P, Liebaers I. Cumulative reproductive outcome after preimplantation genetic diagnosis: a report on 1498 couples. Hum Reprod. 2009 Nov;24(11):2951-9.
60. Vloeberghs V, Peeraer K, Pexsters A, D'Hooghe T. Ovarian hyperstimulation syndrome and complications of ART. Best Pract Res Clin Obstet Gynaecol. 2009Oct;23(5):691-709.

1. Abyholm T, Andersen AN, Balen AH, Braat DD, Devroey P, D'Hooghe TH, Felberbaum R, Fauser BJ, Fridström M, Hillensjö T, Keck C, Kurunmäki H, Lindenberg S, Ombelet W, Tapanainen J, Varila E, Wramsby H, Koper NP, de Haan AF, Struÿs MJ. A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation. Corifollitropin Alfa Dose-finding Study Group. Hum Reprod. 2008 Nov;23(11):2484-92. (IF: 3.543)
2. Anckaert E, Schiettecatte J, Sleurs E, Devroey P, Smitz J. First trimester screening for Down's syndrome after assisted reproductive technology: non-male factor infertility is associated with elevated free beta-human chorionic gonadotropin levels at 10-14 weeks of gestation. Fertil Steril. 2008 Oct;90(4):1206-10. (IF: 3.168)
3. Belva F, Henriet S, Van den Abbeel E, Camus M, Devroey P, Van der Elst J, Liebaers I, Haentjens P, Bonduelle M. Neonatal outcome of 937 children born after transfer of cryopreserved embryos obtained by ICSI and IVF and comparison with outcome data of fresh ICSI and IVF cycles. Hum Reprod. 2008 Oct;23(10):2227-38. (IF: 3.543)
4. Blockeel C, Schutyser V, De Vos A, Verpoest W, De Vos M, Staessen C, Haentjens P, Van der Elst J, Devroey P. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reprod Biomed Online. 2008 Dec;17(6):848-54. (IF: 2.840)
5. Collins J, Diedrich K, Franks S, Geraedts JP, Jacobs PA, Karges B, Kennedy S, Marozzi A, Regan L, Baird DT, Crosignani PG, Devroey P, Diczfalusy E, Evers JL, Fauser BC, Fraser L, Gianaroli L, Glasier A, Liebaers I, Ragni G, Sunde A, Tarlatzis B, Van Steirteghem A, Collins J, Crosignani PG. Genetic aspects of female reproduction. ESHRE Capri Workshop Group. Hum Reprod Update. 2008 Jul-Aug;14(4):293-307. (IF: 7.257)
6. De Temmerman N, Seneca S, Van Steirteghem A, Haentjens P, Van der Elst J, Liebaers I, Sermon KD. CTG repeat instability in a human embryonic stem cell line carrying the myotonic dystrophy type 1 mutation. Mol Hum Reprod. 2008 Jul;14(7):405-12. (IF: 3.543)
7. De Vos A, Van Landuyt L, Van Ranst H, Vandermonde A, D'Haese V, Sterckx J, Haentjens P, Devroey P, Van der Elst J. Randomized sibling-oocyte study using recombinant human hyaluronidase versus bovine-derived Sigma hyaluronidase in ICSI patients. Hum Reprod. 2008 Aug;23(8):1815-9. (IF: 3.543)
8. Fatemi HM, Popovic-Todorovic B, Donoso P, Papanikolaou E, Smitz J, Devroey P. Luteal phase oestradiol suppression by letrozole: a pilot study in oocyte donors. Reprod Biomed Online. 2008 Sep;17(3):307-11. (IF: 2.840)
9. Fauser BC, Diedrich K, Devroey P; Evian Annual Reproduction Workshop Group 2007. Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation. Hum Reprod Update. 2008 Jan-Feb;14(1):1-14. (IF: 7.257)
10. Geens M, Goossens E, De Block G, Ning L, Van Saen D, Tournaye H. Autologous spermatogonial stem cell transplantation in man: current obstacles for a future clinical application. Hum Reprod Update. 2008 Mar-Apr;14(2):121-30. (IF: 7.257)
11. Goossens E, Geens M, De Block G, Tournaye H. Spermatogonial stem cells: An update on spermatogonail stem cell banking and transplantation. Internal Medicine issue 16, 2008, 15:22-24.
12. Goossens E, Van Saen D, Geens M, Ning L, Tournaye H. Spermatogonial survival in long-term human prepubertal xenografts. Fertil Steril. 2008 Nov;90(5):2019-22. (IF: 3.168)
13. Goossens E, De Block G, Tournaye H. Computer-assisted motility analysis of spermatozoa obtained after spermatogonial stem cell transplantation in the mouse. Fertil Steril. 2008 Oct;90(4 Suppl):1411-6. (IF: 3.168)
14. Goossens E, Frederickx V, Geens M, De Block G, Tournaye H. Cryosurvival and spermatogenesis after allografting prepubertal mouse tissue: comparison of two cryopreservation protocols. Fertil Steril. 2008 Mar;89(3):725-7. (IF: 3.168)
15. Goossens V, De Rycke M, De Vos A, Staessen C, Michiels A, Verpoest W, Van Steirteghem A, Bertrand C, Liebaers I, Devroey P, Sermon K. Diagnostic efficiency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosis. Hum Reprod. 2008 Mar;23(3):481-92. Comment in: Hum Reprod. 2008 Mar;23(3):493-8. (IF: 3.543)
16. Heytens E, Soleimani R, Lierman S, De Meester S, Gerris J, Dhont M, Van der Elst J, De Sutter P. Effect of ionomycin on oocyte activation and embryo development in mouse. Reprod Biomed Online. 2008 Dec;17(6):764-71. (IF: 2.840)
17. Kosmas IP, Tatsioni A, Kolibianakis EM, Verpoest W, Tournaye H, Van der Elst J, Devroey P. Effects and clinical significance of GnRH antagonist administration for IUI timing in FSH superovulated cycles: a meta-analysis. Fertil Steril. 2008 Aug;90(2):367-72. (IF: 3.168)
18. Magli MC, Van den Abbeel E, Lundin K, Royere D, Van der Elst J, Gianaroli L; Committee of the Special Interest Group on Embryology. Revised guidelines for good practice in IVF laboratories. Hum Reprod. 2008 Jun;23(6):1253-62. (IF: 3.543)
19. Mateizel I, De Becker A, Van de Velde H, De Rycke M, Van Steirteghem A, Cornelissen R, Van der Elst J, Liebaers I, Van Riet I, Sermon K. Efficient differentiation of human embryonic stem cells into a homogeneous population of osteoprogenitor-like cells. Reprod Biomed Online. 2008 May;16(5):741-53. (IF: 2.840)
20. Nyboe Andersen A, Balen A, Platteau P, Devroey P, Helmgaard L, Arce JC; Bravelle. Predicting the FSH threshold dose in women with WHO Group II anovulatory infertility failing to ovulate or conceive on clomiphene citrate. Ovulation Induction (BOI) Study Group. Hum Reprod. 2008 Jun;23(6):1424-30. (IF: 3.543)
21. Ombelet W, Cooke I, Dyer S, Serour G, Devroey P. Infertility and the provision of infertility medical services in developing countries. Hum Reprod Update. 2008 Nov-Dec;14(6):605-21. (IF: 7.257)
22. Papanikolaou EG, Kolibianakis EM, Tournaye H, Venetis CA, Fatemi H, Tarlatzis B, Devroey P. Live birth rates after transfer of equal number of blastocysts or cleavage-stage embryos in IVF. A systematic review and meta-analysis. Hum Reprod. 2008 Jan;23(1):91-9. (IF: 3.543)
23. Pennings G, de Wert G, Shenfield F, Cohen J, Tarlatzis B, Devroey P. ESHRE task force on ethics and law 15: cross-border reproductive care. Hum Reprod. 2008 Oct;23(10):2182-4. (IF: 3.543)
24. Pennings G, de Wert G, Shenfield F, Cohen J, Tarlatzis B, Devroey P. ESHRE Task Force on Ethics and Law 14: equity of access to assisted reproductive technology. Hum Reprod. 2008 Apr;23(4):772-4. (IF: 3.543)
25. Platteau P, Nyboe Andersen A, Loft A, Smitz J, Danglas P, Devroey P. Highly purified HMG versus recombinant FSH for ovarian stimulation in IVF cycles. Reprod Biomed Online. 2008 Aug;17(2):190-8. (IF: 2.840)
26. Poppe K, Glinoer D, Tournaye H, Devroey P, Velkeniers B. Impact of the ovarian hyperstimulation syndrome on thyroid function. Thyroid. 2008 Jul;18(7):801-2. Comment on: Thyroid. 2007 Aug;17(8):773-7. (IF: 2.692)
27. Poppe K, Glinoer D, Tournaye H, Devroey P, Schiettecatte J, Velkeniers B. Thyroid function and assisted reproduction. In "The Thyroid and Reproduction" Proceedings symposium "Merck European Thyroid Symposium, Riga, 22-25 May 2008. Lazarus J. Pirags V, Butz S (eds), Thieme, Stuttgart, Germany, pp 33-38, 2008
28. Reichenbach J, Van de Velde H, De Rycke M, Staessen C, Platteau P, Baetens P, Güngör T, Ozsahin H, Scherer F, Siler U, Seger RA, Liebaers I. First successful bone marrow transplantation for X-linked chronic granulomatous disease by using preimplantation female gender typing and HLA matching. Pediatrics. 2008 Sep;122(3):e778-82. (IF: 4.473)
29. Soleimani R, Van der Elst J, Heytens E, Van den Broecke R, Gerris J, Dhont M, Cuvelier C, De Sutter P. Back muscle as a promising site for ovarian tissue transplantation, an animal model. Hum Reprod. 2008 Mar;23(3):619-26. (IF: 3.543)
30. Spits C, Mateizel I, Geens M, Mertzanidou A, Staessen C, Vandeskelde Y, Van der Elst J, Liebaers I, Sermon K. Recurrent chromosomal abnormalities in human embryonic stem cells. Nat Biotechnol. 2008 Dec;26(12):1361-3. (IF: 22.848)
31. Staessen C, Verpoest W, Donoso P, Haentjens P, Van der Elst J, Liebaers I, Devroey P. Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Hum Reprod. 2008 Dec;23(12):2818-25. Comment in: Hum Reprod. 2008 Dec;23(12):2617-21. (IF: 3.543)
32. Stouffs K, Tournaye H, Van der Elst J, Liebaers I, Lissens W. Is there a role for the nuclear export factor 2 gene in male infertility? Fertil Steril. 2008 Nov;90(5):1787-91. (IF: 3.168)
33. Stouffs K, Tournaye H, Van der Elst J, Haentjens P, Liebaers I, Lissens W. Do we need to search for gr/gr deletions in infertile men in a clinical setting? Hum Reprod. 2008 May;23(5):1193-9. (IF: 3.543)
34. Tarlatzis BC, Fauser BC, Legro RS, Norman RJ, Hoeger K, Pasquali R, Franks S, Messinis IE, Casper RF, Homburg JN, Lobo R, Rebar RW, Fleming R, Carr BR, Bouchard P, Chang J, Hugues JN, Azziz R, Kolibianakis EM, Griesinger G, Diedrich K, Balen A, Farquhar C, Devroey P, Ho PC, Collins J, Goulis DG, Eijkemans R, Crosignani PG, DeCherney A, Van Steirteghem A. Consensus on infertility treatment related to polycystic ovary syndrome. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Hum Reprod. 2008 Mar;23(3):462-77. Erratum in: Hum Reprod. 2008 Jun;23(6):1474. (IF: 3.543)
35. Tarlatzis BC, Fauser BC, Legro RS, Norman RJ, Hoeger K, Pasquali R, Franks S, Messinis IE, Casper RF, Homburg R, Lobo R, Rebar RW, Fleming R, Carr BR, Bouchard P, Chang J, Hugues JN, Azziz R, Kolibianakis EM, Griesinger G, Diedrich K, Balen A, Farquhar C, Devroey P, Ho PC, Collins J, Goulis DG, Eijkemans R, Crosignani PG, DeCherney A, van Steirteghem A. Consensus on infertility treatment related to polycystic ovary syndrome. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Fertil Steril. 2008 Mar;89(3):505-22. (IF: 3.168)
36. Ullmann U, Gilles C, De Rycke M, Van de Velde H, Sermon K, Liebaers I. GSK-3-specific inhibitor-supplemented hESC medium prevents the epithelial-mesenchymal transition process and the up-regulation of matrix metalloproteinases in hESCs cultured in feeder-free conditions. Mol Hum Reprod. 2008 Mar;14(3):169-79. (IF: 2.871)
37. Van de Velde H, Cauffman G, Tournaye H, Devroey P, Liebaers I. The four blastomeres of a 4-cell stage human embryo are able to develop individually into blastocysts with inner cell mass and trophectoderm. Hum Reprod. 2008 Aug;23(8):1742-7. (IF: 3.543)
38. Van Nieuwerburgh F, Stoop D, Cabri P, Dhont M, Deforce D, De Sutter P. Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome. Gynecol Endocrinol. 2008 Dec;24(12):669-73. (IF: 1.169)
39. Van Saen D, Goossens E, De Block G, Tournaye H. Bone marrow stem cells transplanted to the testis of sterile mice do not differentiate into spermatogonial stem cells and have no protective effect on fertility. Fertil Steril. 2008 Nov 10. In press. (IF: 3.168)
40. Van Saen D, Goossens E, De Block G, Tournaye H. Regeneration of spermatogenesis by grafting testicular tissue or injecting testicular cells into the testes of sterile mice: a comparative study. Fertil Steril. 2008 Apr 2.. In press. (IF: 3.168)
41. Van Steirteghem A. What next for assisted reproductive technology? A plea for an evidence-based approach. Hum Reprod. 2008 Dec;23(12):2615-6. (IF: 3.543)
42. Van Steirteghem A. Human Reproduction. Editor's note. Hum Reprod. 2008 Aug;23(8):1685. (IF: 3.543)
43. Van Steirteghem A. Editor's choice. Hum Reprod. 2008 Jun;23(6):1239. (IF: 3.543)
44. Van Steirteghem A. One year on... Hum Reprod. 2008 Mar;23(3):461. (IF: 3.543)
45. Van Steirteghem A. Current status of assisted reproductive technology (ART) 30 years after the first IVF birth. In "The Thyroid and Reproduction" Proceedings symposium "Merck European Thyroid Symposium, Riga, 22-25 May 2008. Lazarus J. Pirags V, Butz S (eds), Thieme, Stuttgart, Germany, pp 7-14, 2008
46. Vercammen MJ, Verloes A, Van de Velde H, Haentjens P. Accuracy of soluble human leukocyte antigen-G for predicting pregnancy among women undergoing infertility treatment: meta-analysis. Hum Reprod Update. 2008 May-Jun;14(3):209-18. (IF: 7.257)
47. Verpoest W, Fauser BC, Papanikolaou E, Staessen C, Van Landuyt L, Donoso P, Tournaye H, Liebaers I, Devroey P. Chromosomal aneuploidy in embryos conceived with unstimulated cycle IVF. Hum Reprod. 2008 Oct;23(10):2369-71. (IF: 3.543)
48. Verpoest W, De Rademaeker M, Sermon K, De Rycke M, Seneca S, Papanikolaou E, Spits C, Van Landuyt L, Van der Elst J, Haentjens P, Devroey P, Liebaers I. Real and expected delivery rates of patients with myotonic dystrophy undergoing intracytoplasmic sperm injection and preimplantation genetic diagnosis. Hum Reprod. 2008 Jul;23(7):1654-60. (IF: 3.543)
49. Verpoest W. Preimplantation genetic diagnosis and single embryo transfer. In Ingle Embryo Transfer Ed Gerris J, Adamson D, De Sutter P, Racowsky C. Cambridge University Press
50. Verpoest W, De Vos M. Periconceptional issues in neuromuscular disorders. In Periconceptional medicine Ed Macklon, Greer, Steegers
51. Ziebe S, Devroey P; State of ART 2007 Workshop Group. Collaborators: Nyboe Andersen A, de Beke JO, DeCherney AH, Fauser B, Gianarolli L, Grant J, Greenwood B, Henderson M, Henry M, Jensen TK, Ledger W, Pellicer A, Platteau P, Sunde A, Trounson A. Assisted reproductive technologies are an integrated part of national strategies addressing demographic and reproductive challenges. Hum Reprod Update. 2008 Nov-Dec;14(6):583-92. (IF: 7.257)

1. Anckaert E, Schiettecatte J, Sleurs E, Devroey P, Smitz J. First trimester screening for Down's syndrome after assisted reproductive technology: Non-male factor infertility is associated with elevated free beta-human chorionic gonadotropin levels at 10-14 weeks of gestation. Fertil Steril. 2007 Dec 26.
2. Balen A, Platteau P, Andersen AN, Devroey P, Helmgaard L, Arce JC; for the Bravelle Ovulation Induction (BOI) Study Group. Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial. Hum Reprod. 2007 Jul;22(7):1816-23.
3. Belva F, Henriet S, Liebaers I, Van Steirteghem A, Celestin-Westreich S, Bonduelle M. Medical outcome of 8-year-old singleton ICSI children (born >or=32 weeks' gestation) and a spontaneously conceived comparison group. Hum Reprod. 2007 Feb;22(2):506-15.
4. Boeckxstaens A, Devroey P, Collins J, Tournaye H. Getting pregnant after tubal sterilization: surgical reversal or IVF? Hum Reprod. 2007 Oct;22(10):2660-4.
5. Bourgain C, Devroey P. Histologic and functional aspects of the endometrium in the implantatory phase. Gynecol Obstet Invest. 2007 Oct;64(3):131-3.
6. Brugnon F, Van der Elst J, Verheyen G, Tournaye H. Fluorescence microscopy and flow cytometry in measuring activated caspases in human spermatozoa. International Journal of Andrology, in press, 2007.
7. Camus M. Transfert embryonnaire unique. Pour quelles patientes ? Pour quels résultats? Journal de Gynecologie Obstetrique et Biologie de la Reproduction, 36 :931-935, 2007.
8. Dam AH, Koscinski I, Kremer JA, Moutou C, Jaeger AS, Oudakker AR, Tournaye H, Charlet N, Lagier-Tourenne C, van Bokhoven H, Viville S. Homozygous mutation in SPATA16 is associated with male infertility in human globozoospermia. Am J Hum Genet. 2007 Oct;81(4):813-20.
9. della Ragione T, Verheyen G, Papanikolaou EG, Van Landuyt L, Devroey P, Van Steirteghem A. Developmental stage on day-5 and fragmentation rate on day-3 can influence the implantation potential of top-quality blastocysts in IVF cycles with single embryo transfer. Reprod Biol Endocrinol. 2007 Jan 26;5:2.
10. Devroey P, Fauser BC. Preimplantation aneuploidy screening: a research tool for now. Lancet. 2007 Dec 15;370(9604):1985-6.
11. Diedrich K, Fauser BC, Devroey P, Griesinger G; Evian Annual Reproduction (EVAR) Workshop Group. The role of the endometrium and embryo in human implantation. Hum Reprod Update. 2007 Jul-Aug;13(4):365-77.
12. Donoso P, Devroey P. PGD for aneuploidy screening: an expensive hoax? Best Pract Res Clin Obstet Gynaecol. 2007 Feb;21(1):157-68.
13. Donoso P, Staessen C, Fauser BC, Devroey P. Current value of preimplantation genetic aneuploidy screening in IVF. Hum Reprod Update. 2007 Jan-Feb;13(1):15-25.
14. Donoso P, Tournaye H, Devroey P. Which is the best sperm retrieval technique for non-obstructive azoospermia? A systematic review. Hum Reprod Update. 2007 Nov-Dec;13(6):539-49.
15. Donoso P, Verpoest W, Papanikolaou EG, Liebaers I, Fatemi HM, Sermon K, Staessen C, Van der Elst J, Devroey P. Single embryo transfer in preimplantation genetic diagnosis cycles for women <36 years does not reduce delivery rate. Hum Reprod, 22, 1021-5, 2007.
16. ESHRE Task Force on Ethics and Law including, Pennings G, de Wert G, Shenfield F, Cohen J, Tarlatzis B, Devroey P.
17. ESHRE Task Force on Ethics and Law 13: the welfare of the child in medically assisted reproduction. Hum Reprod. 2007 Oct;22(10):2585-8.
18. ESHRE Task Forse on Ethics and Law, Pennings G, de Wert G, Shenfield F, Cohen J, Tarlatzis B, Devroey P. ESHRE Task Force on Ethics and Law 12: oocyte donation for non-reproductive purposes. Hum Reprod. 2007 May;22(5):1210-3.
19. Fatemi HM, Camus M, Kolibianakis EM, Tournaye H, Papanikolaou EG, Donoso P, Devroey P. The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-relasing hormone antagonist in vitro fertilization cycles during supplementation with progesterone or progesterone and estradiol. Fertil Steril. 2007 Mar;87(3):504-8.
20. Fatemi HM, Bourgain C, Donoso P, Blockeel C, Papanikolaou EG, Popovic-Todorovic B, Devroey P. Effect of oral administration of dydrogestrone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept. Hum Reprod. 2007 May;22(5):1260-3.
21. Fatemi HM, Popovic-Todorovic B, Papanikolaou E, Donoso P, Devroey P. An update of luteal phase support in stimulated IVF cycles. Hum Reprod Update. 2007 Nov-Dec;13(6):581-90.
22. Geuns E, De Temmerman N, Hilven P, Van Steirteghem A, Liebaers I, De Rycke M. Methylation analysis of the intergenic differentially methylated region of DLK1-GTL2 in human. Eur J Hum Genet. 2007 Mar;15(3):352-61
23. Goossens E, De Block G, Tournaye H.Computer-assisted motility analysis of spermatozoa obtained after spermatogonial stem cell transplantation in the mouse. Fertil Steril. 2007 Nov 17.
24. Goossens E, Frederickx V, Geens M, De Block G, Tournaye H. Cryosurvival and spermatogenesis after allografting prepubertal mouse tissue: comparison of two cryopreservation protocols. Fertil Steril. 2007 May 19.
25. Griesinger G, Kolibianakis EM, Papanikolaou EG, Diedrich K, Van Steirteghem A, Devroey P, Ejdrup Bredkjaer H, Humaidan P. Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles. Fertil Steril. 2007 Sep;88(3):616-21
26. Heindryckx B, De Sutter P, Gerris J, Dhont M, Van der Elst J. Embryo development after successful somatic cell nuclear transfer to in vitro matured human germinal vesicle oocytes. Hum Reprod. 22, 1982-1990, 2007.
27. Keymolen K, Goossens V, De Rycke M, Sermon K, Boelaert K, Bonduelle M, Van Steirteghem A, Liebaers I. Clinical outcome of preimplantation genetic diagnosis for cystic fibrosis: the Brussels' experience. Eur J Hum Genet. 2007 Jul;15(7):752-8.
28. Kolibianakis EM, Papanikolaou EG, Tournaye H, Camus M, Van Steirteghem AC, Devroey P. Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone. Fertil Steril. 2007 Nov;88(5):1382-8
29. Kosmas IP, Janssens R, De Munck L, Al Turki H, Van der Elst J, Tournaye H, Devroey P. Ultrasound-guided embryo transfer does not offer any benefit in clinical outcome: a randomized controlled trial. Hum Reprod, 22, 1327-34, 2007
30. Kosmas IP, Tatsioni A, Fatemi HM, Kolibianakis EM, Tournaye H, Devroey P. Human chorionic gonadotropin administration vs. luteinizing monitoring for intrauterine insemination timing, after administration of clomiphene citrate: a meta-analysis. Fertil Steril. 2007 Mar;87(3):607-12.
31. Kosmas IP, Tatsioni A, Kolibianakis EM, Verpoest W, Tournaye H, Van der Elst J, Devroey P. Effects and clinical significance of GnRH antagonist administration for IUI timing in FSH superovulated cycles: a meta-analysis. Fertil Steril, 11, 2007 (Epub ahead of print)
32. Lierman S, De Sutter P, Dhont M, Van der Elst J. Double-quality control reveals high-level toxicity in gloves used for operator protection in assisted reproductive technology. Fertil Steril. 88, suppl 2, 1266-1272, 2007
33. Lierman S, De Sutter P, Liu J, Gerris J, Dhont M, Van der Elst J. Co-culture of pre-antral ovarian follicles does not increase the yield of in-vitro-matured oocytes in the mouse. Reprod Biomed Online, 14, 436-43, 2007.
34. Ombelet W, Camus M, de Catte L. Relative contribution of ovarian stimulation versus in vitro fertilization and intracytoplasmic sperm injection to multifetal pregnancies requiring reduction to twins. Fertil Steril, 88(4): 997-9, 2007.
35. Papanikolaou EG, Kolibianakis EM, Pozzobon C, Tank P, Tournaye H, Bourgain C, Van Steirteghem A, Devroey P. Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer. Fertil Steril. 2007 Jun 5.
36. Smitz J, Andersen AN, Devroey P, Arce JC: MERIT Group. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients. Hum Reprod. 2007 Mar;22(3):676-87
37. Smitz J, Picton HM, Platteau P, Rutherford A, Cortvrindt R, Clyde J, Nogueira D, Devroey P, Lyby K, Gröndahl C. Principal findings from a multicenter trial investigating the safety of follicular-fluid meiosis-activating sterol for in vitro maturation of human cumulus-enclosed oocytes. Fertil Steril. 2007 Apr;87(4):949-64.
38. Spits C, De Rycke M, Van Ranst N, Verpoest W, Lissens W, Van Steirteghem A, Liebaers I, Sermon K. Preimplantation genetic diagnosis for cancer predisposition syndromes. Prenat Diagn. 2007 May;27(5):447-56
39. Ullmann U, In't Veld P, Gilles C, Sermon K, De Rycke M, Van de Velde H, Van Steirteghem A, Liebaers I. Epithelial-mesenchymal transition process in human embryonic stem cells cultured in feeder-free conditions. Mol Hum Reprod. 2007 Jan;13(1):21-32.
40. Van den Abbeel E, Schneider U, Liu J, Agca Y, Critser JK, Van Steirteghem A. Osmotic responses and tolerance limits to changes in external osmolalities, and oolemma permeability characteristics, of human in vitro matured MII oocytes. Hum Reprod. 2007 Jul;22(7):1959-72.
41. Vanhoutte L, De Sutter P, Nogueira D, Gerris J, Dhont M, Van der Elst J. Nuclear and cytoplasmic maturation of in vitro matured human oocytes after temporary nuclear arrest by phosphodiesterase 3-inhibitor. Hum Reprod, 22, 1239-46, 2007.
42. Venetis CA, Kolibianakis EM, Papanikolaou E, Bontis J, Devroey P, Tarlatzis BC. Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Hum Reprod Update. 2007 Jul-Aug;13(4):343-55.

1. Anckaert E, Platteau P, Schiettecatte J, Devroey P, Van Steirteghem A, Smitz J. Spuriously elevated serum estradiol concentrations measured by an automated immunoassay rarely cause unnecessary cancellation of in vitro fertilization cycles. Fertil Steril, 85, 1822.e5-8, 2006.
2. Andersen AN, Devroey P, Arce JC. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod, 21, 3217-27, 2006.
3. Arce JC, Ziebe S, Lundin K, Janssens R, Helmgaard L, Sorensen P. Interobserver agreement and intraobserver reproducibility of embryo quality assessments. Hum Reprod, 21, 2141-8, 2006
4. Balen AH, Platteau P, Andersen AN, Devroey P, Sorensen P, Helmgaard L, Arce JC. The influence of body weight on response to ovulation induction with gonadotrophins in 335 women with World Health Organization group II anovulatory infertility.BJOG. 2006 113(10), 1195-202, 2006.
5. Beckers NG, Platteau P, Eijkemans MJ, Macklon NS, de Jong FH, Devroey P, Fauser BC. The early luteal phase administration of estrogen and progesterone does not induce premature luteolysis in normo-ovulatory women. Eur J Endocrinol,155(2):355-63, 2006.
6. Belva F, Henriet S, Liebaers I, Van Steirteghem A, Celestin-Westreich S, Bonduelle M. Medical outcome of 8-year-old singleton ICSI children (born >=32 weeks' gestation) and a spontaneously conceived comparison group. Hum Reprod, 22, 506-515, 2006.
7. Brugnon F, Van Assche E, Verheyen G, Sion B, Boucher D, Pouly JL, Janny L, Devroey P; Liebaers I, Van Steirteghem A. Study of two markers of apoptosis and meiotic segregation in ejaculated sperm of chromosomal translocation carrier patients. Hum Reprod, 21, 685-693, 2006.
8. Cauffman G, Liebaers I, Van Steirteghem A, Van de Velde H. POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos. Stem Cells, 24, 2685-2691, 2006.
9. De Sutter P, Bontinck J, Schutysers V, Van der Elst J, Gerris J, Dhont M. First-trimester bleeding and pregnancy outcome in singletons after assisted reproduction. Hum Reprod, 21, 1907-11, 2006
10. De Sutter P, Delbaere I, Gerris J, Verstraelen H, Goetgeluk S, Van der Elst J, Temmerman M, Dhont M. Birthweight of singletons after assisted reproduction is higher after single- than after double-embryo transfer. Hum Reprod, 21, 2633-7, 2006
11. Donoso P, Devroey P. PGD for aneuploidy screening: an expensive hoax? Best Pract Res Clin Obstet Gynaecol, Nov 2, 2006.
12. Donoso P, Platteau P, Papanikolaou EG, Staessen C, Van Steirteghem A, Devroey P. Does PGD for aneuploidy screening change the selection of embryos derived from testicular sperm extraction in obstructive and non-obstructive azoospermic men? Hum Reprod, 21, 2390-2395, 2006.
13. ESHRE Task Force on Ethics and Law; Pennings G, de Wert G, Shenfield F, Cohen J, Devroey P, Tarlatzis B. ESHRE Task Force on Ethics and Law 11: Posthumous assisted reproduction. Hum Reprod, 21, 3050-3053, 2006.
14. Everaert K, De Croo I, Kerckhaert W, Dekuyper P, Dhont M, Van der Elst J, De Sutter P, Comhaire F, Mahmoud A, Lumen N. Long term effects of micro-surgical testicular sperm extraction on androgen status in patients with non obstructive azoospermia.
15. BMC Urol, 20, 6:9, 2006
16. Fatemi HM, Kolibianakis EM, Camus M, Tournaye H, Donoso P, Papanikolaou E, Devroey P. Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial. Hum Reprod, 21, 2628-32, 2006.
17. Fatemi HM, Camus M, Kolibianakis EM, Tournaye H, Papanikolaou EG, Donoso P, Devroey P. The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation with progesterone or progesterone and estradiol. Fertil Steril, Nov 28, 2006.
18. Geens M, De Block G, Goossens E, Frederickx V, Van Steirteghem A, Tournaye H. Spermatogonial survival after grafting human testicular tissue to immunodeficient mice. Hum Reprod, 21, 390-396, 2006.
19. Goossens E, Frederickx V, De Block G, Van Steirteghem A, Tournaye H. Evaluation of in vivo conception after testicular stem cell transplantation in a mouse model shows altered post-implantation development. Hum Reprod, 21, 2057-2060, 2006.
20. Goossens E, Frederickx V, De Block G, Van Steirteghem A, Tournaye H. Blastocyst development after assisted reproduction using spermatozoa obtained after testicular stem cell transplantation in mice. Hum Reprod, 21, 1759-64, 2006.
21. Goossens E, Tournaye H. Testicular stem cells. Semin Reprod Med, 24, 370-378, 2006.
22. Griesinger G, Diedrich K, Devroey P, Kolibianakis EM. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Hum Reprod Update, 12, 159-68, 2006.
23. Griesinger G, Diedrich K, Devroey P; Kolibianakis E. Reply: Agonist trigger in the context of OHSS prevention: primum non nocere. Hum Reprod Update, 12, 328-329, 2006.
24. Heindryckx B, Van der Elst J, Dhont M. Culture medium preferences of pre-implantation cloned mouse embryos. Methods Mol Biol, 348:59-78, 2006.
25. Kastrop P, Van der Elst J. Richtlijn 2004/23/EG: consequenties van Europese wetgeving. Tijdschrift voor Fertiliteitsonderzoek, juni 2006
26. Kolibianakis E, Devroey P, Van Steirteghem A. Ovulation induction and assisted reproduction. In book Endocrinology, fifth edition, LJ. DeGroot, JL. Jameson (eds), Saunders Elsevier, chapter 158, vol 3, 2983-2992, 2006.
27. Kolibianakis E, Papanikolaou E, Camus M, Tournaye H, Van Steirteghem A, Devroey P. Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Hum Reprod, 21, 352-357, 2006.
28. Kolibianakis EM, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem A, Devroey P. Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists. Hum Reprod, 21, 1012-1017, 2006.
29. Kolibianakis EM, Collins J, Tarlatzis B, Papanikolaou E, Devroey P. Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review. Hum Reprod Update, 12, 3-12, 2006.
30. Kolibianakis EM, Collins J, Tarlatzis BC, Devroey P, Diedrich K, Griesinger G. Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update, 12, 651-71, 2006.
31. Kosmas IP, Tatsioni A, Fatemi HM, Kolibianakis EM, Tournaye H, Devroey P. Human chorionic gonadotropin administration vs. luteinizing monitoring for intrauterine insemination timing, after administration of clomiphene citrate: a meta-analysis. Fertil Steril, Dec 13, 2006.
32. Le Caignec C; Spits C, Sermon K, De Rycke M, Thienpont B, Debrock S, Staessen C, Moreau Y, Fryns JP, Van Steirteghem A, Liebaers I, Vermeesch JR. Single-cell chromosomal imbalances detection by array CGH. Nucleic Acids Res, 34, e68, 2006.
33. Liu J, Schoonjans L, Tielens S, Speleman F, Cornelissen M, De Sutter P, Dhont M, Van der Elst J. Culturing in vitro produced blastocysts in sequential media promotes ES cell derivation. Mol Reprod Dev, 73, 1017-21, 2006.
34. Mateizel I, De Temmerman N, Ullmann U, Cauffman G, Sermon K, Van de Velde H, De Rycke M, Degreef E, Devroey P, Liebaers I, Van Steirteghem A. Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum Reprod, 21, 503-511, 2006.
35. Mertes H, Pennings G, Van Steirteghem A. An ethical analysis of alternative methods to obtain pluripotent stem cells without destroying embryos. Hum Reprod, 21, 2749-2755, 2006.
36. Michiels A, Van Assche E, Liebaers I, Van Steirteghem A, Staessen C. The analysis of one or two blastomeres for PGD using fluorescence in-situ hybridization. Hum Reprod, 21, 2396-2402, 2006.
37. Ogur G, Van Assche E, Vegetti W, Verheyen G, Tournaye H, Bonduelle M, Van Steirteghem A, Liebaers I. Chromosomal segregation in spermatozoa of 14 Robertsonian translocation carriers. Mol Hum Reprod, 12, 209-215, 2006.
38. Papanikolaou E, Camus M, Fatemi H, Tournaye H, Verheyen G, Van Steirteghem A, Devroey P. Early pregnancy loss is significantly higher after day 3 single embryo transfer than after day 5 single blastocyst transfer in GnRH antagonist stimulated IVF cycles. Reprod Biomed Online, 1, 60-5, 2006.
39. Papanikolaou E, Camus M, Kolibianakis EM, Van Landuyt L, Van Steirteghem A, Devroey P. In vitro fertilization with single blastocyst-stage versus single cleavage-stage embryos. N Engl J Med, 354, 1139-46, 2006.
40. Papanikolaou E, Pozzobon C, Kolibianakis E, Camus M, Tournaye H, Fatemi H, Van Steirteghem A, Devroey P. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril, 85, 112-120, 2006.
41. Pennings G, Devroey P. Subsidized in-vitro fertilization treatment and the effect on the number of egg sharers. Reprod Biomed Online, 13(1), 8-10, 2006.
42. Platteau P, Staessen C, Michiels A, Van Steirteghem A, Liebaers I, Devroey P. Which patients with recurrent implantation failure after IVF benefit from PGD for aneuploidy screening? Reprod Biomed Online, 12, 334-9, 2006.
43. Platteau P, Andersen AN, Balen A, Devroey P, Sorensen P, Helmgaard L, Arce JC; Menopur Ovulation Induction (MOI) Study Group. Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study. Hum Reprod, 21, 1798-804, 2006.
44. Poppe K, Glinoer D, Tournaye H, Maniewski U, Haentjens P, Velkeniers B. Is systematic screening for thyroid disorders indicated in subfertile men? Eur J Endocrinol, Mar; 154(3):363-6, 2006.
45. Poppe K, Glinoer D, Tournaye H, Devroey P, Schiettecatte J, Haentjens P, Velkeniers B. Thyroid autoimmunity and female infertility. Verh K. Acad. Geneesk. Belg. Vol. 68 (5-6), 357-377, 2006.
46. Smitz J, Picton HM, Platteau P, Rutherford A, Cortvrindt R, Clyde J, Nogueira D, Devroey P, Lyby K, Grondahl C. Principal findings from a multicenter trial investigating the safety of follicular-fluid meiosis-activating sterol for in vitro maturation of human cumulus-enclosed oocytes. Fertil Steril, Dec 29, 2006.
47. Smitz J, Andersen AN, Devroey P, Arce JC. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients. Hum Reprod, Nov 16, 2006.
48. Soleimani R, De Vos W, Van Oostveldt P, Lierman S, Van den Broecke R, De Sutter P, Dhont M, Van der Elst J. Two novel techniques to detect follicles in human ovarian cortical tissue. Hum Reprod, 21, 1720-4, 2006.
49. Spits C, De Rycke M, Verpoest W, Lissens W, Van Steirteghem A, Liebaers I, Sermon K. Preimplantation genetic diagnosis for Marfan syndrome. Fertil Steril, 86, 310-20, 2006.
50. Spits C, Le Caignec C, De Rycke M, Van Haute L, Van Steirteghem A, Liebaers I, Sermon K. Optimization and evaluation of single-cell whole-genome multiple displacement amplification. Hum Mutat, 27, 496-503, 2006.
51. Stouffs K, Lissens W, Tournaye H, Van Steirteghem A, Liebaers I. Alterations of the USP26 gene in Caucasian men. Int J Androl, 29, 614-7, 2006.
52. Stouffs K, Willems A, Lissens W, Tournaye H, Van Steirteghem A, Liebaers I. The role of the testis-specific gene hTAF7L in the aetiology of male infertility. Mol Hum Reprod, 12, 263-267, 2006.
53. Tarlatzis BC, Fauser BC, Kolibianakis EM, Diedrich K, Rombauts L, Devroey P. GnRH antagonists in ovarian stimulation for IVF. Hum Reprod Update, 12(4), 333-40, 2006. in: Hum Reprod Update. 2006 Nov-Dec;12(6):797. Rombauts, L [added], 2006
54. Tavaniotou A, Devroey P. Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles. Reprod Biomed Online, 13(3), 326-30, 2006
55. Tielens S, Verhasselt B, Liu J, Dhont M, Van Der Elst J, Cornelissen M. Generation of embryonic stem cell lines from mouse blastocysts developed in vivo and in vitro: relation to Oct-4 expression. Reproduction, 132, 59-66, 2006
56. Tournaye H. Evidence-based management of male subfertility. Curr Opin Obstet Gynecol, Jun; 18(3):253-9, 2006.
57. Tournaye H. Spijt na vasectomie: wat nu? Agenda Andrologie.
58. Tournaye H. Het chirurgisch verkrijgen van epidimaire en testiculaire zaadcellen. TFO, 20, 1B, 12-15, 2006
59. Tournaye H. Male contributions to the biology of conception and fertilization. In: "Andrology for the Clinician" by Wolf-Bernhard Schill (Editor), Frank H. Comhaire (Editor), Timothy B. Hargreave (Editor). Springer Verlag, 2006.
60. Tournaye H and Goossens E. Adult stem cell population in the testis. In; "Stem cells in Human Reproduction, Basic Science and Therapeutic Potential" by Simon C and Pellicer A (Editors), Informa, London, pp 77-90, 2006.
61. Tournaye H. Intracytoplasmatische sperma injectie met chirurgisch verkregen zaad. Welke techniek moet men toepassen en welk resultaat kan men verwachten?, Agenda Andrologie.
62. Tournaye H. Evidence-based behandelen van mannelijke subfertiliteit, Agenda Andrologie
63. Van de Velde H, De Rycke M, Liebaers I. HLA-typering en pre-implantatie genetische diagnose. TFO, 20, 3B, 65-71, 2006.
64. Van de Velde H, De Rycke M and Liebaers I. HLA typing and preimplantation genetic diagnosis. Revue de la Société de Médicine de la reproduction. 8, 273-280, 2006.
65. Van der Elst J. Kinderen zonder zwangerschap. De toekomstvoorspeller. Tijdschrift Universiteit Gent, januari 2006
66. Van der Elst J. Kinderen zonder zwangerschap. De toekomstvoorspeller. Tijdschrift Universiteit Gent, januari 2006.
67. Van der Elst J. Vrouwen moeten bewust keuzes maken. Artsenkrant, p14, 12 mei 2006
68. Van Landuyt L, Verheyen G, Tournaye H, Camus M, Devroey P, Van Steirteghem A. New Belgian embryo transfer policy leads to sharp decrease in multiple pregnancy rate. Reprod Biomed Online, 13, 765-71, 2006.
69. Van Steirteghem A, Van der Elst J. "We willen koppels, hetero of homo, een gezond en gelukkig kind geven", AKADEMOS, infomagazine van de VUB, 9, p4-5, april 2006.
70. Verheyen G. Cryopreservatie van testiculaire zaadcellen. TFO, 20, 2, 26-32, 2006
71. Vernaeve V, Verheyen G, Goossens A, Van Steirteghem A, Devroey P, Tournaye H. How successful is repeat testicular sperm extraction in patients with azoospermia? Hum Reprod, 21, 1551-1554, 2006.
72. Verpoest W, Tournaye H. ICSI: hype or hazard. A review. Human Fertility Jun 4; 9(2): 81-92, 2006.
73. Verpoest WM, Kolibianakis E, Papanikolaou E, Smitz J, Van Steirteghem A, Devroey P. Aromatase inhibitors in ovarian stimulation for IVF/ICSI: a pilot study. Reprod Biomed Online, 13, 166-72, 2006.

1. Ameryckx L, Fatemi H M, De Sutter P, Amy JJ. GnRH antagonist in the adjuvant treatment of a recurrent ovarian granulosa cell tumor: A case report", Gynecol Oncol, 99(3):764-766, 2005.
2. Baetens P, Van de Velde H, Camus M, Pennings G, Van Steirteghem A, Devroey P, Liebaers I. HLA-matched embryos selected for siblings requiring haematopoietic stem cell transplantation: a psychological perspective. Reprod Biomed Online, 10, 154-163, 2005.
3. Baetens, P. et M. Camus. IAD et nouvelles parentalités: Les demandes de couples de femmes homosexuelles. La revue du Practicien Gynécologie et Obstétrique, n 92, 2005.
4. Baetens, P. Adoptie door personen van hetzelfde geslacht en zorgouderschap. Verslag hoorzitting Belgische Kamer van Volksvertegenwoordiging. Wetsvoorstel adoptie, 2005.
5. Baetens P (2005) "PMA en Belgique" Livre des communications IIIième Conférence sur l'Homoparentalité, Paris , 25-26 octobre 2005.
6. Bonduelle M, Wennerholm UB, Loft A, Tarlatzis B, Peters C, Henriet S, Mau C, Victorin-Cederquist A, Van Steirteghem A, Balaska A, Emberson JR, Sutcliffe AG. A multi-centre cohort study of the physical health of 5-year-old children conceived after intracytoplasmic sperm injection, in vitro fertilization and natural conception. Hum Reprod, 20, 413-419, 2005.
7. Bruynsesteyn K, Bonsel GJ, Braat DDM, Fauser BCJM, Devroey P, van Genugten MLL. Economic evaluation of the administration of follitropin-ß with a pen device. Reprod Biomed Online, 11, 26-35, 2005.
8. Cauffman G, Van de Velde H, Liebaers I, Van Steirteghem A. Oct-4 mRNA and protein expression during human preimplantation development. Mol Hum Reprod, 11, 173-181, 2005.
9. Cauffman G, Van de Velde H, Liebaers I, Van Steirteghem A. DAZL expression in human oocytes, preimplantation embryos and embryonic stem cells. Mol Hum Reprod, 11, 405-411, 115, 2005.
10. De Rycke M, Georgiou I, Sermon K, Lissens W, Henderix P, Joris H, Platteau P, Van Steirteghem A, Liebaers I. PGD for autosomal dominant polycystic kidney disease type 1. Mol Hum Reprod, 11, 65-71, 2005.
11. Devroey P. Snelle voortplanting is een deugd: IVF, KI, ICSI en KID in de praktijk. ZIZO, 2de jaargang, 70, 8-10, 2005.
12. De Vos, A., Van Steirteghem, A. Assisted reproduction techniques for male-factor infertility: current status of intracytoplasmic sperm injection. In A Textbook of In Vitro Fertilization and Assisted Reproduction (third edition). Brinsden, P.R. (ed). London, The Parthenon Publishing Group, chapter 18, 2005.
13. ESHRE Capri Workshop Group: D.T. Baird, J. Collins, E. Egozcue, L.H. Evers, L. Gianaroli, H. Leridon, A. Sunde, A. Templeton, A. Van Steirteghem, J. Cohen, P.G. Crosignani, P. Devroey, K. Diedrich, B.C.J.M. Fauser, L. Fraser, A. Glasier, I. Liebaers, G. Mautone, G. Penney, B. Tarlatzis. Fertilty and ageing. Hum Reprod Update, 11, 261-276, 2005.
14. Fatemi H, Al-Turki H, Papanikolaou E, Kosmas I, De Sutter P, Devroey P. Case report. Successful treatment of an aggressive recurrent post-menopausal endometriosis with an aromatase inhibitor. Reprod Biomed Online, 11, 455-457, 2005.
15. Fatemi H M, Kolibianakis EM, Camus M, Tournaye H, Van Steirteghem A, Devroey P. Progesterone Versus Progesterone Combined With Estradiol as Luteal Support in Cycles Stimulated With GnRH Antagonist/rec-FSH for IVF: A Randomized Clinical Trial, Fertil Steril, 84, Suppl 1, Page S322, 2005.
16. Fauser BCJM, Devroey P, Macklon NS. Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet, 365, 1807-1816, 2005.
17. Fauser BCJM, Devroey P. Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow? Fertil Steril, 83, 1607-1611, 2005.
18. Hay CJ, B.M. Brady, M. Zitzmann, K. Osmanagaoglu, P. Pollanen, D. Apter, F.C.W. Wu, R.A. Anderson, E. Nieschlag, P. Devroey, I. Huhtaniemi and W.M. Kersemaekers. A multicenter phase IIb study of a novel combination of intramuscular androgen (testosterone decanoate) and oral progestogen (Etonogestrel) for male hormonal contraception. J Clin Endocrinol Metab, 90, 2042-2049, 2005.
19. Kolibianakis EM, Bourgain C, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Prolongation of follicular phase by delaying hCG administration results in a higher incidence of endometrial advancement on the day of oocyte retrieval in GnRH antagonist cycles. Hum Reprod, 20, 2453-2456, 2005.
20. Kolibianakis E, Schultze-Mosgau A, Schroer A, Van Steirteghem A, Devroey P, Diedrich K, Griesinger G. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Hum Reprod, 20, 2887-92, 2005.
21. Kolibianakis E, Tarlatzis B, Devroey P. GnRH antagonists in IVF. Reprod Biomed Online, 10, 705-712, 2005.
22. Kolibianakis E, Papanikolaou E, Fatemi H, Devroey P. Estrogen and folliculogenesis: is one necessary for the other? Curr Opin Obstet Gynecol, 17, 249-253, 2005.
23. Macklon N, Devroey P, Fauser B. Multiple pregnancy after assisted reproduction. Lancet, 366, 453-454, 2005.
24. Papanikolaou E, Camus M, Fatemi HM, Tournaye H, Verheyen G, Van Steirteghem A, Devroey P. Early pregnancy loss is significantly higher after day 3 single embryo transfer than after day 5 single blastocyst transfer in GnRH antagonist stimulated IVF cylces. Reprod Biomed Online, 12, 60-65, 2005.
25. Papanikolaou E, Tournaye H, Verpoest W, Camus M, Vernaeve V, Van Steirteghem A, Devroey P. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Hum Reprod, 20, 636-641, 2005.
26. Papanikolaou E, Bourgain C, Kolibianakis E, Tournaye H, Devroey P. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes. Hum Reprod, 20, 1541-1547, 2005.
27. Papanikolaou E, Vernaeve V, Kolibianakis E, Van Assche E, Bonduelle M, Liebaers I, Van Steirteghem A, Devroey P. Is chromosome analysis mandatory in the initial investigation of normovulatory women seeking infertility treatment? Hum Reprod, 20, 2899-903, 2005.
28. Papanikolaou EG, D'Haeseleer E, Verheyen G, Van de Velde H, Camus M, Van Steirteghem A, Devroey P, Tournaye H. Live birth rate is significantly higher after blastocyst transfer than after cleavage-stage embryo transfer when at least four embryos are available on day 3 of embryo culture. A randomized prospective study. Hum Reprod, 20, 3198-3203, 2005.
29. Papanikolaou E, Platteau P, Albano C, Kolibianakis E, Devroey P. Achievement of pregnancy three times in the same patient during luteal GnRH agonist administration. Reprod Biomed Online, 10, 347-349, 2005.
30. Papanikolaou E, Platteau P, Albano C, Nogueira D, Cortvrindt R, Devroey P, Smitz J. Immature oocyte in-vitro maturation: clinical aspects. Reprod Biomed Online, 10, 587-592, 2005.
31. Papanikolaou E, Kolibianakis E, Devroey P. Emerging drugs in assisted reproduction. Expert Opin Emerg Drugs, 10, 425-440, 2005.
32. Platteau P, Staessen C, Michiels A, Van Steirteghem A, Liebaers I, Devroey P. Preimplantation genetic diagnosis for aneuploidy screening in patients with unexplained recurrent miscarriages. Fertil Steril, 83, 393-397, 2005.
33. Platteau P, Staessen C, Michiels A, Van Steirteghem A, Liebaers I, Devroey P. Preimplantation genetic diagnosis for aneuploidy screening in women older than 37 years. Fertil Steril, 84, 319-2, 2005.
34. Poppe K, Glinoer D, Tournaye H, Schiettecatte J, Haentjens P, Velkeniers B. Thyroid function after assisted reproductive technology in women free of thyroid disease. Fertil Steril, Jun;83(6):1753-7, 2005.
35. Sermon K, Liebaers I, Van Steirteghem A. Preimplantation Genetic Diagnosis. In book "Molecular Diagnostics", G.Patrinos and W. Ansorge (eds), chapter 23, pp 297-309, 2005.
36. Shenfield F, G. Pennings, J. Cohen, P. Devroey, B. Tarlatzis, The ESHRE Task Force on Ethics and Law. Taskforce 9: the application of preimplantation genetic diagnosis for human leukocyte antigen typing of embryos. Hum Reprod, 20, 845-847, 2005.
37. Spits C, De Rycke M, Van Ranst H, Joris H, Verpoest W, Lissens W, Devroey P, Van Steirteghem A, Liebaers I, Sermon K. Preimplantation genetic diagnosis for neurofibromatosis type1. Mol Hum Reprod, 11, 381-387, 2005.
38. Staessen C, Platteau P, Van Assche E, Michiels A, Tournaye H, Camus M, Devroey P, Liebaers I, Van Steirteghem A. Reply to comments on Staessen et al. (2004) Letter to the Editor. Hum Reprod, 20, 2364-2365, 2005.
39. Cohen J. and Munné S. Comment 2 on Staessen et al. (2004): Two-cell biopsy and PGD pregnancy outcome. Letter to the Editor, Hum Reprod, 20, 2363-2364, 2005.
40. Mastenbroek S, Bossuyt P, Heineman MJ, Repping S, van der Veen F. Comment 1 on Staessen et al. (2004): Design and analysis of a randomized controlled trial studying preimplantation genetic screening. Letter to the Editor, Hum Reprod, 20, 2362-2363, 2005.
41. Stouffs K, Lissens W, Tournaye H, Van Steirteghem A, Liebaers I. Possible role of USP26 in patients with severely impaired spermatogenesis. Eur J Hum Genet, 13, 336-340, 2005.
42. Stouffs K, Lissens W, Tournaye H, Van Steirteghem A, Liebaers I. The choice and outcome of the fertility treatment of 38 couples in whom the male partner has a Yq microdeletion. Hum Reprod, 20, 1887-1896, 2005.
43. Stouffs K, Lissens W, Tournaye H, Van Steirteghem A, Liebaers I. SYCP3 mutations are uncommon in patients with azoospermia. Fertil Steril, 84, 1019-20, 2005.
44. Tournaye H. Sperm and assisted reproduction. Minerva Urol Nefrol, Jun;57(2):91-7. Review, 2005
45. Van den Abbeel E, Camus M, Verheyen G, Van Waesberghe L, Devroey P, Van Steirteghem A. Slow controlled-rate freezing of sequentially cultured human blastocysts: an evaluation of two freezing strategies. Hum Reprod, 20, 2939-45, 2005.
46. Van Landuyt L, De Vos A, Joris H, Verheyen G, Devroey P, Van Steirteghem A. Blastocyst formation in in vitro fertilization versus intracytoplasmic sperm injection cycles: influence of the fertilization procedure. Fertil Steril, 83, 1397-1403, 2005.
47. Van Steirteghem A and Evers H. Prijswinnaars 21de ESHRE congres 2005, Kopenhagen, 19-22 juni 2005. TFO 3, 66-67, 2005.
48. Van Steirteghem A. Réalisations et défis après un quart de siècle d'Assistance Médicale à la Procréation. In "Journées de techniques avancées en gynécologie obstétrique PMA et pédiatrie" Azoulay M (eds), Editions ESKA, Paris, France, pp 21-30, 2005.
49. Van Steirteghem A. Le nombre d'embryons transférés et le taux de grossesse: l'expérience Belge. In "Journées de techniques avancées en gynécologie obstétrique PMA et pédiatrie" Azoulay M (eds), Editions ESKA, Paris, France, pp 112-117, 2005.
50. Van Steirteghem A. DPI et choix du sexe. In "Journées de techniques avancées en gynécologie obstétrique PMA et pédiatrie" Azoulay M (eds), Editions ESKA, Paris, France, pp 136-141, 2005.
51. Vernaeve V, Festré V, Baetens P, Devroey P, Van Steirteghem A, Tournaye H. Reproductive decisions by couples undergoing artificial insemination with donor sperm for severe male infertility: implicatins for medical counselling. Int J Androl, 28, 22-26, 2005.
52. Verpoest W, Tournaye H. ICSI: Hype or hazard?, Hum Fertil (Camb), Jun;9(2):81-92. 2006.
53. Ponjaert-Kristoffersen I, Bonduelle M, Barnes J, Nekkebroeck J, Wennerholm U-B, Tarlatzis B, Peters C, Hagberg BS, Berner A, Sutcliffe AG, Loft A. International collaborative study of intracytoplasmic sperm injection conceived, in vitro fertilization-conceived, and naturally conceived 5-year-old child outcomes: Cognitive and motor assessments. Pediatrics 2005 Mar; 115(3):E283-E289
54. Nekkebroeck, J; Daniëls, K; Keirse, L; Bauwens, A, Lemmens, G, Migerode, L. Impact van het verlies van een sibling op relaties tijdens de adolescentie. Tijdschrift voor Familietherapie 2005, 11, (2): 179-196.

1. Tournaye H, Goossens E, Verheyen G, Frederickx V, De Block G, Devroey P, Van Steirteghem A (2004) Preserving the reproductive potential of men and boys with cancer: current concepts and future prospects. Hum Reprod Update 10, 525-521.
2. Vernaeve V, Krikilion A, Verheyen G, Van Steirteghem A, Devroey P, Tournaye H (2004) Outcome of testicular sperm recovery and ICSI in patients with non-obstructive azoospermia with a history of orchidopexy. Hum Reprod 19, 2307-2301.
3. De Rycke M, Georgiou I, Sermon K, Lissens W, Henderix P, Joris H, Platteau P, Van Steirteghem A, Liebaers I (2004) PGD for autosomal dominant polycystic kidney disease type 1. Mol Hum Reprod.
4. Bonduelle M, Wennerholm UB, Loft A, Tarlatzis BC, Peters C, Henriet S, Mau C, Victorin-Cederquist A, Van Steirteghem A, Balaska A, Emberson JR, Sutcliffe AG (2004) A multi-centre cohort study of the physical health of 5-year-old children conceived after intracytoplasmic sperm injection, in vitro fertilization and natural conception. Hum Reprod , .
5. De Sutter P, Lejeune B, Dhont M, Leroy F, Englert Y, Van Steirteghem A (2004) Ten years follow-up of medically assisted procreation in Belgium. Rev Med Brux 25, 160-161.
6. Collins JA, Van Steirteghem A (2004) Overall prognosis with current treatment of infertility. Hum Reprod Update 10, 309-301.
7. Lunenfeld B, Van Steirteghem A (2004) Infertility in the third millennium: implications for the individual, family and society: condensed meeting report from the Bertarelli Foundation's second global conference. Hum Reprod Update 10, 317-311.
8. De Temmerman N, Sermon K, Seneca S, De Rycke M, Hilven P, Lissens W, Van Steirteghem A, Liebaers I (2004) Intergenerational instability of the expanded CTG repeat in the DMPK gene: studies in human gametes and preimplantation embryos. Am J Hum Genet 75, 325-321.
9. Sermon K, Van Steirteghem A, Liebaers I (2004) Preimplantation genetic diagnosis. Lancet 363, 1633-1631.
10. Pennings G, Van Steirteghem A (2004) The subsidiarity principle in the context of embryonic stem cell research. Hum Reprod 19, 1060-1061.
11. Balen AH, Mulders AG, Fauser BC, Schoot BC, Renier MA, Devroey P, Struijs MJ, Mannaerts BM (2004) Pharmacodynamics of a Single Low Dose of Long-Acting Recombinant Follicle-Stimulating Hormone (FSH-Carboxy Terminal Peptide, Corifollitropin Alfa) in Women with World Health Organization Group II Anovulatory Infertility. J Clin Endocrinol Metab 89, 6297-6291.
12. Kolibianakis E, Albano C, Zikopoulos K, Kahn JA, Van Steirteghem A, Devroey P (2004) GnRH antagonists in poor responders. Acta Obstet Gynecol Scand 83, 1216-1211.
13. Kolibianakis E, Bourgain C, Devroey P (2004) Limits of agreement? Fertil Steril 82, 1475-1472.
14. Kosmas IP, Kolibianakis EM, Devroey P (2004) Association of estradiol levels on the day of hCG administration and pregnancy achievement in IVF: a systematic review. Hum Reprod 19, 2446-2441.
15. Shenfield F, Pennings G, Cohen J, Devroey P, Tarlatzis B, Sureau C (2004) Taskforce 8: ethics of medically assisted fertility treatment for HIV positive men and women. Hum Reprod 19, 2454-2451.
16. Devroey P, Kolibianakis E (2004) Is addressing the needs of its membership an easy task for the American Society for Reproductive Medicine? Fertil Steril 82, 555-551.
17. Kolibianakis EM, Zikopoulos K, Verpoest W, Camus M, Joris H, Van Steirteghem AC, Devroey P (2004) Should we advise patients undergoing IVF to start a cycle leading to a day 3 or a day 5 transfer? Hum Reprod 19, 2550-2551.
18. Kolibianakis EM, Devroey P (2004) No decrease occurs in the number of COCs retrieved with repeated IVF cycles. Hum Reprod 19, 1927-1921.
19. Zikopoulos K, Kolibianakis EM, Devroey P (2004) Ovarian stimulation for in vitro fertilization in patients with endometriosis. Acta Obstet Gynecol Scand 83, 651-651.
20. Platteau P, Smitz J, Albano C, Sorensen P, Arce JC, Devroey P (2004) Exogenous luteinizing hormone activity may influence the treatment outcome in in vitro fertilization but not in intracytoplasmic sperm injection cycles. Fertil Steril 81, 1401-1401.
21. Devroey P, Fauser BC, Platteau P, Beckers NG, Dhont M, Mannaerts BM (2004) Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization. J Clin Endocrinol Metab 89, 2062-2061.
22. Devroey P, Bourgain C, Macklon NS, Fauser BC (2004) Reproductive biology and IVF: ovarian stimulation and endometrial receptivity. Trends Endocrinol Metab 15, 84-81.
23. Devroey P, Van Steirteghem A (2004) A review of ten years experience of ICSI. Hum Reprod Update 10, 19-11.
24. Van de Velde H, Georgiou I, De Rycke M, Schots R, Sermon K, Lissens W, Devroey P, Van Steirteghem A, Liebaers I (2004) Novel universal approach for preimplantation genetic diagnosis of beta-thalassaemia in combination with HLA matching of embryos. Hum Reprod 19, 700-701.
25. Verpoest W, Platteau P, Van Steirteghem A, Devroey P (2004) Pregnancy in a couple with a male partner born with severe bladder exstrophy. Reprod Biomed Online 8, 240-241.
26. Kolibianakis EM, Zikopoulos KA, Fatemi HM, Osmanagaoglu K, Evenpoel J, Van Steirteghem A, Devroey P (2004) Endometrial thickness cannot predict ongoing pregnancy achievement in cycles stimulated with clomiphene citrate for intrauterine insemination. Reprod Biomed Online 8, 115-111.
27. Zikopoulos K, Platteau P, Kolibianakis E, Albano C, Van Steirteghem A, Devroey P (2004) Quintuplet pregnancy following transfer of two blastocysts: Case report. Hum Reprod 19, 325-321.
28. Papanikolaou EG, Tournaye H, Verpoest W, Camus M, Vernaeve V, Van Steirteghem A, Devroey P (2004) Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Hum Reprod , .
29. Stouffs K, Lissens W, Tournaye H, Steirteghem AV, Liebaers I (2004) Possible role of USP26 in patients with severely impaired spermatogenesis. Eur J Hum Genet , .
30. Verheyen G, Vernaeve V, Van Landuyt L, Tournaye H, Devroey P, Van Steirteghem A (2004) Should diagnostic testicular sperm retrieval followed by cryopreservation for later ICSI be the procedure of choice for all patients with non-obstructive azoospermia? Hum Reprod 19, 2822-2821.
31. Kolibianakis E, Zikopoulos K, Camus M, Tournaye H, Van Steirteghem A, Devroey P (2004) Modified natural cycle for IVF does not offer a realistic chance of parenthood in poor responders with high day 3 FSH levels, as a last resort prior to oocyte donation. Hum Reprod 19, 2545-2541.
32. Staessen C, Platteau P, Van Assche E, Michiels A, Tournaye H, Camus M, Devroey P, Liebaers I, Van Steirteghem A (2004) Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod 19, 2849-2841.
33. Vernaeve V, Brugnon F, Tournaye H (2004) Inhibin B, predictive factor for testicular sperm recovery?. Gynecol Obstet Fertil 32, 767-761.
34. Bache I, Assche EV, Cingoz S, Bugge M, Tumer Z, Hjorth M, Lundsteen C, Lespinasse J, Winther K, Niebuhr A, Kalscheuer V, Liebaers I, Bonduelle M, Tournaye H, Ayuso C, Barbi G, Blennow E, Bourrouillou G, Brondum-Nielsen K, Bruun-Petersen G, Croquette MF, Dahoun S, Dallapiccola B, Davison V, Delobel B, Duba HC, Duprez L, Ferguson-Smith M, Fitzpatrick DR, Grace E, Hansmann I, Hulten M, Jensen PK, Jonveaux P, Kristoffersson U, Lopez-Pajares I, McGowan-Jordan J, Murken J, Orera M, Parkin T, Passarge E, Ramos C, Rasmussen K, Schempp W, Schubert R, Schwinger E, Shabtai F, Smith K, Stallings R, Stefanova M, Tranebjerg L, Turleau C, van der Hagen CB, Vekemans M, Vokac NK, Wagner K, Wahlstroem J, Zelante L, Tommerup N (2004) An excess of chromosome 1 breakpoints in male infertility. Eur J Hum Genet 12, 993-991.
35. Kolibianakis EM, Zikopoulos K, Schiettecatte J, Smitz J, Tournaye H, Camus M, Van Steirteghem AC, Devroey P (2004) Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF. Hum Reprod 19, 2490-2491.
36. Poppe K, Glinoer D, Tournaye H, Schiettecatte J, Devroey P, van Steirteghem A, Haentjens P, Velkeniers B (2004) Impact of ovarian hyperstimulation on thyroid function in women with and without thyroid autoimmunity. J Clin Endocrinol Metab 89, 3808-3801.
37. Kotaja N, De Cesare D, Macho B, Monaco L, Brancorsini S, Goossens E, Tournaye H, Gansmuller A, Sassone-Corsi P (2004) Abnormal sperm in mice with targeted deletion of the act (activator of cAMP-responsive element modulator in testis) gene. Proc Natl Acad Sci U S A 101, 10620-10621.
38. Kolibianakis EM, Zikopoulos K, Smitz J, Camus M, Tournaye H, Van Steirteghem AC, Devroey P (2004) Administration of gonadotropin-releasing hormone antagonist from day 1 of stimulation in in vitro fertilization. Fertil Steril 82, 223-221.
39. Kolibianakis EM, Albano C, Camus M, Tournaye H, Van Steirteghem AC, Devroey P (2004) Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril 82, 102-101.
40. Zikopoulos KA, Kolibianakis EM, Platteau P, de Munck L, Tournaye H, Devroey P, Camus M (2004) Live delivery rates in subfertile women with Asherman's syndrome after hysteroscopic adhesiolysis using the resectoscope or the Versapoint system. Reprod Biomed Online 8, 720-721.
41. Kolibianakis EM, Zikopoulos K, Smitz J, Camus M, Tournaye H, Van Steirteghem AC, Devroey P (2004) Elevated progesterone at initiation of stimulation is associated with a lower ongoing pregnancy rate after IVF using GnRH antagonists. Hum Reprod 19, 1525-1521.
42. Platteau P, Staessen C, Michiels A, Tournaye H, Van Steirteghem A, Liebaers I, Devroey P (2004) Comparison of the aneuploidy frequency in embryos derived from testicular sperm extraction in obstructive and non-obstructive azoospermic men. Hum Reprod 19, 1570-1571.
43. Vernaeve V, Staessen C, Verheyen G, Van Steirteghem A, Devroey P, Tournaye H (2004) Can biological or clinical parameters predict testicular sperm recovery in 47,XXY Klinefelter's syndrome patients? Hum Reprod 19, 1135-1131.
44. Osmanagaoglu K, Kolibianakis E, Tournaye H, Camus M, Van Steirteghem A, Devroey P (2004) Cumulative live birth rates after transfer of cryopreserved ICSI embryos. Reprod Biomed Online 8, 344-341.
45. Frederickx V, Michiels A, Goossens E, De Block G, Van Steirteghem AC, Tournaye H (2004) Recovery, survival and functional evaluation by transplantation of frozen-thawed mouse germ cells. Hum Reprod 19, 948-941.
46. Zikopoulos K, Kolibianakis EM, Camus M, Tournaye H, Van den Abbeel E, Joris H, Van Steirteghem A, Devroey P (2004) Duration of gonadotropin-releasing hormone antagonist administration does not affect the outcome of subsequent frozen-thawed cycles. Fertil Steril 81, 473-471.
47. Stouffs K, Lissens W, Verheyen G, Van Landuyt L, Goossens A, Tournaye H, Van Steirteghem A, Liebaers I (2004) Expression pattern of the Y-linked PRY gene suggests a function in apoptosis but not in spermatogenesis. Mol Hum Reprod 10, 15-11.
48. Ponjaert-Kristoffersen I, Tjus T, Nekkebroeck J, et al. Psychological follow-up study of 5-year-old ICSI children. Human Reproduction 2004 Dec; 19(12): 2791-2797.
49. Barnes J, Sutcliffe AG, Kristoffersen I, Loft A, Wennerholm U-B, Tarlatzis B, Kantaris X, Nekkebroeck J, Hagberg BS, Madsen SV, Bonduelle M.. The influence of assisted reproduction on family functioning and children's socio-emotional development: results from a European study. Human Reproduction 2004 Jun;19(6); 1480-1487.

1. Goossens E, Frederickx V, De Block G, Van Steirteghem AC, Tournaye H (2003) Reproductive capacity of sperm obtained after germ cell transplantation in a mouse model. Hum Reprod 18, 1874-1871.
2. Van Steirteghem A (2003) Production of (human) embryonal stem cells (ESC) and possible applications in genetics. Verh K Acad Geneeskd Belg 65, 274-271.
3. Geuns E, De Rycke M, Van Steirteghem A, Liebaers I (2003) Methylation imprints of the imprint control region of the SNRPN-gene in human gametes and preimplantation embryos. Hum Mol Genet 12, 2873-2871.
4. Van Steirteghem A, Collins JA (2003) Evidence-based medicine for treatment: an in vitro fertilization trial. Semin Reprod Med 21, 49-41.
5. Devroey P (2003) Ovarian stimulation regimens in women with endometriosis. J Gynecol Obstet Biol Reprod (Paris) 32, S42-S41.
6. Bourgain C, Devroey P (2003) The endometrium in stimulated cycles for IVF. Hum Reprod Update 9, 515-511.
7. Adashi EY, Barri PN, Berkowitz R, Braude P, Bryan E, Carr J, Cohen J, Collins J, Devroey P, Frydman R, Gardner D, Germond M, Gerris J, Gianaroli L, Hamberger L, Howles C, Jones H Jr, Lunenfeld B, Pope A, Reynolds M, Rosenwaks Z, Shieve LA, Serour GI, Shenfield F, Templeton A, van Steirteghem A, Veeck L, Wennerholm UB (2003) Infertility therapy-associated multiple pregnancies (births): an ongoing epidemic. Reprod Biomed Online 7, 515-511.
8. Kolibianakis EM, Zikopoulos K, Devroey P (2003) Implantation potential and clinical impact of cryopreservation--a review. Placenta 24 Suppl B, S27-S21.
9. Tavaniotou A, Devroey P (2003) Effect of human chorionic gonadotropin on luteal luteinizing hormone concentrations in natural cycles. Fertil Steril 80, 654-651.
10. De Schepper J, Schiettecatte J, Velkeniers B, Blumenfeld Z, Shteinberg M, Devroey P, Anckaert E, Smitz J, Verdood P, Hooghe R, Hooghe-Peters E (2003) Clinical and biological characterization of macroprolactinemia with and without prolactin-IgG complexes. Eur J Endocrinol 149, 201-201.
11. Vorsselmans A, Platteau P, De Vos A, Albano C, Van Steirteghem A, Devroey P (2003) Comparison of transfers to Fallopian tubes or uterus after ICSI. Reprod Biomed Online 7, 82-81.
12. Joris H, De Vos A, Janssens R, Devroey P, Liebaers I, Van Steirteghem A (2003) Comparison of the results of human embryo biopsy and outcome of PGD after zona drilling using acid Tyrode medium or a laser. Hum Reprod 18, 1896-1891.
13. Kolibianakis EM, Bourgain C, Platteau P, Albano C, Van Steirteghem AC, Devroey P (2003) Abnormal endometrial development occurs during the luteal phase of nonsupplemented donor cycles treated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril 80, 464-461.
14. Goossens V, Sermon K, Lissens W, De Rycke M, Saerens B, De Vos A, Henderix P, Van de Velde H, Platteau P, Van Steirteghem A, Devroey P, Liebaers I (2003) Improving clinical preimplantation genetic diagnosis for cystic fibrosis by duplex PCR using two polymorphic markers or one polymorphic marker in combination with the detection of the DeltaF508 mutation. Mol Hum Reprod 9, 559-551.
15. Tavaniotou A, Albano C, Van Steirteghem A, Devroey P (2003) The impact of LH serum concentration on the clinical outcome of IVF cycles in patients receiving two regimens of clomiphene citrate/gonadotrophin/0.25 mg cetrorelix. Reprod Biomed Online 6, 421-421.
16. Fauser BC, Devroey P (2003) Reproductive biology and IVF: ovarian stimulation and luteal phase consequences. Trends Endocrinol Metab 14, 236-231.
17. De Vos A, Sermon K, De Rijcke M, Goossens V, Henderix P, Van Ranst N, Platteau P, Lissens W, Devroey P, Van Steirteghem A, Liebaers I (2003) Preimplantation genetic diagnosis for Charcot-Marie-Tooth disease type 1A. Mol Hum Reprod 9, 429-421.
18. Nogueira D, Albano C, Adriaenssens T, Cortvrindt R, Bourgain C, Devroey P, Smitz J (2003) Human oocytes reversibly arrested in prophase I by phosphodiesterase type 3 inhibitor in vitro. Biol Reprod 69, 1042-1041.
19. Platteau P, Staessen C, Liebaers I, Van Steirteghem A, Devroey P (2003) "Floating denominators"--effect of verification bias on accuracy estimates for preimplantation diagnosis. Fertil Steril 79, 1041-1041.
20. Baetens P, Camus M, Devroey P (2003) Should requests for donor insemination on social grounds be expanded to transsexuals? Reprod Biomed Online 6, 281-281.
21. Tavaniotou A, Bourgain C, Albano C, Platteau P, Smitz J, Devroey P (2003) Endometrial integrin expression in the early luteal phase in natural and stimulated cycles for in vitro fertilization. Eur J Obstet Gynecol Reprod Biol 108, 67-61.
22. Baetens P, Camus M, Devroey P (2003) Counselling lesbian couples: requests for donor insemination on social grounds. Reprod Biomed Online 6, 75-71.
23. Beckers NG, Macklon NS, Devroey P, Platteau P, Boerrigter PJ, Fauser BC (2003) First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for in vitro fertilization. Fertil Steril 79, 621-621.
24. Bourgain C, Smitz J, Devroey P (2003) Meta-analysis on luteal phase support. Hum Reprod 18, 656-651.
25. Shenfield F, Pennings G, Devroey P, Sureau C, Tarlatzis B, Cohen J (2003) Taskforce 5: preimplantation genetic diagnosis. Hum Reprod 18, 649-641.
26. Bonduelle M, Ponjaert I, Steirteghem AV, Derde MP, Devroey P, Liebaers I (2003) Developmental outcome at 2 years of age for children born after ICSI compared with children born after IVF. Hum Reprod 18, 342-341.
27. Kolibianakis E, Osmanagaoglu K, De Catte L, Camus M, Bonduelle M, Liebaers I, Van Steirteghem A, Devroey P (2003) Prenatal genetic testing by amniocentesis appears to result in a lower risk of fetal loss than chorionic villus sampling in singleton pregnancies achieved by intracytoplasmic sperm injection. Fertil Steril 79, 374-371.
28. De Vos A, Van De Velde H, Joris H, Verheyen G, Devroey P, Van Steirteghem A (2003) Influence of individual sperm morphology on fertilization, embryo morphology, and pregnancy outcome of intracytoplasmic sperm injection. Fertil Steril 79, 42-41.
29. Fatemi HM, Kolibianakis E, Tournaye H, Camus M, Van Steirteghem AC, Devroey P (2003) Clomiphene citrate versus letrozole for ovarian stimulation: a pilot study. Reprod Biomed Online 7, 543-541.
30. Kolibianakis EM, Albano C, Camus M, Tournaye H, Van Steirteghem AC, Devroey P (2003) Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation: effect on hormonal levels and follicular development in in vitro fertilization cycles. J Clin Endocrinol Metab 88, 5632-5631.
31. Zikopoulos KA, Kolibianakis EM, Tournaye H, de Munck L, Devroey P, Camus M (2003) Hysteroscopic septum resection using the Versapoint system in subfertile women. Reprod Biomed Online 7, 365-361.
32. Kolibianakis E, Zikopoulos K, Albano C, Camus M, Tournaye H, Van Steirteghem A, Devroey P (2003) Reproductive outcome of polycystic ovarian syndrome patients treated with GnRH antagonists and recombinant FSH for IVF/ICSI. Reprod Biomed Online 7, 313-311.
33. Kolibianakis EM, Albano C, Camus M, Tournaye H, Van Steirteghem AC, Devroey P (2003) Relationship between LH and oestradiol in IVF cycles before GnRH antagonist initiation. Reprod Biomed Online 7, 190-191.
34. Vernaeve V, Bonduelle M, Tournaye H, Camus M, Van Steirteghem A, Devroey P (2003) Pregnancy outcome and neonatal data of children born after ICSI using testicular sperm in obstructive and non-obstructive azoospermia. Hum Reprod 18, 2093-2091.
35. Poppe K, Glinoer D, Tournaye H, Devroey P, van Steirteghem A, Kaufman L, Velkeniers B (2003) Assisted reproduction and thyroid autoimmunity: an unfortunate combination? J Clin Endocrinol Metab 88, 4149-4141.
36. Staessen C, Tournaye H, Van Assche E, Michiels A, Van Landuyt L, Devroey P, Liebaers I, Van Steirteghem A (2003) PGD in 47,XXY Klinefelter's syndrome patients. Hum Reprod Update 9, 319-311.
37. Osmanagaoglu K, Vernaeve V, Kolibianakis E, Tournaye H, Camus M, Van Steirteghem A, Devroey P (2003) Cumulative delivery rates after ICSI treatment cycles with freshly retrieved testicular sperm: a 7-year follow-up study. Hum Reprod 18, 1836-1831.
38. Platteau P, Laurent E, Albano C, Osmanagaoglu K, Vernaeve V, Tournaye H, Camus M, Van Steirteghem A, Devroey P (2003) An open, randomized single-centre study to compare the efficacy and convenience of follitropin beta administered by a pen device with follitropin alpha administered by a conventional syringe in women undergoing ovarian stimulation for IVF/ICSI. Hum Reprod 18, 1200-1201.
39. Kolibianakis EM, Albano C, Kahn J, Camus M, Tournaye H, Van Steirteghem AC, Devroey P (2003) Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy. Fertil Steril 79, 873-871.
40. Tournaye H (2003) ICSI: a technique too far? Int J Androl 26, 63-61.
41. Vernaeve V, Tournaye H, Osmanagaoglu K, Verheyen G, Van Steirteghem A, Devroey P (2003) Intracytoplasmic sperm injection with testicular spermatozoa is less successful in men with nonobstructive azoospermia than in men with obstructive azoospermia. Fertil Steril 79, 529-521.
42. Kolibianakis EM, Tournaye H, Osmanagaoglu K, Camus M, Van Waesberghe L, Van Steirteghem A, Devroey P (2003) Outcome for donors and recipients in two egg-sharing policies. Fertil Steril 79, 69-61.

1. Tournaye H, Verheyen G, Albano C, Camus M, Van Landuyt L, Devroey P, Van Steirteghem A (2002) Intracytoplasmic sperm injection versus in vitro fertilization: a randomized controlled trial and a meta-analysis of the literature. Fertil Steril 78, 1030-1031.
2. Osmanagaoglu K, Collins J, Kolibianakis E, Tournaye H, Camus M, Van Steirteghem A, Devroey P (2002) Spontaneous pregnancies in couples who discontinued intracytoplasmic sperm injection treatment: a 5-year follow-up study. Fertil Steril 78, 550-551.
3. De Rycke M, Liebaers I, Van Steirteghem A (2002) Epigenetic risks related to assisted reproductive technologies: risk analysis and epigenetic inheritance. Hum Reprod 17, 2487-2481.
4. Kolibianakis EM, Devroey P (2002) The luteal phase after ovarian stimulation. Reprod Biomed Online 5 Suppl 1, 26-21.
5. Kolibianakis EM, Devroey P (2002) Blastocyst culture: facts and fiction. Reprod Biomed Online 5, 285-281.
6. Fatemi HM, Platteau P, Albano C, Van Steirteghem A, Devroey P (2002) Rescue IVF and coasting with the use of a GnRH antagonist after ovulation induction. Reprod Biomed Online 5, 273-271.
7. Kolibianakis E, Bourgain C, Albano C, Osmanagaoglu K, Smitz J, Van Steirteghem A, Devroey P (2002) Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. Fertil Steril 78, 1025-1021.
8. Platteau P, Sermon K, Seneca S, Van Steirteghem A, Devroey P, Liebaers I (2002) Preimplantation genetic diagnosis for fragile Xa syndrome: difficult but not impossible. Hum Reprod 17, 2807-2801.
9. Sermon K, De Rijcke M, Lissens W, De Vos A, Platteau P, Bonduelle M, Devroey P, Van Steirteghem A, Liebaers I (2002) Preimplantation genetic diagnosis for Huntington's disease with exclusion testing. Eur J Hum Genet 10, 591-591.
10. Bonduelle M, Van Assche E, Joris H, Keymolen K, Devroey P, Van Steirteghem A, Liebaers I (2002) Prenatal testing in ICSI pregnancies: incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters. Hum Reprod 17, 2600-2601.
11. Engel JB, Ludwig M, Felberbaum R, Albano C, Devroey P, Diedrich K (2002) Use of cetrorelix in combination with clomiphene citrate and gonadotrophins: a suitable approach to 'friendly IVF'? Hum Reprod 17, 2022-2021.
12. Bourgain C, Ubaldi F, Tavaniotou A, Smitz J, Van Steirteghem AC, Devroey P (2002) Endometrial hormone receptors and proliferation index in the periovulatory phase of stimulated embryo transfer cycles in comparison with natural cycles and relation to clinical pregnancy outcome. Fertil Steril 78, 237-231.
13. Van Steirteghem A, Bonduelle M, Devroey P, Liebaers I (2002) Follow-up of children born after ICSI. Hum Reprod Update 8, 111-111.
14. Tavaniotou A, Albano C, Smitz J, Devroey P (2002) Impact of ovarian stimulation on corpus luteum function and embryonic implantation. J Reprod Immunol 55, 123-121.
15. Ludwig M, Albano C, Olivennes F, Felberbaum RE, Smitz J, Ortmann O, Romeis P, Niebch G, Pechstein B, Riethmuller-Winzen H, Devroey P, Diedrich K (2002) Plasma and follicular fluid concentrations of LHRH antagonist cetrorelix (Cetrotide) in controlled ovarian stimulation for IVF. Arch Gynecol Obstet 266, 12-11.
16. Van Steirteghem A, Bonduelle M, Liebaers I, Devroey P (2002) Children born after assisted reproductive technology. Am J Perinatol 19, 59-51.
17. Tavaniotou A, Albano C, Smitz J, Devroey P (2002) Effect of clomiphene citrate on follicular and luteal phase luteinizing hormone concentrations in in vitro fertilization cycles stimulated with gonadotropins and gonadotropin-releasing hormone antagonist. Fertil Steril 77, 733-731.
18. Van Steirteghem A, Devroey P, Liebaers I (2002) Intracytoplasmic sperm injection. Mol Cell Endocrinol 186, 199-191.
19. Fauser BC, Bouchard P, Coelingh Bennink HJ, Collins JA, Devroey P, Evers JL, van Steirteghem A (2002) Alternative approaches in IVF. Hum Reprod Update 8, 1-1.
20. Bonduelle M, Liebaers I, Deketelaere V, Derde MP, Camus M, Devroey P, Van Steirteghem A (2002) Neonatal data on a cohort of 2889 infants born after ICSI (1991-1999) and of 2995 infants born after IVF (1983-1999). Hum Reprod 17, 671-671.
21. Poppe K, Glinoer D, Van Steirteghem A, Tournaye H, Devroey P, Schiettecatte J, Velkeniers B (2002) Thyroid dysfunction and autoimmunity in infertile women. Thyroid 12, 997-991.
22. Mateizel I, Verheyen G, Van Assche E, Tournaye H, Liebaers I, Van Steirteghem A (2002) FISH analysis of chromosome X, Y and 18 abnormalities in testicular sperm from azoospermic patients. Hum Reprod 17, 2249-2241.
23. Kolibianakis E, Osmanagaoglu K, Camus M, Tournaye H, Van Steirteghem A, Devroey P (2002) Effect of repeated assisted reproductive technology cycles on ovarian response. Fertil Steril 77, 967-961.
24. Vernaeve V, Tournaye H, Schiettecatte J, Verheyen G, Van Steirteghem A, Devroey P (2002) Serum inhibin B cannot predict testicular sperm retrieval in patients with non-obstructive azoospermia. Hum Reprod 17, 971-971.
25. Osmanagaoglu K, Tournaye H, Kolibianakis E, Camus M, Van Steirteghem A, Devroey P (2002) Cumulative delivery rates after ICSI in women aged >37 years. Hum Reprod 17, 940-941.
26. Osmanagaoglu K, Kolibianakis E, Tournaye H, Devroey P (2002) Estimation of spontaneous pregnancies in patients after unsuccessful ICSI treatment. Hum Reprod 17, 250-251.
27. Nekkebroeck J, Brewaeys A. Lesbische moeders en heteroseksuele ouders, hun rol bekeken vanuit het kindperspectief. Tijdschrift voor Seksuologie, 2002, 26:125-130.

1. Sermon K, Seneca S, De Rycke M, Goossens V, Van de Velde H, De Vos A, Platteau P, Lissens W, Van Steirteghem A, Liebaers I (2001) PGD in the lab for triplet repeat diseases - myotonic dystrophy, Huntington's disease and Fragile-X syndrome. Mol Cell Endocrinol 183 Suppl 1, S77-S71.
2. De Vos A, Van Steirteghem A (2001) Aspects of biopsy procedures prior to preimplantation genetic diagnosis. Prenat Diagn 21, 767-761.
3. Georgiou I, Sermon K, Lissens W, De Vos A, Platteau P, Lolis D, Van Steirteghem A, Liebaers I (2001) Preimplantation genetic diagnosis for spinal and bulbar muscular atrophy (SBMA). Hum Genet 108, 494-491.
4. van Steirteghem A (2001) Twenty years of in vitro fertilization: realization and questions for the future. Verh K Acad Geneeskd Belg 63, 193-192.
5. Manning M, Lissens W, Liebaers I, Van Steirteghem A, Weidner W (2001) Imprinting analysis in spermatozoa prepared for intracytoplasmic sperm injection (ICSI). Int J Androl 24, 87-81.
6. De Rycke M, Van de Velde H, Sermon K, Lissens W, De Vos A, Vandervorst M, Vanderfaeillie A, Van Steirteghem A, Liebaers I (2001) Preimplantation genetic diagnosis for sickle-cell anemia and for beta-thalassemia. Prenat Diagn 21, 214-211.
7. Tavaniotou A, Smitz J, Bourgain C, Devroey P (2001) Ovulation induction disrupts luteal phase function. Ann N Y Acad Sci 943, 55-51.
8. Albano C, Platteau P, Nogueira D, Cortvrindt R, Smitz J, Devroey P (2001) Avoidance of multiple pregnancies after ovulation induction by supernumerary preovulatory follicular reduction. Fertil Steril 76, 820-821.
9. Olivennes F, Mannaerts B, Struijs M, Bonduelle M, Devroey P (2001) Perinatal outcome of pregnancy after GnRH antagonist (ganirelix) treatment during ovarian stimulation for conventional IVF or ICSI: a preliminary report. Hum Reprod 16, 1588-1581.
10. Shenfield F, Pennings G, Sureau C, Cohen J, Devroey P, Tarlatzis B (2001) I. The moral status of the pre-implantation embryo. Hum Reprod 16, 1046-1041.
11. Albano C, Platteau P, Devroey P (2001) Gonadotropin-releasing hormone antagonist: how good is the new hope? Curr Opin Obstet Gynecol 13, 257-251.
12. Diedrich K, Frydman R, Devroey P, Felberbaum R, Schally AV, Reissmann T, Engel J (2001) Comment on the debate article: embryo implantation: the Rubicon for GnRH antagonists. Hum Reprod 16, 1305-1301.
13. Smitz J, Nogueira D, Albano C, Cortvrindt R, Devroey P (2001) Improving in vitro maturation of oocytes in the human taking lessons from experiences in animal species. Reprod Domest Anim 36, 11-11.
14. Grimbizis GF, Camus M, Tarlatzis BC, Bontis JN, Devroey P (2001) Clinical implications of uterine malformations and hysteroscopic treatment results. Hum Reprod Update 7, 161-161.
15. Tavaniotou A, Albano C, Smitz J, Devroey P (2001) Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix. Hum Reprod 16, 663-661.
16. Ludwig M, Riethmuller-Winzen H, Felberbaum RE, Olivennes F, Albano C, Devroey P, Diedrich K (2001) Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix. Fertil Steril 75, 18-11.
17. Van Landuyt L, Lissens W, Stouffs K, Tournaye H, Van Steirteghem A, Liebaers I, Blagosklonova O, Bresson JL (2001) The role of USP9Y and DBY in infertile patients with severely impaired spermatogenesis. Mol Hum Reprod 7, 691-691.
18. Stouffs K, Lissens W, Van Landuyt L, Tournaye H, Van Steirteghem A, Liebaers I (2001) Characterization of the genomic organization, localization and expression of four PRY genes (PRY1, PRY2, PRY3 and PRY4). Mol Hum Reprod 7, 603-601.

1. Van de Velde H, De Vos A, Sermon K, Staessen C, De Rycke M, Van Assche E, Lissens W, Vandervorst M, Van Ranst H, Liebaers I, Van Steirteghem A (2000) Embryo implantation after biopsy of one or two cells from cleavage-stage embryos with a view to preimplantation genetic diagnosis. Prenat Diagn 20, 1030-1031.
2. Tournaye H (2000) Management of male infertility by assisted reproductive technologies. Baillieres Best Pract Res Clin Endocrinol Metab 14, 423-421.
3. Van den Abbeel E, Camus M, Joris H, Van Steirteghem A (2000) Embryo freezing after intracytoplasmic sperm injection. Mol Cell Endocrinol 169, 49-41.
4. Sermon K, Henderix P, Lissens W, De Vos A, Vandervorst M, Vanderfaeillie A, Vamos E, Van Steirteghem A, Liebaers I (2000) Preimplantation genetic diagnosis for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency. Mol Hum Reprod 6, 1165-1161.
5. Manning M, Lissens W, Bonduelle M, Camus M, De Rijcke M, Liebaers I, Van Steirteghem A (2000) Study of DNA-methylation patterns at chromosome 15q11-q13 in children born after ICSI reveals no imprinting defects. Mol Hum Reprod 6, 1049-1041.
6. De Vos A, Sermon K, Van de Velde H, Joris H, Vandervorst M, Lissens W, De Paepe A, Liebaers I, Van Steirteghem A (2000) Two pregnancies after preimplantation genetic diagnosis for osteogenesis imperfecta type I and type IV. Hum Genet 106, 605-601.
7. Nogueira D, Staessen C, Van de Velde H, Van Steirteghem A (2000) Nuclear status and cytogenetics of embryos derived from in vitro-matured oocytes. Fertil Steril 74, 295-291.
8. Goossens V, Sermon K, Lissens W, Vandervorst M, Vanderfaeillie A, De Rijcke M, De Vos A, Henderix P, Van De Velde H, Van Steirteghem A, Liebaers I (2000) Clinical application of preimplantation genetic diagnosis for cystic fibrosis. Prenat Diagn 20, 571-571.
9. Silber SJ, Johnson L, Verheyen G, Van Steirteghem A (2000) Round spermatid injection. Fertil Steril 73, 897-891.
10. De Vos A, Van Steirteghem A (2000) Zona hardening, zona drilling and assisted hatching: new achievements in assisted reproduction. Cells Tissues Organs 166, 220-221.
11. Van Den Abbeel E, Van Steirteghem A (2000) Zona pellucida damage to human embryos after cryopreservation and the consequences for their blastomere survival and in-vitro viability. Hum Reprod 15, 373-371.
12. Vegetti W, Van Assche E, Frias A, Verheyen G, Bianchi MM, Bonduelle M, Liebaers I, Van Steirteghem A (2000) Correlation between semen parameters and sperm aneuploidy rates investigated by fluorescence in-situ hybridization in infertile men. Hum Reprod 15, 351-351.
13. Adashi EY, Cohen J, Hamberger L, Jones HW Jr, de Kretser DM, Lunenfeld B, Rosenwaks Z, Van Steirteghem A (2000) Public perception on infertility and its treatment: an international survey. The Bertarelli Foundation Scientific Board. Hum Reprod 15, 330-331.
14. Ludwig M, Felberbaum RE, Devroey P, Albano C, Riethmuller-Winzen H, Schuler A, Engel W, Diedrich K (2000) Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction. Arch Gynecol Obstet 264, 29-21.
15. Posaci C, Smitz J, Camus M, Osmanagaoglu K, Devroey P (2000) Progesterone for the luteal support of assisted reproductive technologies: clinical options. Hum Reprod 15 Suppl 1, 129-121.
16. Roman E, Aytoz A, Smitz JE, Faguer B, Camus M, Van Steirteghem AC, Devroey P (2000) Analysis of the bleeding pattern in assisted reproduction cycles with luteal phase supplementation using vaginal micronized progesterone. Hum Reprod 15, 1435-1431.
17. Platteau P, Vandervorst M, Devroey P (2000) Long term follow-up of children born after inadvertent administration of a GnRH-analogue in early pregnancy. Hum Reprod 15, 1421.
18. Felberbaum RE, Albano C, Ludwig M, Riethmuller-Winzen H, Grigat M, Devroey P, Diedrich K (2000) Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study. Hum Reprod 15, 1015-1011.
19. Tavaniotou A, Smitz J, Bourgain C, Devroey P (2000) Comparison between different routes of progesterone administration as luteal phase support in infertility treatments. Hum Reprod Update 6, 139-131.
20. Albano C, Felberbaum RE, Smitz J, Riethmuller-Winzen H, Engel J, Diedrich K, Devroey P (2000) Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group. Hum Reprod 15, 526-521.
21. Baetens P, Devroey P, Camus M, Van Steirteghem AC, Ponjaert-Kristoffersen I (2000) Counselling couples and donors for oocyte donation: the decision to use either known or anonymous oocytes. Hum Reprod 15, 476-471.
22. Devroey P (2000) GnRH antagonists. Fertil Steril 73, 15-11.
23. Tournaye H (2000) Storing reproduction for oncological patients: some points for discussion. Mol Cell Endocrinol 169, 133-131.
24. Vandervors M, Staessen C, Sermon K, De Vos A, Van de Velde H, Van Assche E, Bonduelle M, Vanderfaellie A, Lissens W, Tournaye H, Devroey P, Van Steirteghem A, Liebaers I (2000) The Brussels' experience of more than 5 years of clinical preimplantation genetic diagnosis. Hum Reprod Update 6, 364-361.
25. Schats R, Sutter PD, Bassil S, Kremer JA, Tournaye H, Donnez J (2000) Ovarian stimulation during assisted reproduction treatment: a comparison of recombinant and highly purified urinary human FSH. On behalf of The Feronia and Apis study group. Hum Reprod 15, 1691-1691.
26. Van Landuyt L, Lissens W, Stouffs K, Tournaye H, Liebaers I, Van Steirteghem A (2000) Validation of a simple Yq deletion screening programme in an ICSI candidate population. Mol Hum Reprod 6, 291-291.

1. Joris H, Van den Abbeel E, Vos AD, Van Steirteghem A (1999) Reduced survival after human embryo biopsy and subsequent cryopreservation. Hum Reprod 14, 2833-2831.
2. Tournaye H (1999) Surgical sperm recovery for intracytoplasmic sperm injection: which method is to be preferred? Hum Reprod 14 Suppl 1, 71-71.
3. Sermon K, Seneca S, Vanderfaeillie A, Lissens W, Joris H, Vandervorst M, Van Steirteghem A, Liebaers I (1999) Preimplantation diagnosis for fragile X syndrome based on the detection of the non-expanded paternal and maternal CGG. Prenat Diagn 19, 1223-1221.
4. Lofgren A, De Vos A, Sermon K, Liebaers I, Van Steirteghem A, Van Broeckhoven C (1999) Preimplantation diagnosis for Charcot-Marie-Tooth type 1A. Ann N Y Acad Sci 883, 460-461.
5. Staessen C, Camus M, Clasen K, De Vos A, Van Steirteghem A (1999) Conventional in-vitro fertilization versus intracytoplasmic sperm injection in sibling oocytes from couples with tubal infertility and normozoospermic semen. Hum Reprod 14, 2474-2471.
6. Van Steirteghem A, Liebaers I, Camus M (1999) Genetic male infertility. Rev Prat 49, 1309-1301.
7. Nogueira D, Bourgain C, Verheyen G, Van Steirteghem AC (1999) Light and electron microscopic analysis of human testicular spermatozoa and spermatids from frozen and thawed testicular biopsies. Hum Reprod 14, 2041-2041.
8. Danan C, Sternberg D, Van Steirteghem A, Cazeneuve C, Duquesnoy P, Besmond C, Goossens M, Lissens W, Amselem S (1999) Evaluation of parental mitochondrial inheritance in neonates born after intracytoplasmic sperm injection. Am J Hum Genet 65, 463-461.
9. De Vos A, Van de Velde H, Joris H, Van Steirteghem A (1999) In-vitro matured metaphase-I oocytes have a lower fertilization rate but similar embryo quality as mature metaphase-II oocytes after intracytoplasmic sperm injection. Hum Reprod 14, 1859-1851.
10. Van de Velde H, Sermon K, De Vos A, Lissens W, Joris H, Vandervorst M, Van Steirteghem A, Liebaers I (1999) Fluorescent PCR and automated fragment analysis in preimplantation genetic diagnosis for 21-hydroxylase deficiency in congenital adrenal hyperplasia. Mol Hum Reprod 5, 691-691.
11. Van Assche E, Staessen C, Vegetti W, Bonduelle M, Vandervorst M, Van Steirteghem A, Liebaers I (1999) Preimplantation genetic diagnosis and sperm analysis by fluorescence in-situ hybridization for the most common reciprocal translocation t(11;22). Mol Hum Reprod 5, 682-681.
12. Staessen C, Van Assche E, Joris H, Bonduelle M, Vandervorst M, Liebaers I, Van Steirteghem A (1999) Clinical experience of sex determination by fluorescent in-situ hybridization for preimplantation genetic diagnosis. Mol Hum Reprod 5, 382-381.
13. Lissens W, Mahmoud KZ, El-Gindi E, Abdel-Sattar A, Seneca S, Van Steirteghem A, Liebaers I (1999) Molecular analysis of the cystic fibrosis gene reveals a high frequency of the intron 8 splice variant 5T in Egyptian males with congenital bilateral absence of the vas deferens. Mol Hum Reprod 5, 10-11.
14. Sermon K, Lissens W, Messiaen L, Bonduelle M, Vandervorst M, Van Steirteghem A, Liebaers I (1999) Preimplantation genetic diagnosis of Marfan syndrome with the use of fluorescent polymerase chain reaction and the Automated Laser Fluorescence DNA Sequencer. Fertil Steril 71, 163-161.
15. Posaci C, Camus M, Osmanagaoglu K, Devroey P (1999) Tubal surgery in the era of assisted reproductive technology: clinical options. Hum Reprod 14 Suppl 1, 120-121.
16. Fauser BC, Devroey P, Yen SS, Gosden R, Crowley WF Jr, Baird DT, Bouchard P (1999) Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks. Hum Reprod 14, 2681-2681.
17. Aytoz A, Van den Abbeel E, Bonduelle M, Camus M, Joris H, Van Steirteghem A, Devroey P (1999) Obstetric outcome of pregnancies after the transfer of cryopreserved and fresh embryos obtained by conventional in-vitro fertilization and intracytoplasmic sperm injection. Hum Reprod 14, 2619-2611.
18. Kol S, Lightman A, Hillensjo T, Devroey P, Fauser B, Tarlatzis B, Mannaerts B, Itskovitz-Eldor J (1999) High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles. Hum Reprod 14, 2242-2241.
19. Fabre V, Camus M, Devroey P (1999) Endometriosis and sterility. Rev Prat 49, 279-271.
20. Christiaens F, Janssenswillen C, Verborgh C, Moerman I, Devroey P, Van Steirteghem A, Camu F (1999) Propofol concentrations in follicular fluid during general anaesthesia for transvaginal oocyte retrieval. Hum Reprod 14, 345-341.
21. Bonduelle M, Camus M, De Vos A, Staessen C, Tournaye H, Van Assche E, Verheyen G, Devroey P, Liebaers I, Van Steirteghem A (1999) Seven years of intracytoplasmic sperm injection and follow-up of 1987 subsequent children. Hum Reprod 14 Suppl 1, 243-241.
22. Tournaye H (1999) Intracytoplasmic sperm injection (ICSI): the basic and the latest. J Indian Med Assoc 97, 52-51.
23. Osmanagaoglu K, Tournaye H, Camus M, Vandervorst M, Van Steirteghem A, Devroey P (1999) Cumulative delivery rates after intracytoplasmic sperm injection: 5 year follow-up of 498 patients. Hum Reprod 14, 2651-2651.
24. Verheyen G, Tournaye H, Staessen C, De Vos A, Vandervorst M, Van Steirteghem A (1999) Controlled comparison of conventional in-vitro fertilization and intracytoplasmic sperm injection in patients with asthenozoospermia. Hum Reprod 14, 2313-2311.
25. Tournaye H (1999) Non-surgical sperm recovery: part I. Hum Reprod Update 5, 210.
26. Tournaye H, Merdad T, Silber S, Joris H, Verheyen G, Devroey P, Van Steirteghem A (1999) No differences in outcome after intracytoplasmic sperm injection with fresh or with frozen-thawed epididymal spermatozoa. Hum Reprod 14, 90-91.
27. Albano C, Smitz J, Tournaye H, Riethmuller-Winzen H, Van Steirteghem A, Devroey P (1999) Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization/intracytoplasmic sperm injection cycles. Hum Reprod 14, 1426-1421.
28. Crabbe E, Verheyen G, Tournaye H, Van Steirteghem A (1999) Freezing of testicular tissue as a minced suspension preserves sperm quality better than whole-biopsy freezing when glycerol is used as cryoprotectant. Int J Androl 22, 43-41.

1. Staessen C, Janssenswillen C, De Clerck E, Van Steirteghem A (1998) Controlled comparison of commercial media for human in-vitro fertilization: Menezo B2 medium versus Medi-Cult universal and BM1 medium. Hum Reprod 13, 2548-2541.
2. Tournaye H, Clasen K, Aytoz A, Nagy Z, Van Steirteghem A, Devroey P (1998) Fine needle aspiration versus open biopsy for testicular sperm recovery: a controlled study in azoospermic patients with normal spermatogenesis. Hum Reprod 13, 901-901.
3. Bonduelle M, Joris H, Hofmans K, Liebaers I, Van Steirteghem A (1998) Mental development of 201 ICSI children at 2 years of age. Lancet 351, 1553.
4. Sermon K, Goossens V, Seneca S, Lissens W, De Vos A, Vandervorst M, Van Steirteghem A, Liebaers I (1998) Preimplantation diagnosis for Huntington's disease (HD): clinical application and analysis of the HD expansion in affected embryos. Prenat Diagn 18, 1427-1421.
5. Van de Velde H, De Vos A, Joris H, Nagy ZP, Van Steirteghem AC (1998) Effect of timing of oocyte denudation and micro-injection on survival, fertilization and embryo quality after intracytoplasmic sperm injection. Hum Reprod 13, 3160-3161.
6. De Vos A, Sermon K, Van de Velde H, Joris H, Vandervorst M, Lissens W, Mortier G, De Sutter P, Lofgren A, Van Broeckhoven C, Liebaers I, Van Steirteghem A (1998) Pregnancy after preimplantation genetic diagnosis for Charcot-Marie-Tooth disease type 1A. Mol Hum Reprod 4, 978-971.
7. Silber SJ, Verheyen G, Van Steirteghem AC (1998) Spermatid conception. Hum Reprod 13, 2976-2971.
8. Sermon K, De Vos A, Van de Velde H, Seneca S, Lissens W, Joris H, Vandervorst M, Van Steirteghem A, Liebaers I (1998) Fluorescent PCR and automated fragment analysis for the clinical application of preimplantation genetic diagnosis of myotonic dystrophy (Steinert's disease). Mol Hum Reprod 4, 791-791.
9. Staessen C, Van Steirteghem A (1998) The genetic constitution of multinuclear blastomeres and their derivative daughter blastomeres. Hum Reprod 13, 1625-1621.
10. Nagy ZP, Janssenswillen C, Janssens R, De Vos A, Staessen C, Van de Velde H, Van Steirteghem AC (1998) Timing of oocyte activation, pronucleus formation and cleavage in humans after intracytoplasmic sperm injection (ICSI) with testicular spermatozoa and after ICSI or in-vitro fertilization on sibling oocytes with ejaculated spermatozoa. Hum Reprod 13, 1606-1601.
11. Van der Elst J, Amerijckx Y, Van Steirteghem A (1998) Ultra-rapid freezing of mouse oocytes lowers the cell number in the inner cell mass of 5 day old in-vitro cultured blastocysts. Hum Reprod 13, 1595-1591.
12. Verheyen G, Crabbe E, Joris H, Van Steirteghem A (1998) Simple and reliable identification of the human round spermatid by inverted phase-contrast microscopy. Hum Reprod 13, 1570-1571.
13. Bourgain C, Nagy ZP, De Zutter H, Van Ranst H, Nogueira D, Van Steirteghem AC (1998) Ultrastructure of gametes after intracytoplasmic sperm injection. Hum Reprod 13 Suppl 1, 107-101.
14. Joris H, Nagy Z, Van de Velde H, De Vos A, Van Steirteghem A (1998) Intracytoplasmic sperm injection: laboratory set-up and injection procedure. Hum Reprod 13 Suppl 1, 76-71.
15. Van Steirteghem A (1998) Outcome of assisted reproductive technology. N Engl J Med 338, 194-191.
16. Devroey P, Pados G (1998) Preparation of endometrium for egg donation. Hum Reprod Update 4, 856-851.
17. Vandervorst M, Liebaers I, Sermon K, Staessen C, De Vos A, Van de Velde H, Van Assche E, Joris H, Van Steirteghem A, Devroey P (1998) Successful preimplantation genetic diagnosis is related to the number of available cumulus-oocyte complexes. Hum Reprod 13, 3169-3161.
18. Christiaens F, Janssenswillen C, Van Steirteghem AC, Devroey P, Verborgh C, Camu F (1998) Comparison of assisted reproductive technology performance after oocyte retrieval under general anaesthesia (propofol) versus paracervical local anaesthetic block: a case-controlled study. Hum Reprod 13, 2456-2451.
19. Aytoz A, De Catte L, Camus M, Bonduelle M, Van Assche E, Liebaers I, Van Steirteghem A, Devroey P (1998) Obstetric outcome after prenatal diagnosis in pregnancies obtained after intracytoplasmic sperm injection. Hum Reprod 13, 2958-2951.
20. Devroey P (1998) Testicular sperm extraction and intracytoplasmic sperm injection. Hum Reprod 13, 2045-2041.
21. Devroey P (1998) Clinical application of new micromanipulative technologies to treat the male. Hum Reprod 13 Suppl 3, 112-112.
22. Albano C, Grimbizis G, Smitz J, Riethmuller-Winzen H, Reissmann T, Van Steirteghem A, Devroey P (1998) The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin-releasing hormone antagonist Cetrorelix. Fertil Steril 70, 357-351.
23. Bonduelle M, Wilikens A, Buysse A, Van Assche E, Devroey P, Van Steirteghem AC, Liebaers I (1998) A follow-up study of children born after intracytoplasmic sperm injection (ICSI) with epididymal and testicular spermatozoa and after replacement of cryopreserved embryos obtained after ICSI. Hum Reprod 13 Suppl 1, 196-191.
24. Liebaers I, Sermon K, Staessen C, Joris H, Lissens W, Van Assche E, Nagy P, Bonduelle M, Vandervorst M, Devroey P, Van Steirteghem A (1998) Clinical experience with preimplantation genetic diagnosis and intracytoplasmic sperm injection. Hum Reprod 13 Suppl 1, 186-181.
25. Devroey P, Vandervorst M, Nagy P, Van Steirteghem A (1998) Do we treat the male or his gamete? Hum Reprod 13 Suppl 1, 178-171.
26. Bonduelle M, Aytoz A, Van Assche E, Devroey P, Liebaers I, Van Steirteghem A (1998) Incidence of chromosomal aberrations in children born after assisted reproduction through intracytoplasmic sperm injection. Hum Reprod 13, 781-781.
27. Crabbe E, Verheyen G, Silber S, Tournaye H, Van de Velde H, Goossens A, Van Steirteghem A (1998) Enzymatic digestion of testicular tissue may rescue the intracytoplasmic sperm injection cycle in some patients with non-obstructive azoospermia. Hum Reprod 13, 2791-2791.
28. Aytoz A, Camus M, Tournaye H, Bonduelle M, Van Steirteghem A, Devroey P (1998) Outcome of pregnancies after intracytoplasmic sperm injection and the effect of sperm origin and quality on this outcome. Fertil Steril 70, 500-501.
29. Nagy ZP, Verheyen G, Tournaye H, Van Steirteghem AC (1998) Special applications of intracytoplasmic sperm injection: the influence of sperm count, motility, morphology, source and sperm antibody on the outcome of ICSI. Hum Reprod 13 Suppl 1, 143-141.
30. Van Steirteghem A, Nagy P, Joris H, Janssenswillen C, Staessen C, Verheyen G, Camus M, Tournaye H, Devroey P (1998) Results of intracytoplasmic sperm injection with ejaculated, fresh and frozen-thawed epididymal and testicular spermatozoa. Hum Reprod 13 Suppl 1, 134-131.
31. Grimbizis G, Camus M, Clasen K, Tournaye H, De Munck L, Devroey P (1998) Hysteroscopic septum resection in patients with recurrent abortions or infertility. Hum Reprod 13, 1188-1181.
32. Nagy ZP, Joris H, Verheyen G, Tournaye H, Devroey P, Van Steirteghem AC (1998) Correlation between motility of testicular spermatozoa, testicular histology and the outcome of intracytoplasmic sperm injection. Hum Reprod 13, 890-891.
33. Grimbizis G, Vandervorst M, Camus M, Tournaye H, Van Steirteghem A, Devroey P (1998) Intracytoplasmic sperm injection, results in women older than 39, according to age and the number of embryos replaced in selective or non-selective transfers. Hum Reprod 13, 884-881.
34. Devroey P, Tournaye H, Van Steirteghem A, Hendrix P, Out HJ (1998) The use of a 100 IU starting dose of recombinant follicle stimulating hormone (Puregon) in in-vitro fertilization. Hum Reprod 13, 565-561.
35. Ubaldi F, Wisanto A, Camus M, Tournaye H, Clasen K, Devroey P (1998) The role of transvaginal ultrasonography in the detection of pelvic pathologies in the infertility workup. Hum Reprod 13, 330-331.
36. Tournaye H (1998) Urgently wanted for ICSI: clinical andrologists. Hum Reprod 13, 253-251.
37. Aytoz A, Tournaye H, Camus M, Ubaldi F, Verheyen G, Van Steirteghem A, Devroey P (1998) Is there any need for diagnostic laparoscopy in couples undergoing intracytoplasmic sperm injection for severe male-factor infertility. J Assist Reprod Genet 15, 79-71.

1. Van de Velde H, Nagy ZP, Joris H, De Vos A, Van Steirteghem AC (1997) Effects of different hyaluronidase concentrations and mechanical procedures for cumulus cell removal on the outcome of intracytoplasmic sperm injection. Hum Reprod 12, 2246-2241.
2. Tournaye H, Camus M, Vandervorst M, Nagy Z, Joris H, Van Steirteghem A, Devroey P (1997) Surgical sperm retrieval for intracytoplasmic sperm injection. Int J Androl 20 Suppl 3, 69-61.
3. Vandervorst M, Tournaye H, Camus M, Nagy ZP, Van Steirteghem A, Devroey P (1997) Patients with absolutely immotile spermatozoa and intracytoplasmic sperm injection. Hum Reprod 12, 2429-2421.
4. De Vos A, Nagy ZP, Van de Velde H, Joris H, Bocken G, Van Steirteghem A (1997) Percoll gradient centrifugation can be omitted in sperm preparation for intracytoplasmic sperm injection. Hum Reprod 12, 1980-1981.
5. Van Steirteghem A (1997) Intracytoplasmic sperm injection. Baillieres Clin Obstet Gynaecol 11, 725-721.
6. Cortvrindt R, Smitz J, Van Steirteghem AC (1997) Assessment of the need for follicle stimulating hormone in early preantral mouse follicle culture in vitro. Hum Reprod 12, 759-751.
7. Janssenswillen C, Christiaens F, Camu F, Van Steirteghem A (1997) The effect of propofol on parthenogenetic activation, in vitro fertilization and early development of mouse oocytes. Fertil Steril 67, 769-761.
8. Staessen C, Van Steirteghem AC (1997) The chromosomal constitution of embryos developing from abnormally fertilized oocytes after intracytoplasmic sperm injection and conventional in-vitro fertilization. Hum Reprod 12, 321-321.
9. Van den Abbeel E, van der Elst J, van der Linden M, van Steirteghem AC (1997) High survival rate of one-cell mouse embryos cooled rapidly to -196 degrees C after exposure to a propylene glycol-dimethylsulfoxide-sucrose solution. Cryobiology 34, 1-1.
10. Silber SJ, Nagy Z, Devroey P, Camus M, Van Steirteghem AC (1997) The effect of female age and ovarian reserve on pregnancy rate in male infertility: treatment of azoospermia with sperm retrieval and intracytoplasmic sperm injection. Hum Reprod 12, 2693-2691.
11. Adonakis G, Camus M, Joris H, Vandervorst M, Van Steirteghem A, Devroey P (1997) The role of the number of replaced embryos on intracytoplasmic sperm injection outcome in women over the age of 40. Hum Reprod 12, 2542-2541.
12. Van den Abbeel E, Camus M, Van Waesberghe L, Devroey P, Van Steirteghem AC (1997) Viability of partially damaged human embryos after cryopreservation. Hum Reprod 12, 2006-2001.
13. Sermon K, Lissens W, Joris H, Seneca S, Desmyttere S, Devroey P, Van Steirteghem A, Liebaers I (1997) Clinical application of preimplantation diagnosis for myotonic dystrophy. Prenat Diagn 17, 925-921.
14. Van den Abbeel E, Camus M, Van Waesberghe L, Devroey P, Van Steirteghem AC (1997) A randomized comparison of the cryopreservation of one-cell human embryos with a slow controlled-rate cooling procedure or a rapid cooling procedure by direct plunging into liquid nitrogen. Hum Reprod 12, 1554-1551.
15. Van der Elst J, Van den Abbeel E, Vitrier S, Camus M, Devroey P, Van Steirteghem AC (1997) Selective transfer of cryopreserved human embryos with further cleavage after thawing increases delivery and implantation rates. Hum Reprod 12, 1513-1511.
16. Albano C, Smitz J, Camus M, Riethmuller-Winzen H, Van Steirteghem A, Devroey P (1997) Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation. Fertil Steril 67, 917-911.
17. Chapron C, Devroey P, Dubuisson JB, Pouly JL, Vercellini P (1997) ESHRE guidelines for training, accreditation and monitoring in gynaecological endoscopy. European Society for Human Reproduction and Embryology. Committee of Special Interest Group on Reproductive Surgery. Hum Reprod 12, 867-861.
18. Ubaldi F, Nagy Z, Janssenwillen C, Smitz J, Van Steirteghem A, Devroey P (1997) Ovulation by repeated human chorionic gonadotrophin in 'empty follicle syndrome' yields a twin clinical pregnancy. Hum Reprod 12, 454-451.
19. Tournaye H (1997) Use of testicular sperm for the treatment of male infertility. Baillieres Clin Obstet Gynaecol 11, 753-751.
20. Silber SJ, Nagy Z, Devroey P, Tournaye H, Van Steirteghem AC (1997) Distribution of spermatogenesis in the testicles of azoospermic men: the presence or absence of spermatids in the testes of men with germinal failure. Hum Reprod 12, 2422-2421.
21. Janssenswillen C, Tournaye H, Pierard D, Devroey P, Van Steirteghem A (1997) Microsurgical epididymal sperm aspiration with motile trophozoite cells but no spermatozoa. Hum Reprod 12, 2217-2211.
22. Tournaye H, Staessen C, Camus M, Verheyen G, Devroey P, Van Steirteghem A (1997) No evidence for a decreased fertilizing potential after in-vitro fertilization using spermatozoa from polyzoospermic men. Hum Reprod 12, 2183-2181.
23. Aytoz A, Ubaldi F, Tournaye H, Nagy ZP, Van Steirteghem A, Devroey P (1997) The predictive value of uterine artery blood flow measurements for uterine receptivity in an intracytoplasmic sperm injection program. Fertil Steril 68, 935-931.
24. Verheyen G, Joris H, Crits K, Nagy Z, Tournaye H, Van Steirteghem A (1997) Comparison of different hypo-osmotic swelling solutions to select viable immotile spermatozoa for potential use in intracytoplasmic sperm injection. Hum Reprod Update 3, 195-191.
25. Crabbe E, Verheyen G, Tournaye H, Van Steirteghem A (1997) The use of enzymatic procedures to recover testicular germ cells. Hum Reprod 12, 1682-1681.
26. Nagy ZP, Verheyen G, Tournaye H, Devroey P, Van Steirteghem AC (1997) An improved treatment procedure for testicular biopsy specimens offers more efficient sperm recovery: case series. Fertil Steril 68, 376-371.
27. Tournaye H (1997) Declining clinical andrology: fact or fiction? Hum Reprod 12, 876-871.
28. Clasen K, Camus M, Tournaye H, Devroey P (1997) Ectopic pregnancy: let's cut! Strict laparoscopic approach to 194 consecutive cases and review of literature on alternatives. Hum Reprod 12, 596-591.
29. Ubaldi F, Bourgain C, Tournaye H, Smitz J, Van Steirteghem A, Devroey P (1997) Endometrial evaluation by aspiration biopsy on the day of oocyte retrieval in the embryo transfer cycles in patients with serum progesterone rise during the follicular phase. Fertil Steril 67, 521-521.
30. Tournaye H, Verheyen G, Nagy P, Ubaldi F, Goossens A, Silber S, Van Steirteghem AC, Devroey P (1997) Are there any predictive factors for successful testicular sperm recovery in azoospermic patients? Hum Reprod 12, 80-81.
31. Novero V, Camus M, Tournaye H, Smitz J, Verheyen G, Joris H, Derde MP, Van Steirteghem AC, Devroey P (1997) Relationship between serum follicle stimulating hormone in the male and standard sperm parameters, and the results of intracytoplasmic sperm injection. Hum Reprod 12, 59-51.
32. Verheyen G, Nagy Z, Joris H, De Croo I, Tournaye H, Van Steirteghem A (1997) Quality of frozen-thawed testicular sperm and its preclinical use for intracytoplasmic sperm injection into in vitro-matured germinal-vesicle stage oocytes. Fertil Steril 67, 74-71.

1. Tournaye H, Staessen C, Liebaers I, Van Assche E, Devroey P, Bonduelle M, Van Steirteghem A (1996) Testicular sperm recovery in nine 47,XXY Klinefelter patients. Hum Reprod 11, 1644-1641.
2. Tournaye H, Liu J, Nagy Z, Verheyen G, Van Steirteghem A, Devroey P (1996) The use of testicular sperm for intracytoplasmic sperm injection in patients with necrozoospermia. Fertil Steril 66, 331-331.
3. Cortvrindt R, Smitz J, Van Steirteghem AC (1996) In-vitro maturation, fertilization and embryo development of immature oocytes from early preantral follicles from prepuberal mice in a simplified culture system. Hum Reprod 11, 2656-2651.
4. Cortvrindt R, Smitz J, Van Steirteghem AC (1996) A morphological and functional study of the effect of slow freezing followed by complete in-vitro maturation of primary mouse ovarian follicles. Hum Reprod 11, 2648-2641.
5. Smitz J, Cortvrindt R, Van Steirteghem AC (1996) Normal oxygen atmosphere is essential for the solitary long-term culture of early preantral mouse follicles. Mol Reprod Dev 45, 466-461.
6. Van Blerk M, Smitz J, Rozenski E, Mees M, Roelandt P, Laermans L, Callewaert M, Van Steirteghem AC (1996) Four radioisotopic immunoassays of free thyroxine compared. Ann Clin Biochem 33 ( Pt 4), 335-331.
7. Sermon K, Lissens W, Joris H, Van Steirteghem A, Liebaers I (1996) Adaptation of the primer extension preamplification (PEP) reaction for preimplantation diagnosis: single blastomere analysis using short PEP protocols. Mol Hum Reprod 2, 209-201.
8. Lissens W, Sermon K, Staessen C, Assche EV, Janssenswillen C, Joris H, Van Steirteghem A, Liebaers I (1996) Review: preimplantation diagnosis of inherited disease. J Inherit Metab Dis 19, 709-701.
9. Bonduelle M, Wilikens A, Buysse A, Van Assche E, Wisanto A, Devroey P, Van Steirteghem AC, Liebaers I (1996) Prospective follow-up study of 877 children born after intracytoplasmic sperm injection (ICSI), with ejaculated epididymal and testicular spermatozoa and after replacement of cryopreserved embryos obtained after ICSI. Hum Reprod 11 Suppl 4, 131-132.
10. Liu J, Lissens W, Devroey P, Liebaers I, Van Steirteghem A (1996) Cystic fibrosis, Duchenne muscular dystrophy and preimplantation genetic diagnosis. Hum Reprod Update 2, 531-531.
11. Albano C, Smitz J, Camus M, Riethmuller-Winzen H, Siebert-Weigel M, Diedrich K, Van Steirteghem AC, Devroey P (1996) Hormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotrophin and gonadotrophin-releasing hormone antagonist (Cetrorelix). Hum Reprod 11, 2114-2111.
12. Van der Elst J, Van den Abbeel E, Camus M, Smitz J, Devroey P, Van Steirteghem A (1996) Long-term evaluation of implantation of fresh and cryopreserved human embryos following ovarian stimulation with buserelin acetate-human menopausal gonadotrophin (HMG) or clomiphene citrate-HMG. Hum Reprod 11, 2097-2091.
13. Albano C, Smitz J, Camus M, Bennink HC, Van Steirteghem AC, Devroey P (1996) Pregnancy and birth in an in-vitro fertilization cycle after controlled ovarian stimulation in a woman with a history of allergic reaction to human menopausal gonadotrophin. Hum Reprod 11, 1632-1631.
14. Ubaldi F, Camus M, Smitz J, Bennink HC, Van Steirteghem A, Devroey P (1996) Premature luteinization in in vitro fertilization cycles using gonadotropin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulating hormone (FSH) and GnRH-a and urinary FSH. Fertil Steril 66, 275-271.
15. Bonduelle M, Legein J, Buysse A, Van Assche E, Wisanto A, Devroey P, Van Steirteghem AC, Liebaers I (1996) Prospective follow-up study of 423 children born after intracytoplasmic sperm injection. Hum Reprod 11, 1558-1551.
16. Ubaldi F, Albano C, Peukert M, Riethmuller-Winzen H, Camus M, Smitz J, Van Steirteghem A, Devroey P (1996) Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist cetrorelix in intracytoplasmic sperm injection cycles. Hum Reprod 11, 1405-1401.
17. Nagy ZP, Cecile J, Liu J, Loccufier A, Devroey P, Van Steirteghem A (1996) Pregnancy and birth after intracytoplasmic sperm injection of in vitro matured germinal-vesicle stage oocytes: case report. Fertil Steril 65, 1047-1041.
18. Wisanto A, Bonduelle M, Camus M, Tournaye H, Magnus M, Liebaers I, Van Steirteghem A, Devroey P (1996) Obstetric outcome of 904 pregnancies after intracytoplasmic sperm injection. Hum Reprod 11 Suppl 4, 121-121.
19. Lissens W, Mercier B, Tournaye H, Bonduelle M, Ferec C, Seneca S, Devroey P, Silber S, Van Steirteghem A, Liebaers I (1996) Cystic fibrosis and infertility caused by congenital bilateral absence of the vas deferens and related clinical entities. Hum Reprod 11 Suppl 4, 55-52.
20. Van Assche E, Bonduelle M, Tournaye H, Joris H, Verheyen G, Devroey P, Van Steirteghem A, Liebaers I (1996) Cytogenetics of infertile men. Hum Reprod 11 Suppl 4, 1-2.
21. Van Steirteghem A, Nagy P, Joris H, Verheyen G, Smitz J, Camus M, Tournaye H, Ubaldi F, Bonduelle M, Silber S, Liebaers I, Devroey P (1996) The development of intracytoplasmic sperm injection. Hum Reprod 11 Suppl 1, 59-52.
22. Tournaye H, Camus M, Ubaldi F, Clasen K, Van Steirteghem A, Devroey P (1996) Tubal transfer: a forgotten ART? Is there still an important role for tubal transfer procedures? Hum Reprod 11, 1815-1811.
23. Staessen C, Coonen E, Van Assche E, Tournaye H, Joris H, Devroey P, Van Steirteghem AC, Liebaers I (1996) Preimplantation diagnosis for X and Y normality in embryos from three Klinefelter patients. Hum Reprod 11, 1650-1651.
24. Silber SJ, van Steirteghem A, Nagy Z, Liu J, Tournaye H, Devroey P (1996) Normal pregnancies resulting from testicular sperm extraction and intracytoplasmic sperm injection for azoospermia due to maturation arrest. Fertil Steril 66, 110-111.
25. Devroey P, Godoy H, Smitz J, Camus M, Tournaye H, Derde MP, Van Steirteghem A (1996) Female age predicts embryonic implantation after ICSI: a case-controlled study. Hum Reprod 11, 1324-1321.
26. Devroey P, Nagy P, Tournaye H, Liu J, Silber S, Van Steirteghem A (1996) Outcome of intracytoplasmic sperm injection with testicular spermatozoa in obstructive and non-obstructive azoospermia. Hum Reprod 11, 1015-1011.
27. Novero V Jr, Goossens A, Tournaye H, Silber S, Van Steirteghem AC, Devroey P (1996) Seminoma discovered in two males undergoing successful testicular sperm extraction for intracytoplasmic sperm injection. Fertil Steril 65, 1051-1051.
28. Ubaldi F, Camus M, Tournaye H, Clasen K, Nagy Z, Smitz J, Van Steirteghem A, Devroey P (1996) Results of microsurgical epididymal sperm aspiration (MESA) ans testicular sperm extraction (TESE) in azoospermic men using intracytoplasmic sperm injection (ICSI). Andrologia 28 Suppl 1, 71-71.
29. Tournaye H, Liu J, Nagy PZ, Camus M, Goossens A, Silber S, Van Steirteghem AC, Devroey P (1996) Correlation between testicular histology and outcome after intracytoplasmic sperm injection using testicular spermatozoa. Hum Reprod 11, 127-121.

1. Tournaye H, Camus M, Goossens A, Liu J, Nagy P, Silber S, Van Steirteghem AC, Devroey P (1995) Recent concepts in the management of infertility because of non-obstructive azoospermia. Hum Reprod 10 Suppl 1, 115-111.
2. Devroey P, Tjandraprawira K, Mannaerts B, Coelingh Bennink H, Smitz J, Bonduelle M, De Brabanter A, Van Steirteghem AC (1995) A randomized, assessor-blind, group-comparative efficacy study to compare the effects of Normegon and Metrodin in infertile female patients undergoing in-vitro fertilization. Hum Reprod 10, 332-331.
3. Ron-El R, Liu J, Nagy Z, Joris H, Van den Abbeel E, Van Steirteghem A (1995) Intracytoplasmic sperm injection in the mouse. Hum Reprod 10, 2831-2831.
4. Sermon K, Lissens W, Nagy ZP, Van Steirteghem A, Liebaers I (1995) Simultaneous amplification of the two most frequent mutations of infantile Tay-Sachs disease in single blastomeres. Hum Reprod 10, 2214-2211.
5. Liu J, Lissens W, Van Broeckhoven C, Lofgren A, Camus M, Liebaers I, Van Steirteghem A (1995) Normal pregnancy after preimplantation DNA diagnosis of a dystrophin gene deletion. Prenat Diagn 15, 351-351.
6. Van der Elst J, Van den Abbeel E, Van Steirteghem AC (1995) The effect of equilibration temperature and time on the outcome of ultrarapid freezing of 1-cell mouse embryos. Hum Reprod 10, 379-371.
7. Janssenswillen C, Nagy ZP, Van Steirteghem A (1995) Maturation of human cumulus-free germinal vesicle-stage oocytes to metaphase II by coculture with monolayer Vero cells. Hum Reprod 10, 375-371.
8. Bonduelle M, Legein J, Derde MP, Buysse A, Schietecatte J, Wisanto A, Devroey P, Van Steirteghem A, Liebaers I (1995) Comparative follow-up study of 130 children born after intracytoplasmic sperm injection and 130 children born after in-vitro fertilization. Hum Reprod 10, 3327-3321.
9. Staessen C, Nagy ZP, Liu J, Janssenswillen C, Camus M, Devroey P, Steirteghem AC (1995) One year's experience with elective transfer of two good quality embryos in the human in-vitro fertilization and intracytoplasmic sperm injection programmes. Hum Reprod 10, 3305-3301.
10. Nagy ZP, Liu J, Joris H, Bocken G, Desmet B, Van Ranst H, Vankelecom A, Devroey P, Van Steirteghem AC (1995) The influence of the site of sperm deposition and mode of oolemma breakage at intracytoplasmic sperm injection on fertilization and embryo development rates. Hum Reprod 10, 3171-3171.
11. Ubaldi F, Smitz J, Wisanto A, Joris H, Schiettecatte J, Derde MP, Borkham E, Van Steirteghem A, Devroey P (1995) Oocyte and embryo quality as well as pregnancy rate in intracytoplasmic sperm injection are not affected by high follicular phase serum progesterone. Hum Reprod 10, 3091-3091.
12. Nagy ZP, Staessen C, Liu J, Joris H, Devroey P, Van Steirteghem AC (1995) Prospective, auto-controlled study on reinsemination of failed-fertilized oocytes by intracytoplasmic sperm injection. Fertil Steril 64, 1130-1131.
13. Liebaers I, Bonduelle M, Van Assche E, Devroey P, Van Steirteghem A (1995) Sex chromosome abnormalities after intracytoplasmic sperm injection. Lancet 346, 1095.
14. Brewaeys A, Devroey P, Helmerhorst FM, Van Hall EV, Ponjaert I (1995) Lesbian mothers who conceived after donor insemination: a follow-up study. Hum Reprod 10, 2731-2731.
15. Chedid S, Camus M, Smitz J, Van Steirteghem AC, Devroey P (1995) Comparison among different ovarian stimulation regimens for assisted procreation procedures in patients with endometriosis. Hum Reprod 10, 2406-2401.
16. Nagy ZP, Verheyen G, Liu J, Joris H, Janssenswillen C, Wisanto A, Devroey P, Van Steirteghem AC (1995) Results of 55 intracytoplasmic sperm injection cycles in the treatment of male-immunological infertility. Hum Reprod 10, 1775-1771.
17. Baetens P, Ponjaert-Kristoffersen I, Devroey P, Van Steirteghem AC (1995) Artificial insemination by donor: an alternative for single women. Hum Reprod 10, 1537-1531.
18. Bauer O, Devroey P, Wisanto A, Gerling W, Kaisi M, Diedrich K (1995) Small diameter laparoscopy using a microlaparoscope. Hum Reprod 10, 1461-1461.
19. Silber SJ, Van Steirteghem AC, Devroey P (1995) Sertoli cell only revisited. Hum Reprod 10, 1031-1031.
20. Verhulst G, Devroey P (1995) Endoscopic surgery in gynecologic practice. Int J Gynaecol Obstet 49, 107-101.
21. Nagy Z, Liu J, Cecile J, Silber S, Devroey P, Van Steirteghem A (1995) Using ejaculated, fresh, and frozen-thawed epididymal and testicular spermatozoa gives rise to comparable results after intracytoplasmic sperm injection. Fertil Steril 63, 808-801.
22. Sermon K, Lissens W, Devroey P, Van Steirteghem A, Liebaers I (1995) Amplification of exon 11 of the gene for the alpha-chain of beta-N-acetylhexosaminidase in single human blastomeres. Fertil Steril 63, 407-401.
23. Van der Elst J, Camus M, Van den Abbeel E, Maes R, Devroey P, Van Steirteghem AC (1995) Prospective randomized study on the cryopreservation of human embryos with dimethylsulfoxide or 1,2-propanediol protocols. Fertil Steril 63, 92-91.
24. Ubaldi F, Smitz J, Bourgain C, Van Steirteghem A, Devroey P (1995) Pregnancy and birth after high serum progesterone concentrations during the follicular phase in an in-vitro fertilization cycle with gonadotrophin-releasing hormone agonist suppression. Hum Reprod 10, 211-211.
25. Ubaldi F, Liu J, Nagy Z, Tournaye H, Camus M, Van Steirteghem A, Devroey P (1995) Indications for and results of intracytoplasmic sperm injection (ICSI). Int J Androl 18 Suppl 2, 88-81.
26. Verheyen G, De Croo I, Tournaye H, Pletincx I, Devroey P, van Steirteghem AC (1995) Comparison of four mechanical methods to retrieve spermatozoa from testicular tissue. Hum Reprod 10, 2956-2951.
27. Tournaye H, Devroey P, Camus M, Van der Linden M, Janssens R, Van Steirteghem A (1995) Use of pentoxifylline in assisted reproductive technology. Hum Reprod 10 Suppl 1, 72-71.
28. Wisanto A, Magnus M, Bonduelle M, Liu J, Camus M, Tournaye H, Liebaers I, Van Steirteghem AC, Devroey P (1995) Obstetric outcome of 424 pregnancies after intracytoplasmic sperm injection. Hum Reprod 10, 2713-2711.
29. Liu J, Nagy Z, Joris H, Tournaye H, Smitz J, Camus M, Devroey P, Van Steirteghem A (1995) Analysis of 76 total fertilization failure cycles out of 2732 intracytoplasmic sperm injection cycles. Hum Reprod 10, 2630-2631.
30. Van Steirteghem A, Tournaye H, Van der Elst J, Verheyen G, Liebaers I, Devroey P (1995) Intracytoplasmic sperm injection three years after the birth of the first ICSI child. Hum Reprod 10, 2527-2521.
31. Silber SJ, Nagy Z, Liu J, Tournaye H, Lissens W, Ferec C, Liebaers I, Devroey P, Van Steirteghem AC (1995) The use of epididymal and testicular spermatozoa for intracytoplasmic sperm injection: the genetic implications for male infertility. Hum Reprod 10, 2031-2031.
32. Devroey P, Liu J, Nagy Z, Goossens A, Tournaye H, Camus M, Van Steirteghem A, Silber S (1995) Pregnancies after testicular sperm extraction and intracytoplasmic sperm injection in non-obstructive azoospermia. Hum Reprod 10, 1457-1451.
33. Nagy ZP, Liu J, Joris H, Verheyen G, Tournaye H, Camus M, Derde MC, Devroey P, Van Steirteghem AC (1995) The result of intracytoplasmic sperm injection is not related to any of the three basic sperm parameters. Hum Reprod 10, 1123-1121.
34. Devroey P, Silber S, Nagy Z, Liu J, Tournaye H, Joris H, Verheyen G, Van Steirteghem A (1995) Ongoing pregnancies and birth after intracytoplasmic sperm injection with frozen-thawed epididymal spermatozoa. Hum Reprod 10, 903-901.
35. Liu J, Nagy Z, Joris H, Tournaye H, Devroey P, Van Steirteghem A (1995) Successful fertilization and establishment of pregnancies after intracytoplasmic sperm injection in patients with globozoospermia. Hum Reprod 10, 626-621.
36. Ubaldi F, Tournaye H, Camus M, Van der Pas H, Gepts E, Devroey P (1995) Fertility after hysteroscopic myomectomy. Hum Reprod Update 1, 81-81.
37. Ubaldi F, Tournaye H, Nagy Z, Liu J, Camus M, Smitz J, Van Steirteghem A, Devroey P (1995) Azoospermia and intracytoplasmic sperm injection. Acta Eur Fertil 26, 21-21.
38. Ubaldi F, Nagy Z, Liu J, Tournaye H, Camus M, Smitz J, Liebaers I, Devroey P, Van Steirteghem A (1995) A survey of four years of experience with intracytoplasmic sperm injection. Acta Eur Fertil 26, 7-1.
39. Silber SJ, Van Steirteghem AC, Liu J, Nagy Z, Tournaye H, Devroey P (1995) High fertilization and pregnancy rate after intracytoplasmic sperm injection with spermatozoa obtained from testicle biopsy. Hum Reprod 10, 148-141.
40. Silber SJ, Devroey P, Tournaye H, Van Steirteghem AC (1995) Fertilizing capacity of epididymal and testicular sperm using intracytoplasmic sperm injection (ICSI). Reprod Fertil Dev 7, 281-282.
41. Tournaye H, Liu J, Nagy Z, Joris H, Wisanto A, Bonduelle M, Van der Elst J, Staessen C, Smitz J, Silber S, et al. (1995) Intracytoplasmic sperm injection (ICSI): the Brussels experience. Reprod Fertil Dev 7, 269-262.

1. Tournaye H, Wieme P, Janssens R, Verheyen G, Devroey P, Van Steirteghem A (1994) Incubation of spermatozoa from asthenozoospermic semen samples with pentoxifylline and 2-deoxyadenosine: variability in hyperactivation and acrosome reaction rates. Hum Reprod 9, 2038-2031.
2. Van den Abbeel E, Van der Elst J, Van Steirteghem AC (1994) The effect of temperature at which slow cooling is terminated and of thawing rate on the survival of one-cell mouse embryos frozen in dimethyl sulfoxide or 1,2-propanediol solutions. Cryobiology 31, 423-421.
3. Van Steirteghem A (1994) IVF and micromanipulation techniques for male-factor infertility. Curr Opin Obstet Gynecol 6, 173-171.
4. Liu J, Lissens W, Silber SJ, Devroey P, Liebaers I, Van Steirteghem A (1994) Birth after preimplantation diagnosis of the cystic fibrosis delta F508 mutation by polymerase chain reaction in human embryos resulting from intracytoplasmic sperm injection with epididymal sperm. JAMA 272, 1858-1851.
5. Van Steirteghem AC, Van der Elst J, Van den Abbeel E, Joris H, Camus M, Devroey P (1994) Cryopreservation of supernumerary multicellular human embryos obtained after intracytoplasmic sperm injection. Fertil Steril 62, 775-771.
6. Staessen C, Van den Abbeel E, Janssenswillen C, Devroey P, Van Steirteghem AC (1994) Controlled comparison of Earle's balanced salt solution with Menezo B2 medium for human in-vitro fertilization performance. Hum Reprod 9, 1915-1911.
7. Bonduelle M, Desmyttere S, Buysse A, Van Assche E, Schietecatte J, Devroey P, Van Steirteghem AC, Liebaers I (1994) Prospective follow-up study of 55 children born after subzonal insemination and intracytoplasmic sperm injection. Hum Reprod 9, 1765-1761.
8. Nagy ZP, Liu J, Joris H, Devroey P, Van Steirteghem A (1994) Time-course of oocyte activation, pronucleus formation and cleavage in human oocytes fertilized by intracytoplasmic sperm injection. Hum Reprod 9, 1743-1741.
9. Silber SJ, Nagy ZP, Liu J, Godoy H, Devroey P, Van Steirteghem AC (1994) Conventional in-vitro fertilization versus intracytoplasmic sperm injection for patients requiring microsurgical sperm aspiration. Hum Reprod 9, 1705-1701.
10. Devroey P, Mannaerts B, Smitz J, Coelingh Bennink H, Van Steirteghem A (1994) Clinical outcome of a pilot efficacy study on recombinant human follicle-stimulating hormone (Org 32489) combined with various gonadotrophin-releasing hormone agonist regimens. Hum Reprod 9, 1064-1061.
11. Liu J, Lissens W, Devroey P, Van Steirteghem A, Liebaers I (1994) Amplification of X- and Y-chromosome-specific regions from single human blastomeres by polymerase chain reaction for sexing of preimplantation embryos. Hum Reprod 9, 716-711.
12. Verhulst G, Vandersteen N, van Steirteghem AC, Devroey P (1994) Bilateral salpingectomy does not compromise ovarian stimulation in an in-vitro fertilization/embryo transfer programme. Hum Reprod 9, 624-621.
13. Pados G, Camus M, Van Steirteghem A, Bonduelle M, Devroey P (1994) The evolution and outcome of pregnancies from oocyte donation. Hum Reprod 9, 538-531.
14. Bourgain C, Smitz J, Camus M, Erard P, Devroey P, Van Steirteghem AC, Kloppel G (1994) Human endometrial maturation is markedly improved after luteal supplementation of gonadotrophin-releasing hormone analogue/human menopausal gonadotrophin stimulated cycles. Hum Reprod 9, 32-31.
15. Van Steirteghem A, Liu J, Joris H, Nagy Z, Staessen C, Camus M, Wisanto A, Van Assche E, Devroey P (1994) Assisted fertilization by subzonal insemination and intracytoplasmic sperm injection. Reprod Fertil Dev 6, 85-82
16. Smitz J, Devroey P, Mannaerts B, Coeling-Bennink H, Van Steirteghem AC (1994) The use of recombinant FSH for ovulation induction. Ann Endocrinol (Paris) 55, 79-71.
17. Verheyen G, Tournaye H, Janssenswillen C, Henderix P, Devroey P, Van Steirteghem A (1994) The effect of pentoxifylline on in-vitro fertilization in the presence of anti-sperm antibodies. J Reprod Immunol 27, 187-181.
18. Tournaye H, Van der Linden M, Van den Abbeel E, Devroey P, Van Steirteghem A (1994) The effect of pentoxifylline on mouse in-vitro fertilization and early embryonic development. Hum Reprod 9, 1903-1901.
19. Tournaye H, Van der Linden M, Van den Abbeel E, Devroey P, Van Steirteghem A (1994) Mouse in vitro fertilization using sperm treated with pentoxifylline and 2-deoxyadenosine. Fertil Steril 62, 644-641.
20. Devroey P, Liu J, Nagy Z, Tournaye H, Silber SJ, Van Steirteghem AC (1994) Normal fertilization of human oocytes after testicular sperm extraction and intracytoplasmic sperm injection. Fertil Steril 62, 639-631.
21. Tournaye H, Janssens R, Verheyen G, Devroey P, Van Steirteghem A (1994) In vitro fertilization in couples with previous fertilization failure using sperm incubated with pentoxifylline and 2-deoxyadenosine. Fertil Steril 62, 574-571.
22. Tournaye H, Janssens R, Verheyen G, Camus M, Devroey P, Van Steirteghem A (1994) An indiscriminate use of pentoxifylline does not improve in-vitro fertilization in poor fertilizers. Hum Reprod 9, 1289-1281.
23. Tournaye H, Devroey P, Liu J, Nagy Z, Lissens W, Van Steirteghem A (1994) Microsurgical epididymal sperm aspiration and intracytoplasmic sperm injection: a new effective approach to infertility as a result of congenital bilateral absence of the vas deferens. Fertil Steril 61, 1045-1051.
24. Tournaye H, Van Steirteghem AC, Devroey P (1994) Pentoxifylline in idiopathic male-factor infertility: a review of its therapeutic efficacy after oral administration. Hum Reprod 9, 996-991.
25. Liu J, Nagy Z, Joris H, Tournaye H, Devroey P, Van Steirteghem AC (1994) Intracytoplasmic sperm injection does not require special treatment of the spermatozoa. Hum Reprod 9, 1127-1121.
26. Verheyen G, Tournaye H, Laurier K, Devroey P, Van Steirteghem A (1994) Auto-controlled study on in-vitro fertilization performance with 'antibody-free' spermatozoa selected by immunobead adsorption from semen of patients with anti-sperm antibodies. Hum Reprod 9, 1119-1111.
27. Van Steirteghem A, Nagy Z, Liu J, Joris H, Verheyen G, Smitz J, Tournaye H, Liebaers I, Devroey P (1994) Intracytoplasmic sperm injection. Baillieres Clin Obstet Gynaecol 8, 85-81.
28. Tournaye H, Janssens R, Devroey P, van Steirteghem A (1994) The influence of pentoxifylline on motility and viability of spermatozoa from normozoospermic semen samples. Int J Androl 17, 1-1.

1. Verheyen G, Pletincx I, Van Steirteghem A (1993) Effect of freezing method, thawing temperature and post-thaw dilution/washing on motility (CASA) and morphology characteristics of high-quality human sperm. Hum Reprod 8, 1678-1671.
2. Tournaye H, Van der Linden M, Van den Abbeel E, Devroey P, Van Steirteghem A (1993) Effect of pentoxifylline on implantation and post-implantation development of mouse embryos in vitro. Hum Reprod 8, 1948-1941.
3. Van der Elst J, Nerinckx S, Van Steirteghem AC (1993) Association of ultrarapid freezing of mouse oocytes with increased polyploidy at the pronucleate stage, reduced cell numbers in blastocysts and impaired fetal development. J Reprod Fertil 99, 25-21.
4. Liu J, Van den Abbeel E, Van Steirteghem A (1993) The in-vitro and in-vivo developmental potential of frozen and non-frozen biopsied 8-cell mouse embryos. Hum Reprod 8, 1481-1481.
5. Edwards RG, Van Steirteghem AC (1993) Intracytoplasmic sperm injections (ICSI) and human fertilization: does calcium hold the key to success? Hum Reprod 8, 988-981.
6. Liu J, Van den Abbeel E, Van Steirteghem AC (1993) Assessment of ultrarapid and slow freezing procedures for 1-cell and 4-cell mouse embryos. Hum Reprod 8, 1115-1111.
7. Van der Elst JC, Nerinckx SS, Van Steirteghem AC (1993) Slow and ultrarapid freezing of fully grown germinal vesicle-stage mouse oocytes: optimization of survival rate outweighed by defective blastocyst formation. J Assist Reprod Genet 10, 202-201.
8. Van Steirteghem AC, Van den Abbeel E (1993) Freezing of embryos: early vs late stages. J Assist Reprod Genet 10, 185-181.
9. Baker G, Brinsden P, Jouannet P, Loumaye E, Van Steirteghem A, Winston R (1993) Treatment of severe male infertility with pure follicle-stimulating hormone (FSH): the need for a properly controlled multicentre trial. Hum Reprod 8, 500-501.
10. Nagy ZP, Joris H, Liu J, Staessen C, Devroey P, Van Steirteghem AC (1993) Intracytoplasmic single sperm injection of 1-day-old unfertilized human oocytes. Hum Reprod 8, 2180-2181.
11. Wisanto A, Laureys M, Camus M, Devroey P, Verheyen G, Van Steirteghem AC (1993) Loa loa microfilariae aspirated during oocyte retrieval. Hum Reprod 8, 2096-2091.
12. Staessen C, Janssenswillen C, Van den Abbeel E, Devroey P, Van Steirteghem AC (1993) Avoidance of triplet pregnancies by elective transfer of two good quality embryos. Hum Reprod 8, 1650-1651.
13. Liu J, Lissens W, Devroey P, Van Steirteghem A, Liebaers I (1993) Polymerase chain reaction analysis of the cystic fibrosis delta F508 mutation in human blastomeres following oocyte injection of a single sperm from a carrier. Prenat Diagn 13, 873-871.
14. Verhulst G, Camus M, Bollen N, Van Steirteghem A, Devroey P (1993) Analysis of the risk factors with regard to the occurrence of ectopic pregnancy after medically assisted procreation. Hum Reprod 8, 1284-1281.
15. Delvaux G, Devroey P, De Waele B, Willems G (1993) Transvaginal removal of gallbladders with large stones after laparoscopic cholecystectomy. Surg Laparosc Endosc 3, 307-301.
16. Van Steirteghem AC, Nagy Z, Joris H, Liu J, Staessen C, Smitz J, Wisanto A, Devroey P (1993) High fertilization and implantation rates after intracytoplasmic sperm injection. Hum Reprod 8, 1061-1061.
17. Godoy H, Erard P, De Munck L, Camus M, Gepts E, Van Steirteghem AC, Devroey P (1993) Comparison of two local anaesthetics in transvaginal ultrasound-guided oocyte retrieval. Hum Reprod 8, 1093-1091.
18. Devroey P, Mannaerts B, Smitz J, Coelingh Bennink H, Van Steirteghem A (1993) First established pregnancy and birth after ovarian stimulation with recombinant human follicle stimulating hormone (Org 32489). Hum Reprod 8, 863-861.
19. Palermo G, Joris H, Derde MP, Camus M, Devroey P, Van Steirteghem A (1993) Sperm characteristics and outcome of human assisted fertilization by subzonal insemination and intracytoplasmic sperm injection. Fertil Steril 59, 826-821.
20. Liu J, Lissens W, Devroey P, Liebaers I, Van Steirteghem AC (1993) Efficiency of polymerase chain reaction assay for cystic fibrosis in single human blastomeres according to the presence or absence of nuclei. Fertil Steril 59, 815-811.
21. Staessen C, Janssenswillen C, Devroey P, Van Steirteghem AC (1993) Cytogenetic and morphological observations of single pronucleated human oocytes after in-vitro fertilization. Hum Reprod 8, 221-221.
22. Smitz J, Bourgain C, Van Waesberghe L, Camus M, Devroey P, Van Steirteghem AC (1993) A prospective randomized study on oestradiol valerate supplementation in addition to intravaginal micronized progesterone in buserelin and HMG induced superovulation. Hum Reprod 8, 40-41.
23. Brewaeys A, Ponjaert-Kristoffersen I, Van Steirteghem AC, Devroey P (1993) Children from anonymous donors: an inquiry into homosexual and heterosexual parents' attitudes. J Psychosom Obstet Gynaecol 14 Suppl, 23-21.
24. Sapienza F, Verheyen G, Tournaye H, Janssens R, Pletincx I, Derde M, Van Steirteghem A (1993) An auto-controlled study in in-vitro fertilization reveals the benefit of Percoll centrifugation to swim-up in the preparation of poor-quality semen. Hum Reprod 8, 1856-1851.
25. Van Steirteghem A, Liu J, Nagy Z, Joris H, Tournaye H, Liebaers I, Devroey P (1993) Use of assisted fertilization. Hum Reprod 8, 1784-1781.
26. Bollen N, Camus M, Tournaye H, Wisanto A, Van Steirteghem AC, Devroey P (1993) Embryo reduction in triplet pregnancies after assisted procreation: a comparative study. Fertil Steril 60, 504-501.
27. Tournaye H, Van der Linden M, Van den Abbeel E, Devroey P, Van Steirteghem A (1993) Effects of pentoxifylline on in-vitro development of preimplantation mouse embryos. Hum Reprod 8, 1475-1471.
28. Van Steirteghem AC, Liu J, Joris H, Nagy Z, Janssenswillen C, Tournaye H, Derde MP, Van Assche E, Devroey P (1993) Higher success rate by intracytoplasmic sperm injection than by subzonal insemination. Report of a second series of 300 consecutive treatment cycles. Hum Reprod 8, 1055-1051.
29. Tournaye H, Van Steirteghem A, Devroey P (1993) Semen cryobanking for men with cancer. Fertil Steril 60, 197-191.
30. Tournaye H, Camus M, Bollen N, Van Steirteghem AC, Devroey P (1993) Salpingitis and its consequences for fertility. Acta Urol Belg 61, 175-171.
31. Tournaye H, Janssens R, Camus M, Staessen C, Devroey P, Van Steirteghem A (1993) Pentoxifylline is not useful in enhancing sperm function in cases with previous in vitro fertilization failure. Fertil Steril 59, 210-211.

1. Van Blerk M, Smitz J, De Catte L, Kumps C, Van der Elst J, Van Steirteghem AC (1992) Second-trimester cancer antigen 125 and Down's syndrome. Prenat Diagn 12, 1062-1061.
2. Tournaye H, Devroey P, Camus M, Valkenburg M, Bollen N, Van Steirteghem AC (1992) Zygote intrafallopian transfer or in vitro fertilization and embryo transfer for the treatment of male-factor infertility: a prospective randomized trial. Fertil Steril 58, 344-341.
3. Nijs M, Van Blerk M, Van Steirteghem AC (1992) Activation of mouse oocytes, fertilization and development of mouse embryos in vitro after staining with trypan blue or fluorescein diacetate. Biotech Histochem 67, 351-351.
4. Chedid S, Van den Abbeel E, Van Steirteghem AC (1992) Effects of cryopreservation on survival and development of interphase- and mitotic-stage 1-cell mouse embryos. Hum Reprod 7, 1451-1451.
5. Van der Elst J, Nerinckx S, Van Steirteghem AC (1992) In vitro maturation of mouse germinal vesicle-stage oocytes following cooling, exposure to cryoprotectants and ultrarapid freezing: limited effect on the morphology of the second meiotic spindle. Hum Reprod 7, 1440-1441.
6. Van der Elst J, Van den Abbeel E, Nerinckx S, Van Steirteghem A (1992) Parthenogenetic activation pattern and microtubular organization of the mouse oocyte after exposure to 1,2-propanediol. Cryobiology 29, 549-541.
7. Aigner S, Van der Elst J, Siebzehnrubl E, Wildt L, Lang N, Van Steirteghem AC (1992) The influence of slow and ultra-rapid freezing on the organization of the meiotic spindle of the mouse oocyte. Hum Reprod 7, 857-851.
8. Devroey P, Van Steirteghem A, Mannaerts B, Coelingh Bennink H (1992) First singleton term birth after ovarian superovulation with rhFSH. Lancet 340, 1108-1101.
9. Sermon K, Lissens W, Tarlatzis B, Braude PR, Devroey P, Van Steirteghem A, Liebaers I (1992) Beta-N-acetylhexosaminidase activity in human oocytes and preimplantation embryos. Hum Reprod 7, 1278-1271.
10. Smitz J, Devroey P, Faguer B, Bourgain C, Camus M, Van Steirteghem AC (1992) A randomized prospective study comparing supplementation of the luteal phase and early pregnancy by natural progesterone administered by intramuscular or vaginal route. Rev Fr Gynecol Obstet 87, 507-501.
11. Pados G, Camus M, De Munck L, Devroey P (1992) Laparoscopic application of interceed (TC7). Hum Reprod 7, 1141-1141.
12. Pados G, Camus M, Van Waesberghe L, Liebaers I, Van Steirteghem A, Devroey P (1992) Oocyte and embryo donation: evaluation of 412 consecutive trials. Hum Reprod 7, 1111-1111.
13. Palermo G, Joris H, Devroey P, Van Steirteghem AC (1992) Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet 340, 17-11.
14. Pados GA, Devroey P (1992) Adhesions. Curr Opin Obstet Gynecol 4, 412-411.
15. Liebaers I, Sermon K, Lissens W, Liu J, Devroey P, Tarlatzis B, Van Steirteghem A (1992) Preimplantation diagnosis. Hum Reprod 7 Suppl 1, 107-101.
16. Van Steirteghem A, van den Abbeel E, Camus M, Devroey P (1992) Cryopreservation of human embryos. Baillieres Clin Obstet Gynaecol 6, 313-311
17. Liu J, Lissens W, Devroey P, Van Steirteghem A, Liebaers I (1992) Efficiency and accuracy of polymerase-chain-reaction assay for cystic fibrosis allele delta F508 in single cell. Lancet 339, 1190-1191.
18. Devroey P, van Steirteghem A, Mannaerts B, Bennink HC (1992) Successful in-vitro fertilisation and embryo transfer after treatment with recombinant human FSH. Lancet 339, 1170
19. Staessen C, Camus M, Bollen N, Devroey P, Van Steirteghem AC (1992) The relationship between embryo quality and the occurrence of multiple pregnancies. Fertil Steril 57, 626-621.
20. Palermo G, Joris H, Devroey P, Van Steirteghem AC (1992) Induction of acrosome reaction in human spermatozoa used for subzonal insemination. Hum Reprod 7, 248-241.
21. Smitz J, Devroey P, Faguer B, Bourgain C, Camus M, Van Steirteghem AC (1992) A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement. Hum Reprod 7, 168-161.
22. Bourgain C, Smitz J, Vandesteen N, Kloppel G, Devroey P, van Steirteghem AC (1992) Endometrial estrogen and progesterone receptors in cycles treated for infertility. Prog Histochem Cytochem 26, 132-131.
23. Bollen N, Camus M, Tournaye H, De Munck L, Devroey P (1992) Laparoscopic removal of benign mature teratoma. Hum Reprod 7, 1429-1421.
24. Tournaye H, Van Steirteghem A, Devroey P (1992) Pregnancy after zygote intra-fallopian transfer using spermatozoa from a patient with Kallmann's syndrome. Hum Reprod 7, 1268-1261.
25. Smitz J, Erard P, Camus M, Devroey P, Tournaye H, Wisanto A, Van Steirteghem AC (1992) Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol. Hum Reprod 7, 1225-1221.
26. Smitz J, Van Den Abbeel E, Bollen N, Camus M, Devroey P, Tournaye H, Van Steirteghem AC (1992) The effect of gonadotrophin-releasing hormone (GnRH) agonist in the follicular phase on in-vitro fertilization outcome in normo-ovulatory women. Hum Reprod 7, 1098-1091.
27. Tournaye H, Devroey P, Camus M, Staessen C, Bollen N, Smitz J, Van Steirteghem AC (1992) Comparison of in-vitro fertilization in male and tubal infertility: a 3 year survey. Hum Reprod 7, 218-211.

1. Tournaye H, Camus M, Khan I, Staessen C, Van Steirteghem AC, Devroey P (1991) In-vitro fertilization, gamete- or zygote intra-fallopian transfer for the treatment of male infertility. Hum Reprod 6, 263-261.
2. Tournaye H, Camus M, Bollen N, Wisanto A, Van Steirteghem AC, Devroey P (1991) In vitro fertilization techniques with frozen-thawed sperm: a method for preserving the progenitive potential of Hodgkin patients. Fertil Steril 55, 443-441.
3. Palermo G, Van Steirteghem A (1991) Enhancement of acrosome reaction and subzonal insemination of a single spermatozoon in mouse eggs. Mol Reprod Dev 30, 339-331.
4. Van Blerk M, Nijs M, Van Steirteghem AC (1991) Decompaction and biopsy of late mouse morulae: assessment of in-vitro and in-vivo developmental potential. Hum Reprod 6, 1298-1291.
5. Van Blerk M, Lissens W, Nijs M, Van der Linden M, Van Steirteghem AC, Liebaers I (1991) Beta-glucuronidase activity in mouse oocytes, mouse preimplantation embryos, and human gametes. Prenat Diagn 11, 509-501.
6. Sermon K, Nijs M, Lissens W, Van Steirteghem AC, Liebaers I (1991) Beta-N-acetylhexosaminidase activity in mouse oocytes and preimplantation embryos. Hum Reprod 6, 280-281.
7. Khan I, Staessen C, Devroey P, Van Steirteghem AC (1991) Human serum albumin versus serum: a comparative study on embryo transfer medium. Fertil Steril 56, 98-91.
8. Bollen N, Camus M, Staessen C, Tournaye H, Devroey P, Van Steirteghem AC (1991) The incidence of multiple pregnancy after in vitro fertilization and embryo transfer, gamete, or zygote intrafallopian transfer. Fertil Steril 55, 314-311.
9. Smitz J, Camus M, Devroey P, Bollen N, Tournaye H, Van Steirteghem AC (1991) The influence of inadvertent intranasal buserelin administration in early pregnancy. Hum Reprod 6, 290-291.

1. Nijs M, Van Steirteghem A (1990) Developmental potential of biopsied mouse blastocysts. J Exp Zool 256, 232-231.
2. Smitz J, Camus M, Devroey P, Erard P, Wisanto A, Van Steirteghem AC (1990) Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist/HMG superovulation for in-vitro fertilization. Hum Reprod 5, 933-931.
3. Bourgain C, Devroey P, Van Waesberghe L, Smitz J, Van Steirteghem AC (1990) Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure. Hum Reprod 5, 537-531.
4. Smitz J, Devroey P, Van Steirteghem AC (1990) Endocrinology in luteal phase and implantation. Br Med Bull 46, 709-701.
5. Staessen C, Van den Abbeel E, Carle M, Khan I, Devroey P, Van Steirteghem AC (1990) Comparison between human serum and Albuminar-20 (TM) supplement for in-vitro fertilization. Hum Reprod 5, 336-331.
6. Smitz J, Bollen N, Camus M, Devroey P, Wisanto A, Van Steirteghem AC (1990) Short-term use of buserelin in combination with human menopausal gonadotrophins for ovarian stimulation for in-vitro fertilization in endocrinologically normal women. Hum Reprod 5, 157-151.
7. Devroey P, Camus M, Palermo G, Smitz J, Van Waesberghe L, Wisanto A, Wijbo I, Van Steirteghem AC (1990) Placental production of estradiol and progesterone after oocyte donation in patients with primary ovarian failure. Am J Obstet Gynecol 162, 66-61.
8. Devroey P, Camus M, Godoy H, Staessen C, Tournaye H, Van Steirteghem AC (1990) Curreny results of GIFT and ZIFT. Rev Prat 40, 2703-2701.

1. Khan I, Staessen C, Van den Abbeel E, Camus M, Wisanto A, Smitz J, Devroey P, Van Steirteghem AC (1989) Time of insemination and its effect on in-vitro fertilization, cleavage and pregnancy rates in GnRH agonist/HMG-stimulated cycles. Hum Reprod 4, 921-921
2. Palermo G, Devroey P, Camus M, Khan I, Wisanto A, Van Steirteghem AC (1989) Assisted procreation in the presence of a positive direct mixed antiglobulin reaction test. Fertil Steril 52, 645-641.
3. Brewaeys A, Olbrechts H, Devroey P, Van Steirteghem AC (1989) Counselling and selection of homosexual couples in fertility treatment. Hum Reprod 4, 850-851.
4. Wisanto A, Bollen N, Camus M, De Grauwe E, Devroey P, Van Steirteghem AC (1989) Effect of transuterine puncture during transvaginal oocyte retrieval on the results of human in-vitro fertilization. Hum Reprod 4, 790-791.
5. Devroey P, Camus M, van den Abbeel E, van Waesberghe L, Wisanto A, van Steirteghem AC (1989) Establishment of 22 pregnancies after oocyte and embryo donation. Br J Obstet Gynaecol 96, 900-901.
6. Hens L, Devroey P, Van Waesberghe L, Bonduelle M, Van Steirteghem AC, Liebaers I (1989) Chromosome studies and fertility treatment in women with ovarian failure. Clin Genet 36, 81-81.
7. Louis O, Devroey P, Kalender W, Osteaux M (1989) Bone loss in young hypoestrogenic women due to primary ovarian failure: spinal quantitative computed tomography. Fertil Steril 52, 227-221.
8. Devroey P, Staessen C, Camus M, De Grauwe E, Wisanto A, Van Steirteghem AC (1989) Zygote intrafallopian transfer as a successful treatment for unexplained infertility. Fertil Steril 52, 246-241.
9. Wisanto A, Janssens R, Deschacht J, Camus M, Devroey P, Van Steirteghem AC (1989) Performance of different embryo transfer catheters in a human in vitro fertilization program. Fertil Steril 52, 79-71.
10. Palermo G, Devroey P, Camus M, De Grauwe E, Khan I, Staessen C, Wisanto A, Van Steirteghem AC (1989) Zygote intra-fallopian transfer as an alternative treatment for male infertility. Hum Reprod 4, 412-411.
11. Devroey P, Palermo G, Bourgain C, Van Waesberghe L, Smitz J, Van Steirteghem AC (1989) Progesterone administration in patients with absent ovaries. Int J Fertil 34, 188-181.
12. Khan I, Devroey P, Van den Bergh M, Camus M, Wisanto A, Staessen C, Smitz J, Van Steirteghem A (1989) The effect of pneumoperitoneum gases on fertilization, cleavage and pregnancy in human in-vitro fertilization and gamete intra-fallopian transfer. Hum Reprod 4, 323-321.
13. Devroey P, Smitz J, Camus M, Wisanto A, Deschacht J, Van Waesberghe L, Van Steirteghem AC (1989) Synchronization of donor's and recipient's cycles with GnRH analogues in an oocyte donation programme. Hum Reprod 4, 270-271.
14. Camus M, Van den Abbeel E, Van Waesberghe L, Wisanto A, Devroey P, Van Steirteghem AC (1989) Human embryo viability after freezing with dimethylsulfoxide as a cryoprotectant. Fertil Steril 51, 460-461.
15. Staessen C, Camus M, Khan I, Smitz J, Van Waesberghe L, Wisanto A, Devroey P, Van Steirteghem AC (1989) An 18-month survey of infertility treatment by in vitro fertilization, gamete and zygote intrafallopian transfer, and replacement of frozen-thawed embryos. J In Vitro Fert Embryo Transf 6, 22-21.

1. Nijs M, Camus M, Van Steirteghem AC (1988) Evaluation of different biopsy methods of blastomeres from 2-cell mouse embryos. Hum Reprod 3, 999-991.
2. Van der Elst J, Van den Abbeel E, Jacobs R, Wisse E, Van Steirteghem A (1988) Effect of 1,2-propanediol and dimethylsulphoxide on the meiotic spindle of the mouse oocyte. Hum Reprod 3, 960-961.
3. Bonduelle ML, Dodd R, Liebaers I, Van Steirteghem A, Williamson R, Akhurst R (1988) Chorionic gonadotrophin-beta mRNA, a trophoblast marker, is expressed in human 8-cell embryos derived from tripronucleate zygotes. Hum Reprod 3, 909-901.
4. Van Steirteghem AC, van den Abbeel E (1988) Survey on cryopreservation. Ann N Y Acad Sci 541, 571-571.
5. Khan I, Camus M, Staessen C, Wisanto A, Devroey P, Van Steirteghem AC (1988) Success rate in gamete intrafallopian transfer using low and high concentrations of washed spermatozoa. Fertil Steril 50, 922-921.
6. Devroey P, Braeckmans P, Camus M, Khan I, Smitz J, Staessen C, Van den Abbeel E, Van Waesberghe L, Wisanto A, Van Steirteghem AC (1988) Embryo donation in patients with primary ovarian failure. Hum Reprod 3 Suppl 2, 85-81.
7. Van den Abbeel E, Van der Elst J, Van Waesberghe L, Camus M, Devroey P, Khan I, Smitz J, Staessen C, Wisanto A, Van Steirteghem A (1988) Hyperstimulation: the need for cryopreservation of embryos. Hum Reprod 3 Suppl 2, 53-51.
8. Smitz J, Devroey P, Camus M, Khan I, Staessen C, Van Waesberghe L, Wisanto A, Van Steirteghem AC (1988) Addition of Buserelin to human menopausal gonadotrophins in patients with failed stimulations for IVF or GIFT. Hum Reprod 3 Suppl 2, 35-31.
9. Van Steirteghem AC, Van Waesberghe L, Camus M, Deschacht J, Devroey P, Smitz J, Wisanto A (1988) Hormonal monitoring for in-vitro fertilization and related procedures. Hum Reprod 3 Suppl 2, 1-1.
10. Smitz J, Devroey P, Camus M, Deschacht J, Van Waesberghe L, Wisanto A, Van Steirteghem AC (1988) Inhibition of gonadotropic and ovarian function by intranasal administration of D-Ser (TBU)6-EA10-LHRH in normo-ovulatory women and patients with polycystic ovary disease. J Endocrinol Invest 11, 647-641.
11. Devroey P, Wisanto A, Camus M, Van Waesberghe L, Bourgain C, Liebaers I, Van Steirteghem AC (1988) Oocyte donation in patients without ovarian function. Hum Reprod 3, 699-691.
12. Verbessem D, Camu F, Devroey P, Van Steirteghem A (1988) Pneumoperitoneum induced pH changes in follicular and Douglas fluids during laparoscopic oocyte retrieval in humans. Hum Reprod 3, 751-751.
13. Smitz J, Devroey P, Camus M, Deschacht J, Khan I, Staessen C, Van Waesberghe L, Wisanto A, Van Steirteghem AC (1988) The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT. Hum Reprod 3, 585-581.
14. Hens L, Bonduelle M, Liebaers I, Devroey P, Van Steirteghem AC (1988) Chromosome aberrations in 500 couples referred for in-vitro fertilization or related fertility treatment. Hum Reprod 3, 451-451.
15. Wisanto A, Braeckmans P, Camus M, Devroey P, Khan I, Staessen C, Smitz J, Van Waesberghe L, Van Steirteghem AC (1988) Perurethral ultrasound-guided ovum pickup. J In Vitro Fert Embryo Transf 5, 107-101.
16. Van Steirteghem AC, Smitz J, Camus M, Van Waesberghe L, Deschacht J, Khan I, Staessen C, Wisanto A, Bourgain C, Devroey P (1988) The luteal phase after in-vitro fertilization and related procedures. Hum Reprod 3, 161-161.
17. Noppen M, Velkeniers B, Buydens P, Devroey P, Van Steirteghem A, Vanhaelst L (1988) Hyperthyroidism after gonadotrophic ovarian stimulation. Br Med J (Clin Res Ed) 296, 171-171.
18. Deschacht J, Devroey P, Camus M, Khan I, Smitz J, Staessen C, Van Waesberghe L, Wisanto A, Van Steirteghem AC (1988) In-vitro fertilization with husband and donor sperm in patients with previous fertilization failures using husband sperm. Hum Reprod 3, 105-101.
19. Devroey P, Smitz J, Wisanto A, Braeckmans P, Camus M, Khan I, Staessen C, van den Abbeel E, van Waesberghe L, van Steirteghem AC (1988) Primary ovarian failure. Embryo donation after substitution therapy. Ann N Y Acad Sci 541, 755-751.
20. Goes E, Keymolen K, Claes H, Wissanto A, Braeckman P, Camu M, Devroey P, Osteaux M (1988) Echography in the infertility clinic. J Belge Radiol 71, 347-341.

1. Van Steirteghem AC, Van den Abbeel E, Camus M, Van Waesberghe L, Braeckmans P, Khan I, Nijs M, Smitz J, Staessen C, Wisanto A, et al. (1987) Cryopreservation of human embryos obtained after gamete intra-Fallopian transfer and/or in-vitro fertilization. Hum Reprod 2, 593-591.
2. Nijs M, Van Steirteghem AC (1987) Assessment of different isolation procedures for blastomeres from two-cell mouse embryos. Hum Reprod 2, 421-421.
3. Van den Abbeel E, Van Steirteghem AC (1987) Cryopreservation of in vitro cultured mouse preimplantation embryos. Ann Biol Clin (Paris) 45, 460-461
4. Pierard D, Van Waesberghe L, Smitz J, Van Steirteghem AC (1987) Evaluation of five commercially available direct radio-immunoassays for the determination of 17 beta-estradiol in serum for the hormonal monitoring of ovarian stimulation. Ann Biol Clin (Paris) 45, 444-441.
5. Van Steirteghem AC, Van den Abbeel E, Braeckmans P, Camus M, Khan I, Smitz J, Staessen C, Van Waesberghe L, Wisanto A, Devroey P (1987) Pregnancy with a frozen-thawed embryo in a woman with primary ovarian failure. N Engl J Med 317, 113.
6. Smitz J, Devroey P, Braeckmans P, Camus M, Khan I, Staessen C, Van Waesberghe L, Wisanto A, Van Steirteghem AC (1987) Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analogue and HMG. Hum Reprod 2, 309-301.
7. Braeckmans P, Devroey P, Camus M, Khan I, Staessen C, Smitz J, Van Waesberghe L, Wisanto A, Van Steirteghem AC (1987) Gamete intra-Fallopian transfer: evaluation of 100 consecutive attempts. Hum Reprod 2, 201-201.
8. Heytens L, Devroey P, Camu F, Van Steirteghem AC (1987) Effects of etomidate on ovarian steroidogenesis. Hum Reprod 2, 85-81.
9. Naaktgeboren N, Devroey P, Wisanto A, Van Steirteghem AC (1987) Pregnancies without corpus luteum rescue. Ann Biol Clin (Paris) 45, 456-451.
10. Devroey P, Braeckmans P, Camus M, Khan I, Smith J, Staessen C, Van den Abbeel E, Van Waesberghe L, Wisanto A, Van Steirteghem AC (1987) Gamete intra-fallopian transfer versus in vitro fertilization and embryo transfer in endometriosis. Contrib Gynecol Obstet 16, 332-331.
11. Devroey P, Wisanto A, Smitz J, Braeckmans P, Van Waesberghe L, Van Steirteghem AC (1987) Ovarian stimulation, including in vitro fertilisation. Ann Biol Clin (Paris) 45, 346-341.

1. Hoing LM, Devroey P, Van Steirteghem AC (1986) Treatment of infertility because of oligoasthenoteratospermia by transcervical intrauterine insemination of motile spermatozoa. Fertil Steril 45, 388-381.
2. Devroey P, Braeckmans P, Smitz J, Van Waesberghe L, Wisanto A, Van Steirteghem A, Heytens L, Camu F (1986) Pregnancy after translaparoscopic zygote intrafallopian transfer in a patient with sperm antibodies. Lancet 1, 1329.
3. Temmerman M, Cammu H, Devroey P, Amy JJ (1986) Evaluation of one-hundred open-ended vasectomies. Contraception 33, 529-521.
4. Naessens A, Foulon W, Debrucker P, Devroey P, Lauwers S (1986) Recovery of microorganisms in semen and relationship to semen evaluation. Fertil Steril 45, 101-101.
5. Heip J, Liu Y, Devroey P, Naaktgeboren N, Van Steirteghem AC (1986) Evaluation of radioimmunoassays using mono- and polyclonal antibodies for the quantitation of human chorionic gonadotropin in early pregnancy. Ann Biol Clin (Paris) 44, 131-131.
6. Naaktgeboren N, Devroey P, Wisanto A, Traey E, Van Steirteghem AC (1986) Endocrine profiles in early pregnancies with delayed implantation. Hum Reprod 1, 9-1.

1. Naaktgeboren N, Devroey P, Traey E, Wisanto A, Van Steirteghem AC (1985) Success of in vitro fertilization and embryo transfer in relation to the causes of infertility. Acta Eur Fertil 16, 281-281.
2. Devroey P, Naaktgeboren N, Traey E, Wisanto A, Van Steirteghem AC (1985) Follicular rupture changes the endocrine profile of peritoneal fluid. Acta Eur Fertil 16, 237-231.
3. Devroey P, Temmerman M, Naaktgeboren N, Van Steirteghem AC (1985) Ovarian adhesions impair ovulation. Acta Eur Fertil 16, 183-181.
4. Naaktgeboren N, Devroey P, van Steirteghem AC (1985) Successful in vitro fertilization with sperm cells from a man with immune infertility. Ann N Y Acad Sci 442, 304-301.

1. Liu Y, Naaktgeboren N, Heip J, Devroey P, Temmerman M, Verhoeven N, Van Steirteghem AC (1984) Evaluation of commercially available radioimmunoassays for the determination of luteinizing hormone in serum and urine. Application for the detection of endogenous rise of luteinizing hormone in a in vitro fertilization program. Ann Biol Clin (Paris) 42, 419-411
2. Temmerman M, Devroey P, Naaktgeboren N, Amy JJ, Van Steirteghem AC (1984) Incidence, recurrence and treatment of the luteinized unruptured follicle syndrome. Acta Eur Fertil 15, 179-171.